0001121781-13-000363.txt : 20130923 0001121781-13-000363.hdr.sgml : 20130923 20130923171727 ACCESSION NUMBER: 0001121781-13-000363 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20121031 FILED AS OF DATE: 20130923 DATE AS OF CHANGE: 20130923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDCAREERS GROUP, Inc. CENTRAL INDEX KEY: 0001438901 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 261580812 STATE OF INCORPORATION: NV FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-152444 FILM NUMBER: 131110675 BUSINESS ADDRESS: STREET 1: 758 E. BETHEL SCHOOL RD. CITY: COPPELL STATE: TX ZIP: 75019 BUSINESS PHONE: 9723935892 MAIL ADDRESS: STREET 1: 758 E. BETHEL SCHOOL RD. CITY: COPPELL STATE: TX ZIP: 75019 FORMER COMPANY: FORMER CONFORMED NAME: Rx Scripted, Inc. DATE OF NAME CHANGE: 20080630 10-Q 1 mcgi10q103112.htm MEDCAREERS GROUP, INC.

 

United States

Securities and Exchange Commission

Washington, D.C. 20549

 

FORM 10-Q

 

 

(Mark One)

 

[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 31, 2012

 

OR

 

[ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934

 

From the transition period ___________ to ____________.

 

Commission File Number  333-152444

 

MEDCAREERS GROUP, INC.

(Exact name of small business issuer as specified in its charter)

 

Nevada 7389 26-1580812
(State or jurisdiction of incorporation or organization) 

(Primary Standard Industrial

Classification Code Number)

(IRS Employer

Identification No.) 

 

758 E Bethel School Road, Coppell, Texas 75019

(Address of principal executive offices)

 

(972) 393-5892

(Issuer's telephone number)

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:

Yes [  ] No [X ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes  ¨    No  x

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Large Accelerated Filer   [  ]     Accelerated Filer   [  ]
Non-Accelerated Filer [  ]     Smaller Reporting Company [X]

  

Indicate by a check mark whether the company is a shell company (as defined by Rule 12b-2 of the Exchange Act:

 

Yes [ ] No [X ].

 

As of September 5, 2013, there were 52,708,863 shares of Common Stock of the issuer outstanding.

 

1
 

TABLE OF CONTENTS

 

 

     
PART I. FINANCIAL STATEMENTS  
     
ITEM 1. Financial Statements 3
 

 

Notes to Financial Statements

7
   
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 12

 

ITEM 3.

 

Quantitative and Qualitative Disclosure About Market Risk

17
     
ITEM 4. Controls and Procedures 17
     
     
PART II. OTHER INFORMATION  
     
ITEM 1. Legal Proceedings 18
     
ITEM 1A. Risk Factors 18
     
ITEM 2. Unregistered Sales of Securities and Use of Proceeds 18
     
ITEM 3. Default Upon Senior Securities 23
     
ITEM 4. Mine Safety Disclosures 24
     
ITEM 5. Other Information 24
     
ITEM 6. Exhibits 24
     
     
     
     
     

 

2
 

 

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Consolidated Balance Sheets

October 31, 2012 and January 31, 2012

(Unaudited)

 

 

 

   As of
October 31, 2012
  As of
January 31, 2012
Assets  
Current Assets          
  Cash and Cash Equivalents  $5,215   $912 
           
Property, Plant & Equipment          
  Equipment   1,799    1,799 
  Less: Accumulated Amortization   (1,799)   (1,799)
    Total Fixed Assets   0    0 
           
Other Assets          
  Deferred Fees (net)   148,987    113,833 
  Deposits   0    0 
           
Total Assets  $154,602   $114,745 
           
Liabilities and Stockholders’ Equity  
Current Liabilities          
  Accounts Payable  $6,718   $6,718 
  Accrued Expenses   22,633    22,471 
  Due to Related Parties   158,058    74,394 
  Accrued Interest Payable   86,915    36,045 
  Current Portion of Long Term Debt   540,650    495,000 
    Total Current Liabilities   814,974    634,628 
           
Long Term Liabilities          
  Notes Payable   565,650    520,000 
  Less: Current Portion   (540,650)   (495,000)
    Total Long Term Liabilities   25,000    25,000 
           
  Total Liabilities   839,974    659,628 
           
Stockholders’ Equity          
Preferred Stock, $0.001 par value, 10,000,000 shares, none outstanding          
Common Stock, $0.001 par value, 350,000,000 shares,          
   48,125,028 and 43,315,000 shares issued and outstanding   48,126    43,315 
           
Additional Paid In Capital   3,500,013    2,819,470 
Accumulated (Deficit)   (4,233,511)   (3,407,668)
Total Stockholders’ Equity (Deficit)   (685,372)   (544,883)
           
Total Liabilities and Stockholders’ Equity  $154,602   $114,745 

 

 

 

The Accompanying Notes are an Integral Part of these Financial Statements.

 

3
 

 

 

 

  

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Consolidated Statement of Operations

For the Three and Nine Months Ended October 31, 2012 and 2011, and

Cumulative Since Re-Entering the Development Stage January 1, 2009

(Unaudited)

 

 

 

 

 

   Three Months Ended  Nine Months Ended  Cumulative Since Re-entering the Development Stage,
January 1, 2009
   October 31, 2012  October 31, 2011  October 31, 2012  October 31, 2011   
                
  Revenue  $8,040   $3,265   $13,990   $20,153   $35,001 
  Cost of Sales   7,430    12,623    23,128    38,447    94,428 
  Gross Profit (Loss)   610    (9,358)   (9,138)   (18,294)   (59,427)
                          
Operating Expenses:                         
   Depreciation and Amortization   54,825    45,493    274,816    146,399    491,010 
   Selling and Marketing   7,712    5,897    21,129    24,748    65,024 
   General and Administrative   96,974    23,812    470,174    81,401    2,398,674 
    Total Operating Expenses   159,511    75,202    766,119    252,548    2,954,908 
                          
Net Operating Loss   (158,901)   (84,560)   (775,257)   (270,842)   (3,014,135)
                          
Other Income (Expense)                         
    Loss on Sale of Assets   0    (4,087)   0    (4,087)   (4,087)
    Loss on Recapitalization   0    0    0    0    (223,454)
    Interest Expense   (17,760)   (12,124)   (50,586)   (37,471)   (318,934)
    Total Other Income (Expense)   (17,760)   (16,211)   (50,586)   (41,558)   (546,4755)
                          
Net Loss  $(176,661)  $(100,771)  $(825,843)  $(312,400)  $(3,560,610)
                          
Basic and Diluted Earnings (Loss) per share  $(0.00)  $(0.00)  $(0.02)  $(0.01)     
                          
Weighted Average Shares Outstanding:                         
Basic and Diluted   47,256,131    40,840,000    45,016,265    40,838,974      
                          
                          

 

 

 

 

The Accompanying Notes are an Integral Part of these Financial Statements.

 

 

 

4
 

 

 

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Consolidated Statement of Changes in Stockholders’ Equity

For the Nine Months Ended October 31, 2012 and

For the Year Ended January 31, 2012

(Unaudited)

  

               
    Common Stock    Paid-In    Retained Earnings 
    Shares    Amount    Capital    (Deficit)    Totals 
                          
Balance, January 31, 2011   40,700,000   $40,700   $2,668,718   $(2,908,905)  $(199,487)
                          
Issuance of Common Stock for Services   25,000    25    2,475         2,500 
Issuance of Common Stock for Deferred Fees   2,590,000    2,590    140,610         143,200 
                          
Stock Option Expense             7,667         7,667 
                          
Net (Loss)                  (498,763)   (498,763)
                          
Balance, January 31, 2012   43,315,000   $43,315   $2,819,470   $(3,407,668)  $(544,883)
                          
Issuance of Common Stock for Cash   1,220,000    1,220    120,780         122,000 
Issuance of Common Stock for Services   750,000    750    74,250         50,000 
Issuance of Common Stock for Deferred Fees   2,840,528    2,841    307,129         309,970 
                          
Stock Option Expense             178,384         178,384 
                          
Net (Loss)                  (825,843)   (825,843)
                          
Balance, October 31, 2012   48,125,548   $48,126   $3,500,013   $(4,233,511)  $(685,372)

 

 

 

The Accompanying Notes are an Integral Part of these Consolidated Financial Statements.

 

 

5
 

 

 

 

 

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Consolidated Statements of Cash Flows

For the Nine Months Ended October 31, 2012 and 2011, and

Cumulative Since Re-Entering the Development Stage January 1, 2009

(Unaudited)

 

 

 

 


  Nine Months Ended October 31, 2012  Nine Months Ended October 31, 2011  Cumulative Since Re-Entering the Development Stage,
January 1, 2009
CASH FLOWS FROM OPERATING ACTIVITIES               
                
Net Income (Loss)  $(825,843)  $(312,400)  $(3,560,610)
                
Adjustments to reconcile net deficit to cash used
by operating activities:
               
    Depreciation and Amortization of Property and Equipment   0    17,2496    25,826 
    Amortization of Deferred Fees   274,816    129,150    465,183 
    Common Stock Issued for Services   75,000    0    165,000 
    Stock Option Expense   178,384    0    1,686,034 
Change in Assets and Liabilities:               
  (Increase) Decrease in Other Current Assets   (400)   0    59,794 
  (Increase) Decrease in Other Assets   0    (1,280)   0 
  Increase (Decrease) in Accounts Payable   0    0    14,938 
  Increase (Decrease) in Accrued Expenses   51,032    35,778    100,710 
  Increase (Decrease) in Due to Related Party   83,664    9,494    158,058 
  Increase (Decrease) in Other Liabilities   0    0    0 
CASH FLOWS USED BY OPERATING ACTIVITIES   (163,347)   (122,009)   (885,067)
CASH FLOWS FROM INVESTING ACTIVITIES               
  Proceeds from Disposal of Fixed Assets   0    191,026    191,026 
  Purchase of Fixed Assets   0    0    (215,543)
CASH FLOWS (USED IN) INVESTING ACTIVITIES   0    191,026    (24,427)
                
CASH FLOWS FROM FINANCING ACTIVITIES               
  Proceeds from Notes Payable   46,650    155,000    540.650 
  Payments on Notes Payable   0    (7,173)   (35,731)
  Proceeds from Sale of Common Stock   122,000    0    122,000 
  Debt Assumed on Acquisition   0    0    246,670 
  Debt Assumed by Buyer on Asset Sale   0    (185,939)   (185,939)
  Interest Added to Notes Payable   0    0    209,429 
  Common Stock Issued on Recapitalization   0    0    16,000 
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES   167,650    (38,112)   913,079 
                
NET DECREASE IN CASH   4,302    30,905    3,584 
Cash, beginning of period   912    1,124    1,630 
Cash, end of period  $5,215   $32,029   $5,215 
                
SUPPLEMENTAL CASH FLOW INFORMATION               
Interest paid  $0   $6,943   $21,693 
Taxes paid  $0   $0   $0 
Issuance of Common Stock for Services  $75,000   $0   $165,000 
Issuance of Common Stock for Debt  $0   $0   $884,741 
Issuance of Common Stock for Fees  $309,970   $11,200   $614,170 

 

The Accompanying Notes are an Integral Part of these Financial Statements.

 

6
 

 

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Notes to Financial Statements

October 31, 2012 and January 31, 2012

 

 

NOTE 1 – NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Activities, History and Organization – The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007.  On December 16, 2009, an amendment was filed with the State of Nevada to change the name to “MedCareers Group, Inc.” (the “Company” or “MedCareers”) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its common stock in exchange for 100% of Nurses Lounge, Inc. (“Nurses Lounge”), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly owned subsidiary of MedCareers. As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers. The transaction was accounted for as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company. The share exchange was treated as a recapitalization of MedCareers. As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital  The Company operates a website for nurses, nursing schools and nurses organizations which enables the respective entities to communicate more easily and efficiently with their members.

 

Significant Accounting Policies:

 

The Company’s management selects accounting principles generally accepted in the United States of America and adopts methods for their application.  The application of accounting principles requires the estimating, matching and timing of revenue and expense. The accounting policies used conform to generally accepted accounting principles which have been consistently applied in the preparation of these financial statements.

 

The financial statements and notes are representations of the Company’s management which is responsible for their integrity and objectivity. Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud.  The Company's system of internal  accounting control is designed to assure, among other items, that  1) recorded  transactions  are valid;  2) valid  transactions  are recorded;  and  3) transactions  are  recorded in the proper  period in a timely  manner to produce financial  statements which present fairly the financial  condition,  results of operations  and cash  flows of the  Company  for the  respective  periods  being presented.

 

Basis of Presentation:

 

The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States.

 

Principles of Consolidation:

 

The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc. All significant inter-company transactions have been eliminated.  All amounts are presented in U.S. Dollars unless otherwise stated.

 

Reclassifications – Certain prior year amounts have been reclassified to conform with the current year presentation.  Specifically, additional paid-in capital has been reclassified to show the effect of a forward 10 for 1 stock split effective January 7, 2010.

 

7
 

 

 

Cash and Cash Equivalents:

 

The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents.  At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits.  The carrying amount approximates fair market value.

 

Fixed Assets:

 

Fixed assets are carried at cost.  Depreciation is provided over each asset’s estimated useful life.  Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income.   Additions and significant improvements are capitalized and depreciated.

 

Advertising Costs:

 

The Company incurred no advertising costs for the periods ended October 31, 2012 and 2011.

 

Income Taxes:

 

Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code.  Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration.  Accordingly, the future income tax asset amounts have been fully offset by a valuation allowance.

 

Use of Estimates:

 

In order to prepare financial statement in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determines whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based.

 

Income Taxes – Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

Fair Value of Financial Instruments – Pursuant to ASC No. 820, “Fair Value Measurements and Disclosures”, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of October 31, 2012 and January 31, 2012.  The Company’s financial instruments consist of cash, accounts payable, advances and notes payable.  The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments.

 

Stock Split - On January 4, 2010, MedCareers approved a 10 for 1 forward stock split on its issued and outstanding shares of common stock to the holders of record as of January 7, 2010. The accompanying financial statements and related notes thereto have been adjusted accordingly to reflect this forward stock split retroactively.

 

Reclassifications – Certain prior year amounts have been reclassified to conform with the current year presentation.

 

8
 

 

 

Net Loss Per Share – Basic earnings (loss) per share equals net income (loss) divided by weighted average shares outstanding during the year.  Diluted earnings per share include the impact on dilution from all contingently issuable shares, including options, warrants and convertible securities.  As of October 31, 2012 and January 31, 2012, MedCareers did not have any outstanding contingently issuable shares.

 

Revenue Recognition – Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned.  The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured.  For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "Revenue Recognition in Financial Statements", (formerly Staff Accounting Bulletin No. 104 (“SAB 104”).   Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable.

 

Development Stage Company – The Company complies with Accounting Codification Standard 915-10 for its characterization of the Company as development stage.

 

Earnings per Common Share:

 

Earnings (loss) per share are calculated in accordance with ASC 260 “Earnings per Share”.   The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share.  Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding.   Dilutive potential common shares are additional common shares assumed to be exercised.     Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive.

 

There were no potentially dilutive common stock equivalents as of January 31, 2012, therefore basic earnings per share equals diluted earnings per share for the year ended January 31, 2012.  The Company had 6,127,500 options outstanding at January 31, 2012. As the Company incurred a net loss during the year ended January 31, 2012, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive.

 

As the Company incurred a net loss during the period ended October 31, 2012, the basic and diluted loss per common share is the same amount.   As of October 31, 2012, the Company had 7,743,000 stock options outstanding of which zero options could potentially have a dilutive effect on basic earnings per share in the future. As the Company incurred a net loss during the period ended October 31, 2012, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive.

 

Recently Issued Accounting Pronouncements:

 

The Company  does not expect  the  adoption  of  recently  issued  accounting pronouncements  to have a significant  impact on the Company’s  results of  operations, financial position or cash flow.  See Note 12 for a discussion of new accounting pronouncements.

 

NOTE 2 – DEFERRED FEES

 

Deferred fees represent stock issued as fees to make or extend notes payable. Stock issued was valued at the date of issue and amortized over the term of the loan. Deferred fees at October 31, 2012 and January 31, 2012 were as follows:

 

   October 31, 2012  January 31, 2012
Deferred Fees – Net  $148,987   $113,833 

 

 

9
 

 

NOTE 3 - DUE TO RELATED PARTIES

 

As of January 31, 2010, MedCareers Group, Inc. was advanced funds from its current Chief Executive Officer for operations. On November 5, 2010, the date of the merger between the Company and Nurses Lounge, Inc., all balances were cancelled or assumed by the current Chief Executive Officer. The balance of these advanced funds was $128,308 and $74,394 on October 31, 2012 and January 31, 2012 respectively. These advances are due on demand and accrue interest.

 

NOTE 4 - NOTES PAYABLE

 

 

The components of the Company’s debt as of October 31, 2012 and January 31, 2012 were as follows:

   2012  2012
Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2011  $100,000   $100,000 
Note Payable - $50,000, 12% interest payable monthly or accrued, due Nov 14, 2011   0    0 
Note Payable - $190,000, 12% interest payable monthly or accrued, due October 29, 2012   265,650    240,000 
Note Payable - $25,000, 12% interest payable monthly or accrued, due March 11, 2014   25,000    25,000 
Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2012   25,000    25,000 
Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014   16,000    16,000 
Note Payable - $70,000, 12% interest added to note quarterly, due February 4, 2013   70,000    70,000 
Note Payable - $40,000, 12% interest added to note quarterly, due July 28, 2012   40,000    40,000 
Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2012   4,000    4,000 
Note Payable - $5,000, 12% interest added to note quarterly, due April 30, 2012   5,000    0 
Note Payable - $15,000, 12% interest added to note quarterly, due April 30, 2012   15,000    0 
Subtotal   565,650    520,000 
Less – currently payable   (540,650)   (495,000)
Long-term debt  $25,000   $25,000 

 

The Company had accrued $86,915 and $36,046 of accrued interest on the notes at October 31, 2012 and January 31, 2012 respectively.

 

NOTE 5 - STOCKHOLDERS’ EQUITY

 

Preferred Stock:

The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share.  There are no preferred shares outstanding at October 31, 2012 and January 31, 2012.

 

Common Stock:

The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share.  These shares have full voting rights.  At October 31, 2012 there were 48,125,528 shares outstanding and 43,315,000 shares outstanding at January 31, 2012.  No dividends were paid in the periods ended October 31, 2012 or year ended January 31, 2012.  

10
 

 

Options and Warrants:

The Company had the following options or warrants outstanding at October 31, 2012:

 

Issued To # Options Dated Expire Strike Price
President and CEO 4,000,000 11/18/2010 11/18/2015 $0.25 per share
Vice President 2,000,000 11/18/2010 11/18/2015 $0.25 per share
Shareholder 127,500 08/28/2011 08/28/2016 $0.10 per share
Shareholder 50,000 04/04/2012 04/04/2013 $0.20 per share
Shareholder 8,000 04/27/2012 04/27/2013 $0.20 per share
Shareholder 127,500 04/29/2012 04/29/2017 $0.10 per share
Shareholder 200,000 05/17/2012 05/17/2013 $0.20 per share
Shareholder 50,000 05/22/2012 05/22/2013 $0.20 per share
Shareholder 80,000 05/21/2012 05/21/2013 $0.20 per share
Shareholder 25,000 07/12/2012 07/12/2013 $0.20 per share
Shareholder 25,000 07/10/2012 07/10/2013 $0.20 per share
Shareholder 50,000 08/09/2012 08/09/2013 $0.20 per share
Shareholder 1,000,000 08/31/2012 08/31/2016 $0.12 per share

 

NOTE 6 – EMPLOYEE BENEFIT PLANS

 

At October 31, 2012, there were no qualified or non-qualified employee pension, profit sharing, stock option, or other plans authorized for any class of employees.

 

NOTE 7 – INCOME TAXES

 

MedCareers Group, Inc. has incurred losses since inception.  Therefore, MedCareers has no federal tax liability.  Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes.  The net deferred tax asset generated by the loss carryforward has been fully reserved.  The cumulative net operating loss carryforward is about $4,233,511 at October 31, 2012 of which $3,288,877 is available for carryforward for federal income tax purposes and will expire in fiscal year 2026 to 2027.  At October 31, 2012 and January 31, 2012, the deferred tax asset consisted of the following:

 

   October 31, 2012  January 31, 2012
Deferred tax asset:          
   Net operating loss  $1,118,218   $837,432 
   Less valuation allowance   (1,118,218)   (837,432)
   Net deferred tax asset  $0   $0 

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

The Company may from time to time be involved with various litigation and claims that arise in the normal course of business.  As of October 31, 2012, no such matters were outstanding.

 

NOTE 9 - GOING CONCERN

 

MedCareers’ financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.  The Company has incurred cumulative losses through October 31, 2012 of $4,233,511 and has a working capital deficit at October 31, 2012 of $809,359.

 

Historically, revenues have not been sufficient to cover operating costs that would permit the Company to continue as a going concern.  The potential proceeds from the sale of common stock and other contemplated debt and equity financing, and increases in operating revenues from new development and business acquisitions might enable MedCareers to continue as a going concern.  There can be no assurance that the Company can or will be able to complete any debt or equity financing, or develop or acquire one or more business interests on terms favorable to it.  MedCareers’ financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

NOTE 10 – RECENT ACCOUNTING PRONOUNCEMENTS

 

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows.

11
 

  

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, which we refer to in this quarterly report as the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, which we refer to in this quarterly report as the Exchange Act. Forward-looking statements are not statements of historical fact but rather reflect our current expectations, estimates and predictions about future results and events. These statements may use words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “predict,” “project” and similar expressions as they relate to us or our management. When we make forward-looking statements, we are basing them on our management’s beliefs and assumptions, using information currently available to us. These forward-looking statements are subject to risks, uncertainties and assumptions, including but not limited to, risks, uncertainties and assumptions discussed in this quarterly report. Factors that can cause or contribute to these differences include those described under the headings “Risk Factors” and “Management Discussion and Analysis and Plan of Operation.”

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we projected. Any forward-looking statement you read in this quarterly report reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. All subsequent written and oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by this paragraph. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this quarterly report. The Company expressly disclaims any obligation to release publicly any updates or revisions to these forward-looking statements to reflect any change in its views or expectations. The Company can give no assurances that such forward-looking statements will prove to be correct.

 

Company.

MedCareers Group, Inc. (“MedCareers”, the “Company”, “MCGI”, “we” or “us”), the Company described herein, is a Nevada corporation, with offices located at 758 E Bethel School Road, Coppell, Texas 75019. It can be reached by phone at (972) 393-5892.

 

History.

The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada Corporation as RX Scripted, Inc. on December 5, 2007.  On December 16, 2009, an amendment was filed with the State of Nevada to among other things, change the name of the company to “MedCareers Group, Inc.” and affect a 10 for 1 forward stock split (which became effective January 7, 2010). Unless otherwise stated or the context suggests otherwise, the number of shares disclosed throughout this report have been retroactively reflected for the stock split.

 

12
 

 

 

On or around November 19, 2010, the Company entered into a Share Exchange Agreement (the “Exchange”) with Nurses Lounge, Inc., a Texas corporation (“Nurses Lounge”) and the nine shareholders of Nurses Lounge (the “Nurses Lounge Shareholders”).  Pursuant to the Exchange, we agreed to issue 24,000,000 restricted shares of our common stock to the Nurses Lounge Shareholders in exchange for 100% of the issued and outstanding shares of common stock of Nurses Lounge.  Pursuant to the Exchange, Nurses Lounge became a wholly-owned subsidiary of the Company.

 

History and Description of the Operations of Nurses Lounge

 

At the beginning of 2003 in Dallas, Texas, Timothy Armes (our Chief Executive Officer, sole director and largest shareholder) took over control of the nursing internet portal and nursing job board NursesLounge.com and re-launched the web site shortly thereafter.  Mr. Armes also launched a localized direct mail magazine as a companion to the website. Years of managing a portal and publishing a monthly magazine gave Mr. Armes insight to numerous organizations in need of a more efficient way to communicate important information to nursing professionals such as news, meetings and continuing education requirements on a timely basis.

 

With this understanding, and the development of social media technology, Mr. Armes designed and launched a beta version of a professional network for nurses in the summer of 2009 designed to provide a common platform for nursing organizations such as nursing schools, associations and major nurse employers to connect and communicate more effectively to their nurse constituents and broader nursing profession. Additionally, the network was developed to allow individual nurses the ability to interact with these organizations and other professionals via a professional profile separate from a social profile that they may have on Facebook as example.

 

Today, Nurses Lounge operates as a free online professional network for nursing professionals, and provides a secure place for nurses to connect with colleagues, network on a professional level and subscribe to professional “Lounges” (groups) to receive email updates of relevant news, events and other info.

 

Interactive Lounges are created primarily by nursing schools, local chapters of nurse associations and major nurse employers. Additionally, Nurses Lounge also has 73 metro/state lounges which aggregate all of the professional nursing news, events and employment opportunities within that certain geographic region.

 

As a communication utility, Nurses Lounge solves many of the communication issues these organizations face:

 

· Local chapters of nurse associations use Nurses Lounge (opposed to outdated, hard to manage static web sites and email lists) as a more efficient way to communicate with their members as well as for recruiting new members and disseminating news and information to their local nursing profession.

 

· Nursing Schools benefit with a group in the Nurses Lounge not only as a means to easily distribute news and info, but also to manage and keep alumni notified of educational opportunities as well as providing a professional networking platform between students, faculty and alumni.

 

· Employer’s benefits include managing a positive brand, distribution of news, job postings, managing employee referral programs as well as internal communications for things such as shared governance.

 

There is no cost to schools, associations or other non-profit organizations to utilize the Nurses Lounge communication and networking capabilities while employers, and other for profit organizations, are charged minimal set-up fees that also may include unlimited job postings for a limited time.

 

Nurses that register with the Nurses Lounge by creating a professional profile are then able to share their perspectives through their participation in these groups in order to keep current on news, information, meetings and jobs openings as well as to network professionally with like-minded colleagues.  Participation and postings by members in Lounges creates new connections and makes it easier for people to find and connect with each other.  Finally, by inviting new colleagues and contacts to join them in the Nurses Lounge, members both grow their own network of connections and help to increase membership in Nurses Lounge.

 

Along with the professional network, Nurses Lounge has a fully functional job board for nursing professionals as well as a nursing faculty job board specialty site for nursing schools looking to hire faculty. This specialty site was launched in June 2012.

 

The faculty job board was launched in response to the increasing number of schools joining our network and adding their faculty and graduate degree nurses coupled with a growing shortage of nursing faculty.

 

To date Nurses Lounge, with no dedicated sales force or marketing campaign, has generated small amounts of job posting revenue from these job sites as well as from employers and other for profit organizations paying set-up fees for activating their interactive lounges.

 

13
 

 

 

Plans Moving Forward

 

The Company previously operated as an event planning consulting company engaged in the planning and execution of medical meetings and educational programs for nurses, physicians, pharmacists and other healthcare professionals.  Subsequent to the acquisition of Nurses Lounge, we have focused solely on Nurses Lounge, and have discontinued and spun-off the event planning and consulting operations as of November 30, 2010.  

 

Moving forward in the near term, management intends to concentrate on growing individual nurse membership by adding Nursing Schools, Student Nurse Associations and Professional Nurse Associations to our network.

 

We expect to do this by introducing these organizations to and educating them on the benefits that our network offers. Specifically in terms of providing them a free, branded turn-key solution for instant communications of news and information to their constituents as well as increased exposure for their organization to the broader nursing profession.

 

As these organizations join our network they invite their members to join their “interactive lounge”. As an example, the University of Texas at Arlington College of Nursing to date has had over 900 students, alumni and faculty connect with them in the Nurses Lounge via an invitation sent from the Dean of their nursing school as well as Nurses Lounge “NL” icon they have placed on their web site.

 

We also intend to strengthen our brand and grow membership through increased marketing efforts and expanded and enhanced features and functionalities over time, funding permitting.

 

Additionally, as membership grows, management will look to diversify the revenue model from primarily job posting revenue. Potential income streams are expected to include targeted banner ads, email sponsorships, Groupon type sales as well as mobile apps.

 

With funds permitting, to support these revenue streams and grow our network, management will be looking to hire 12-15 “regional publishers” as well as marketing support personnel. These publishers will be responsible for revenue generation and membership growth in their assigned markets.

 

We are currently considering offerings of securities under private placements, acquisitions (which are directly related to Nurses Lounge), issuing debt instruments, and joint ventures with other companies public and private and other activities to either build sales or generate much needed capital to grow and undertake our business plan (for example, obtain, if possible, loans).  However, we do not currently have any lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt securities and loans from our shareholders and other third parties.

 

Our financial statements contain information expressing substantial doubt about our ability to continue as a going concern. The consolidated financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we satisfy our liabilities and commitments in the ordinary course of business.

 

Moving forward throughout fiscal year 2014, we hope to expand our services into providing Student Nurse Associations (SNAs), a needed professional communication platform that will allow them to help communicate more efficiently with current members while additionally building their organizations membership. Additionally, with our administration and after our SEC reporting obligations are current, we will be positioned to spend the majority of any equity raised to build a national sales team with needed sales and marketing.  The Company estimates it needs $750,000 to fully implement its business plan.  However, the Company can support its operations for 90 days with its cash on hand.

 

14
 

 

Recent Activity

 

From the launch of the Nurses Lounge network in 2009 through the year ending January 31, 2011 Nurses Lounge focused on working with organizations around the Dallas Fort Worth, Texas area. This process and time allowed us to better understand the communication needs and desires of these organizations and provided us the insight on how best to structure the network to meet the communication needs of our target markets across the nation.

 

During the fiscal year ending January 31, 2012, with 2 full time employees, Nurses Lounge concentrated on building out the network by creating 73 metro lounges representing all the major metro areas and/or states across the U.S.  Additionally we created over 500 “interactive lounges” for Bachelor of Science in Nursing (BSN) schools across the nation and positioned ourselves for a national rollout as funds became available.

 

During the fiscal year that ended January 31, 2013 we began marketing to BSN schools and selected associations across the U.S.

 

Additionally we launched a “Nursing Faculty” specialty job site in June of 2012. This was done based on the numerous experienced faculty members and educationally qualified nurses (MSN and PhD candidates) that were joining our network as well as the growing demand for nursing faculty across the U.S.  Additionally management found very little direct competition in the space.

 

***

 

Results for the three and nine months ended October 31, 2012

Revenue. Revenue for the three months ended October 31, 2012 and 2011 was $8,040 and $3,265, respectively. The increase is due to revenue from the Company’s operating websites. Revenue for the nine months ended October 31, 2012 and 2011 was $13,990 and $20,153, respectively.

Cost of Revenues. Cost of revenues were $7,430 and $12,623 for the three months ended October 31, 2012 and 2011 respectively. Cost of revenues were $23,128 and $38,447 for the nine months ended October 31, 2012 and 2011 respectively. The increase in costs was due to the operation of the Company’s websites which started generating revenue.

Operating Expenses. Operating expenses for the three months ended October 31, 2012 and 2011 were $159,511 and $75,202, respectively. The above expenses include depreciation and amortization amounts of $54,825 and $45,493 for the three months ended October 31, 2012 and 2011, respectively and general and administrative expenses of $96,974 and $23,812, respectively. Operating expenses for the nine months ended October 31, 2012 and 2011 were $766,119 and $252,548, respectively. The above expenses include depreciation and amortization amounts of $274,816 and $146,399 for the nine months ended October 31, 2012 and 2011, respectively and general and administrative expenses of $470,174 and $81,401, respectively.

Other Income (Expense). Other income mainly represents interest paid on loans which was $17,760 and $16,211 for the three months ended October 31, 2012 and 2011, respectively, and $50,586 and $41,558 for the nine months ended October 31, 2012 and 2011, respectively.

Net Loss. We had a net loss of $176,661 for the three months ended October 31, 2012 and a net loss of $100,771 for the three months ended October 31, 2011. We had a net loss of $825,843 and $312,400 for the nine months ended October 31, 2012 and 2011, respectively.

Liquidity and Capital Resources

As of October 31, 2012, the Company had total current assets of $5,215, and total long-term assets of $148,987 consisting of deferred fees of $148,987 relating to consideration paid for making or extending loans. We had total liabilities of $839,974, including total current liabilities of $814,974, including accounts payable of $6,718, accrued expenses of $22,633, amounts due to related party of $158,058, which amounts were due to Tim Armes and Garrett Armes (the Company’s sole officer and director and the Vice President of Nurses Lounge, respectively) and are due on demand, accrued interest payable of $86,915 and $540,650 of current portion of long-term debt in connection with working capital loans, and long term liabilities consisting of $25,000 of notes payable.

 

15
 

 

 

As of October 31, 2012, the Company had negative working capital of $809,359, comprised of current assets of $5,615 and current liabilities of $814,974.

 

Net cash used in operations for the nine months ended October 31, 2012 was $163,347 compared to $122,009 for the nine months ended October 31, 2011.

 

Cash provided by financing activities for the nine months ended October 31, 2012 was $167,650 compared to $38,112 of net cash used by financing activities for the same period in 2011.

 

On or around March 2, 2010, we entered into a Letter of Intent to acquire the Uniform Resource Locator (“URL”) www.WorkAbroad.com (“WorkAbroad.com” and the “Purchase”).  The purchase price was $225,000 (the “Purchase Price”).  On March 8, 2010, the Company paid the required 10% down payment (equal to $22,500) on the purchase price to Steve Elisberg (the “Seller”).  The remaining balance due ($202,500) pursuant to the Purchase was payable at a rate of $2,248 per month, beginning in April 2010, based on a 10 year amortizing loan with interest at 6% with a balloon payment of all unpaid principal and interest due 36 months after closing (the “Loan”).  The parties entered into a definitive Asset Purchase Agreement on August 10, 2010 and a formal closing of the Purchase occurred on August 10, 2010.  The Company made the initial payment to the Seller in March 2010 so that it could assume operations of WorkAbroad.com at the time of the parties’ entry into the Letter of Intent rather than waiting for the formal closing.

 

The repayment of the Loan was secured by a security interest over WorkAbroad.com. Since the closing of the Nurses Lounge acquisition, Timothy Armes, the controlling shareholder of the Company, decided to terminate pursuit of the previously disclosed acquisition opportunities so that the Company could focus on developing Nurses Lounge and businesses that are complementary to Nurses Lounge.

 

In connection therewith on July 8, 2011, the Company entered into an Asset Purchase Agreement with Fiakow Properties, LLC (“Fiakow”) pursuant to which Fiakow purchased the Company’s entire right and interest in workabroad.com and the August 10, 2010 Asset Purchase Agreement for an aggregate of $1,000, provided that the Seller did not formally release the Company from liability in connection with the August 10, 2010 Asset Purchase Agreement and the Loan, which Loan has been repaid in full as of the date of this filing.

 

On November 4, 2010, the Company obtained a $100,000 loan from a third party, which was evidenced by a Promissory Note. The note bears interest at the rate of 12% per annum, payable monthly in arrears, and has a maturity date of November 4, 2011. The repayment of the note is secured by a security interest in substantially all of the Company’s assets. In consideration for making the loan, the Company agreed to issue the third party 400,000 shares of restricted common stock. The stock issued had a value of $60,000 on the date of the grant, based on the closing trading price on November 4, 2010. The $60,000 is treated as a discount on the loan. Accordingly, the loan will be reflected as a liability of $40,000 and the $60,000 discount will be reduced pro rata over the term of the loan as additional interest expense on the note and added to the loan balance on a monthly basis.

 

On February 8, 2011, the Company obtained a $70,000 loan from a third party, which was evidenced by a Promissory Note. The note bears interest at the rate of 12% per annum, payable monthly in arrears, and has a maturity date of February 15, 2012. In consideration for making the loan, the Company agreed to issue the third party 100,000 shares of restricted common stock. The loan will be funded in three installments: $30,000 on or before February 10, 2011; $20,000 on or before February 24, 2011; and $20,000 on or before March 10, 2011. The stock issued had a value of $18,200 on the date of the grant, based on the closing trading price on February 8, 2011. The $18,200 is treated as a deferred fee in conjunction with the loan. Accordingly, the loan will be reflected as a liability and the $18,200 deferred fee will be amortized pro rata over the term of the loan as additional interest expense on the note and added to the loan balance on a monthly basis.

 

The Company has borrowed funds and/or sold stock for working capital.  These transactions are detailed in the section “Recent Sales of Unregistered Securities”.

 

16
 

 

 

Currently the Company does not have sufficient cash reserves or revenues to meet its contractual obligations under its outstanding notes payable and to pay its ongoing monthly expenses, which the Company anticipates totaling approximately $250,000 over the next 12 months.  The Company has been able to continue operating to date largely from loans made by its shareholders and other debt financings to date.  The Company is currently looking at both short-term and more permanent financing opportunities, including debt or equity funding, bridge or short term loans, and/or traditional bank funding, but we have not decided on any specific path moving forward.  Until we have raised sufficient funding to pay our ongoing expenses associated with being a public company, and we have sufficient funds to support our planned operations, the Company can provide no assurances that it will be able to meet its short and long term liquidity needs, until necessary financing is secured.  The Company has started to generate revenue from the Nurses Lounge business in 2011, which the Company hopes will increase to the point where the Company can finance at least a substantial portion of the Company’s obligations, of which there can be no assurance.

 

We do not currently have any additional formal commitments or identified sources of additional capital from third parties or from our officers, director or significant shareholders. We can provide no assurance that additional financing will be available on favorable terms, if at all. If we are not able to raise the capital necessary to continue our business operations, we may be forced to abandon or curtail our business plan.

 

In the future, we may be required to seek additional capital by selling additional debt or equity securities, selling assets, if any, or otherwise be required to bring cash flows in balance when we approach a condition of cash insufficiency. The sale of additional equity or debt securities, if accomplished, may result in dilution to our then shareholders. We provide no assurance that financing will be available in amounts or on terms acceptable to us, or at all.

 

ITEM 3. Quantitative and Qualitative Disclosure about Market Risk.

 

Pursuant to Item 305(e) of Regulation S-K (§ 229.305(e)), we are not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

 

ITEM 4. Controls and Procedures

(a)           Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Principal Financial Officer, after evaluating the effectiveness of our "disclosure controls and procedures" (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q (the "Evaluation Date"), has concluded that as of the Evaluation Date, our disclosure controls and procedures were not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.  Moving forward, we hope that our Chief Executive Officer and Principal Financial Officer will be able to devote the additional time and effort required so that our disclosure controls and procedures are once again effective.  Notwithstanding the assessment that our internal controls and procedures were not effective, we believe that our financial statements contained in this Quarterly Report for the quarter ended October 31, 2012 fairly present our financial position, results of operations and cash flows for the years and months covered thereby in all material respects.

 

(b)           Changes in internal control over financial reporting. There were no changes in our internal control over financial reporting during our most recent fiscal quarter that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

 

17
 

PART II

 

Item 1. Legal Proceedings

 

From time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.

 

Item 1A. Risk Factors

 

There have been no material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the year ended January 31, 2012, filed with the Commission on September 23, 2013, other than as set forth below, and investors are encouraged to review such risk factors below and in the Form 10-K, prior to making an investment in the Company.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

In February 2011, the Company borrowed $70,000 from a third party and agreed to issue said third party 140,000 restricted shares of common stock in consideration for agreeing to make such loan. This transaction is described in greater detail above.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

In January 2011, in connection with and as a required term and condition of the Exchange, a former Chief Executive Officer, Director and significant shareholder, MaryAnne McAdams and our former significant shareholder, David M. Loev, each agreed to cancel 2,820,000 shares of common stock which they owned (representing an aggregate of 5,640,000 shares of our common stock) upon the consummation of the Exchange.

 

Recent Sales of Unregistered Securities

 

The following table describes sales of unregistered securities since the end of our last fiscal year:

 

  Consideration   Date # Shares
Balance, Number of shares outstanding, January 31, 2012       43,315,000
         
Sale of common shares for cash $0.10 per share (1) Various 1,220,000
Sale of common shares for cash $0.10 per share (2) Various 2,000,000
Shares issued for deferred fees Incentive for new loan (3) February 28, 2012 134,500
Shares issued for consulting services Services @ $0.10/share (4) July 2012 500,000
Shares issued for consulting services Services @ $0.10/share (5) August 2012 250,000
Shares issued for deferred fees Incentive for new loan (6) September 30, 2012 1,777,778
Shares issued for deferred fees Incentive for new loan (7) October 2, 2012 478,250
Shares issued for deferred fees Incentive for new loan (8) October 2, 2012 450,000

 

18
 

 

  

         
Balance, Number of shares outstanding, January 31, 2013       50,125,528
 Shares issued for consulting services Services @ $0.10/share (9) February 2012 600,000
Shares issued for deferred fees Incentive for new loan (10) July 19, 2013 200,000
Shares issued for deferred fees Incentive for new loan (11) July 31, 2013 166,667
Shares issued for deferred fees Incentive for new loan (12) July 31, 2013 133,334
Shares issued for deferred fees Incentive for new loan (13) July 31, 2013 133,334
Shares issued for deferred fees Note extension (14) July 31, 2013 1,100,000
Shares issued for note conversion Convert $25,000 note (15) Aug 5, 2013 250,000
Balance, Number of shares outstanding, September 5, 2013       52,708,863

 

  In conjunction with the recapitalization with Nurses Lounge, Inc.  in November 2010, Archtype Partners agreed to cancel 11,185,000 shares of its common stock. The shares were formally cancelled in November 2012 but by Agreement were cancelled in November 2010. The financial statements reflect the cancellation in November 2010 so the number of shares outstanding is not misleading.

 

(1) Sale of Common Stock for cash. Between April 4, 2012 and October 1, 2012 the company issued 488,000 units of its securities in a private placement to accredited investors. The price of these Units was $0.25 per unit. Each Unit consists of 2.5 shares of restricted common stock valued at .10 per share and one 1 year warrant. Total shares purchased 1,220,000 and 488,000 warrants. Each Series A Warrant entitles the holder to purchase one share of common stock at an exercise price of $0.20 per share and subject to adjustments due to recapitalization or reclassification of common stock. The Company received proceeds of $122,000.

 

  Acceptance   New Shares    
Investment Date Units (.25) Issued (.10) Warrants Warrant#
$12,500 04/03/12 50,000 125,000 50,000 A-10
$2,000 04/26/12 8,000 20,000 8,000 A-20
$50,000 05/16/12 200,000 500,000 200,000 A-30
$12,500 05/21/12 50,000 125,000 50,000 A-40
$20,000 05/20/12 80,000 200,000 80,000 A-50
$6,250 07/11/12 25,000 62,500 25,000 A-60
$12,500 08/08/12 50,000 125,000 50,000 A-70
$6,250 09/30/12 25,000 62,500 25,000 A-80
$122,000   488,000 1,220,000 488,000  
    Exercise Price $0.20  
    Potential Proceeds 97,600  

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(2) Sale of Common Stock for cash.  On January 9, 2013 the company issued 2,000,000 units of its securities in a private placement to an accredited investor. The price of these Units was $0.10 per unit. Each Unit consists of 1 share of restricted common stock valued at $0.10 per share for a total of 2,000,000 shares and one 5 year Warrant. Each Series B Warrant entitles the holder to purchase one share of common stock at an exercise price of $0.12 per share and subject to adjustments due to recapitalization or reclassification of common stock. The Company received proceeds of $200,000.

 

19
 

 

 

  Acceptance   New Shares    
Investment Date Units (.25) Issued (.10) Warrants Warrant#
$200,000 01/09/13 2,000,000 2,000,000 2,000,000 B-100
    Exercise Price $0.12  
    Potential Proceeds 240,000  

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(3) 134,500 total shares issued on January 30, 2012, in consideration for lending the Company $12,500, note dated May 8, 2012. The note bears interest at 12%, with the Company paying the Holder interest only commencing on December 1, 2011 and continuing on the first day (1st) day of each month thereafter through and including November 1, 2011, the Maturity Date, which final payment shall include all principal and accrued interest. The value of these shares were determined on the day of agreement and booked in the financial statement as Deferred Fees and amortized over the life of the loan.

 

Additionally, the Holder received 72,000 restricted shares of common stock as a 1st quarter interest payment of $7,200 on his 190,000, 12% note renewed in November 2011 and 50,000, 12% note originated in December 2011.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(4) 500,000 shares issued July 2012, The Company entered into a contract for services with Caro Consulting in July 2012. Based on the agreement, CARO Consulting was issued 500,000 shares of restricted common stock. Consultant paid $200.00 for shares. Another 500,000 shares (second Tranche) of stock was to be delivered to consultant as part of contract in September 2012, however it was mutually agreed that the contract would be put on hold and then revisited about moving forward with consulting services until the time that MCGI SEC filings are current.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(5) 250,000 total shares issued in August 2012 when the Company entered into a contract for services with Wennerholm in April, 2012. Based on the agreement, if satisfactory work was delivered through August 1, 2012 as defined by Company, Wennerholm would be eligible to receive a bonus payment of 250,000 shares of Company's restricted common stock. As result of satisfactory performance from April through August, Wennerholm was issued 250,000 shares of Company's restricted common stock valued at $0.10 per share.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

20
 

 

 

(6) 1,777,778 shares issued in September, 2012. On October 28th, 2011, Optimus MCGI Holdings, LLC made the company a short-term (6-month) $40,000 loan at an annual Interest rate of 20%. In consideration for lending the Company $40,000, the Company granted Optimus Holdings MCGI, LLC an option to buy 1,777,778 share of the Company's restricted common stock at $0.045 per share. At the end of the first Term Interest was paid and the note was extended an additional 3 months. As an incentive to extend the note the option was canceled and shares totaling 1,777,778 was granted to Optimus. At the end of the 3 month extension Optimus was issued 1,777,778 restricted shares and it was agreed that interest would accrue until such time the Company had the ability to make timely interest and principle payments in order to extinguish the obligation.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(7) 478,250 shares issued on October 2, 2012 in consideration for lending the Company $95,650 to be funded over 12 months at $7,500 per month after initial payment of $5,650. The note was dated September, 2012, and it was agreed the Holder would receive a total of 957,000 of restricted common stock as an incentive to make the loan. 478,500 shares were issued as agreed after the first payment was received with the additional 478,500 shares to be issued in September 2013 after funding the entire note. The note bears interest at 12%, with the Company paying the Holder interest only on the first day (1st) day of each month thereafter through and including January 31, 2014, the Maturity Date, which final payment shall include all principal and accrued interest. The value of these shares were determined on the day of agreement and booked in the financial statement as Deferred Fees and amortized over the life of the loan.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(8) 450,000 shares issued on October 2, 2012 in consideration for lending the Company $45,000, in a note dated October, 2012. The note bears interest at 12%, with the Company paying the Holder interest only on the first day (1st) day of each month thereafter through and including November 1, 2011, the Maturity Date, which final payment shall include all principal and accrued interest. The value of these shares was determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(9) 600,000 Shares Restricted common stock issued as compensation for engagement term for one year of Consultant's (Inspire Value) services valued at $5,000 per month or $60,000 total. The stock was issued with an agreed upon value of $0.10 per share. The value of these shares were determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

 

21
 

 

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(10) 200,000 total shares issued on July 19, 2013 in consideration for lending the Company $30,000, note dated July 19, 2013, 12% annual interest rate, due October 31, 2013, Jamie Bernard was issued a total of 200,000 shares of restricted common stock. Additionally, the note is convertible at $0.10 per share. The value of these shares were determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(11) 166,667 shares were issued on July 31, 2013 in consideration for lending the Company $25,000, note dated July 31, 2013, 12% annual interest rate, due October 31, 2013. Additionally, the note is convertible at $0.10 per share. The value of these shares was determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(12) 133,334 shares were issued on July 31, 2013 in consideration for lending the Company $20,000, note dated July 31, 2013, 12% annual interest rate, due October 31, 2013. Additionally, the note is convertible at $0.10 per share. The value of these shares was determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(13) 133,334 total shares issued July 31, 2013, in consideration for lending the Company $20,000, note dated July 31, 2013, 12% annual interest rate, due October 31, 2013 - the note was converted on August 5, 2013. Additionally, the note is convertible at $0.10 per share. The value of these shares was determined on the day of agreement and booked in the financial statement as Deferred Fees and amortized over the life of the loan.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

22
 

 

 

(14) 1,100,000 shares issued on July 31, 2013 in consideration for extending his original  note a second time with his original note  dated  November 4, 2010 and due November 4, 2011 and then renewed and due November 4, 2012 and additionally renewed a second time and due November 4, 2013 in the amount of $100,000 for an additional year. The value of these shares was determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

(15) Conversion of Note dated July 31, 2013 that had a conversion feature at $.10 per share. These shares were issued for the conversion of a $20,000 note.

 

Options and Warrants

 

Three options for 127,500 shares of restricted common stock at an exercise price of $0.10 per share and for a term of 5 years were awarded Geneva7, LLC in consideration for loaning the Company $25,000 and renewing the note two additional times. Geneva7, LLC originally loaned the Company $25,000 at 12% interest on August 29, 2011 and was awarded an option to purchase 127,500 shares of restricted common stock at an exercise price of $0.10. The term of the option is 5 years. The loan matured on April 30th 2012 and Geneva 7 agreed to renew the loan and accrue interest thru July 31, 2013 and additionally renewed the loan thru October 31, 2103 when it matured on July 31, 2013. With each additional renewal Geneva7 received an additional option to purchase 127,500 shares of restricted common stock at an exercise price of $0.10 per share and for a term of 5 years.

 

Warrant to purchase 1,000,000 shares. The Company entered into a contract for services with Horse and Hammerhead Marketing Solutions, LLC , a management consulting firm. Based on the agreement, the consultant was issued a warrant for 1,000,000 shares of MCGI’s restricted common stock at an exercise price of $0.12 per/share with a 4-year term.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

Warrant to purchase 100,000 shares. The Company entered into a contract for services with EBCO, LLC. Based on the agreement, in consideration for extending their $16,000 loan, they were issued a warrant for 100,000 shares of MCGI’s restricted common stock at an exercise price of $0.10 per/share, expiring March 29, 2016.

 

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

 

Item 3. Default Upon Senior Securities

 

None.

 

23
 

 

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

See the Exhibit Index immediately following the signature page of this Report on Form 10-Q.

 

24
 

 

 

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

MedCareers Group, Inc.

 

By:  /s/  Timothy Armes

Timothy Armes

Chairman (Director), Chief Executive Officer, President, Secretary and Treasurer

(Principal Executive Officer and Principal Financial/Accounting Officer)

 

Date: September 23, 2013

 

 

25
 

EXHIBIT INDEX

 

Exhibit

Number

Description of Exhibit
   
3.1(1) Articles of Incorporation
   
3.2(5) Certificate of Amendment to Articles of Incorporation
   
3.3(5) Certificate of Correction to Certificate of Amendment to Articles of Incorporation
   
3.2(1) Bylaws
   
10.1(1) Revolving Credit Promissory Note with Kevin McAdams (December 12, 2007)
   
10.2(1) Convertible Promissory Note with David M. Loev (March 11, 2008)
   
10.3(2) Amended Convertible Promissory Note with David M. Loev
   
10.4(3) Amended Revolving Credit Promissory Note with Kevin McAdams
   
10.5(3) Second Amended Convertible Promissory Note with David M. Loev
   
10.6(4) Stock Purchase Agreement
   
10.7(4) Voting Agreement
   
10.8(4) Debt Extinguishment Agreement (Kevin McAdams)
   
10.9(4) Debt Extinguishment Agreement (David M. Loev)
   
10.10(6) Agreement with Premier Healthcare Professionals, Inc.
   
10.11(7) Promissory Note
   
10.12(8) Asset Purchase Agreement Relating to the Purchase of WorkAbroad.com
   
10.13(8) WorkAbroad.com Development Proposal
   
10.14(9) Share Exchange Agreement with Nurses Lounge and the Shareholders of Nurses Lounge
   
10.15(9) Cancellation of Shares Agreements
   
10.16(9) Voting Agreement
   
10.17(9) Employment Agreement with Timothy Armes (Nurses Lounge)
   
10.18(9) Option Agreement with Garret Armes
   
10.19(9) Option Agreement with Timothy Armes
   
10.20(9) Spin-Off Agreement
   
10.21(9) $190,000 Promissory Note

 

 

26
 

 

   
10.22(9) $100,000 Promissory Note
   
10.23(10) $50,000 Promissory Note
   
10.24(13) Asset Purchase Agreement workabroad.com (July 8, 2011)
   
10.25(13) Employment Agreement (Timothy Armes)( November 18, 2010)
   
10.26(13) Employment Agreement (Garret Armes)(November 18, 2010)
   
10.27(13) Common Stock Purchase Option (Timothy Armes)(November 18, 2010)(4,000,000 shares)
   
10.28(13) Common Stock Purchase Option (Garret Armes)(November 18, 2010)(2,000,000 shares)
   
16.1(11) Letter from GBH CPAs, PC dated March 29, 2013
   
31.1* Certificate of the Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
32.1**  Certificate of the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   
99.1(8) Financial Statements of WorkAbroad.com
   
99.2(8) Pro Forma Financial Information of WorkAbroad.com
   
99.3(12) Audited Balance Sheets of Nurses Lounge as of October 31, 2010 and December 31, 2009; Audited Statement of Operations of Nurses Lounge for the ten months ended October 31, 2010, year ended December 31, 2009 and cumulative period since re-entering the development stage on January 1, 2009; Audited Statement of Partners’ Capital of Nurses Lounge for the year ended December 31, 2009 and ten months ended October 31, 2010; and Audited Statements of Cash Flows of Nurses Lounge for the ten months ended October 31, 2010, year ended December 31, 2009 and cumulative period since re-entering the development stage on January 1, 2009, and the notes thereto
   
99.4(12) Unaudited Pro Forma Condensed Statement of Operations for the nine months ended October 31, 2010 and Unaudited Pro Forma Condensed Balance Sheet as of October 31, 2010, and the notes thereto

 

101.INS+ XBRL Instance Document
             
101.SCH+ XBRL Taxonomy Extension Schema Document
             
101.CAL+ XBRL Taxonomy Extension Calculation Linkbase Document
             
101.DEF+ XBRL Taxonomy Extension Definition Linkbase Document
             
101.LAB+ XBRL Taxonomy Extension Label Linkbase Document
             
101.PRE+ XBRL Taxonomy Extension Presentation Linkbase Document

 

*   Filed herewith.

 

** Furnished herewith. 

 

27
 

 

 

(1)  Filed as Exhibits to the Company’s Registration Statement on Form S-1 filed with the Commission on July 22, 2008, and incorporated herein by reference.

 

(2) Filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q filed with the Commission on December 19, 2008, and incorporated herein by reference.

 

(3) Filed as an Exhibit to the Company’s Annual Report on Form 10-K filed with the Commission on May 8, 2009, and incorporated herein by reference.

 

(4) Filed as an Exhibit to the Company’s Current Report on Form 8-K filed with the Commission on October 9, 2009, and incorporated herein by reference.

 

(5) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on January 7, 2010, and incorporated herein by reference.

 

(6) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on May 7, 2010, and incorporated herein by reference.

 

(7) Filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q, filed with the Commission on May 14, 2010, and incorporated herein by reference.

 

(8) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on August 11, 2010, and incorporated herein by reference.

 

(9) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on December 2, 2010, and incorporated herein by reference.

 

(10) Filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q, filed with the Commission on March 11, 2011, and incorporated herein by reference.

 

(11) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on March 29, 2011, and incorporated herein by reference.

 

(12) Filed as an Exhibit to the Company’s Current Report on Form 8-K/A, filed with the Commission on August 16, 2013, and incorporated herein by reference.

 

(13) Filed as an Exhibit to the Company’s Annual Report on Form 10-K, filed with the Commission on September 3, 2013, and incorporated herein by reference. 

+XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

28
 

EX-31.1 2 ex31one.htm CERTIFICATION

 

 

EXHIBIT 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Timothy Armes, certify that:

 

  1. I have reviewed this report on Form 10-Q of MEDCAREERS GROUP, INC.;
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)Disclosed in this report any change to the registrant's internal controls over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal controls over financial reporting; and,
  1. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and,
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

 

Date: September 23, 2013

/s/ Timothy Armes

Timothy Armes

Chief Executive Officer

(Principal Executive Officer and Principal Financial/Accounting Officer)

EX-32.1 3 ex32one.htm CERTIFICATION

 

 

EXHIBIT 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Timothy Armes, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of MedCareers Group, Inc. on Form 10-Q for the period ended October 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of MedCareers Group, Inc.

 

By:/s/ Timothy Armes

Timothy Armes

Chief Executive Officer

(Principal Executive Officer and Principal Financial/Accounting Officer)

 

September 23, 2013

EX-101.INS 4 mcgi-20121031.xml XBRL INSTANCE FILE 0001438901 2013-08-01 2013-10-31 0001438901 2013-09-05 0001438901 2012-10-31 0001438901 2012-01-31 0001438901 2012-02-01 2012-10-31 0001438901 2009-07-01 2012-10-31 0001438901 2011-02-01 2011-10-31 0001438901 2010-07-31 0001438901 2012-08-01 2012-10-31 0001438901 2011-08-01 2011-10-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares MEDCAREERS GROUP, Inc. 0001438901 10-Q 2012-10-31 false --01-31 No No No Smaller Reporting Company Q3 2013 52708863 48126000 43315000 1799 1799 1799 1799 0 0 148987 113833 154602 114745 6718 6718 22633 22471 158058 74394 86915 34046 814974 634629 565650 520000 -540650 -495000 25000 25000 839974 659629 0 0 3500013 2819470 -4233511 -3407669 -685372 -544884 154602 114745 0.001 0.001 10000000 10000000 0 0 0.001 0.001 350000000 350000000 5215 912 4986 540650 495000 48126 43315 52708863 <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 1 &#8211; NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="font-style: italic; display: inline; text-decoration: underline">Nature of Activities, History and Organization</font>&#160;&#8211; The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007.&#160;&#160;On December 16, 2009, an amendment was filed with the State of Nevada to change the name to &#8220;MedCareers Group, Inc.&#8221; (the &#8220;Company&#8221; or &#8220;MedCareers&#8221;) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its common stock in exchange for 100% of Nurses Lounge, Inc. (&#8220;Nurses Lounge&#8221;), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers.&#160;&#160;As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers.&#160;&#160;The transaction was accounted for as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company.&#160;&#160;The share exchange was treated as a recapitalization of MedCareers.&#160;&#160;As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital.&#160;&#160;The Company operates a website for nurses, nursing schools and nurses organizations which enable the respective entities to communicate more easily and efficiently with their members.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Significant Accounting Policies:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company&#8217;s management selects accounting principles generally accepted in the United States of America and adopts methods for their application.&#160;&#160;The application of accounting principles requires the estimating, matching and timing of revenue and expense. The accounting policies used conform to generally accepted accounting principles which have been consistently applied in the preparation of these financial statements.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The financial statements and notes are representations of the Company&#8217;s management which is responsible for their integrity and objectivity. Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud.&#160;&#160;The Company's system of internal&#160;&#160;accounting control is designed to assure, among other items, that&#160;&#160;1) recorded&#160;&#160;transactions&#160;&#160;are valid;&#160;&#160;2) valid&#160;&#160;transactions&#160;&#160;are recorded;&#160;&#160;and&#160;&#160;3) transactions&#160;&#160;are&#160;&#160;recorded in the proper&#160;&#160;period in a timely&#160;&#160;manner to produce financial&#160;&#160;statements which present fairly the financial&#160;&#160;condition,&#160;&#160;results of operations&#160;&#160;and cash&#160;&#160;flows of the&#160;&#160;Company&#160;&#160;for the&#160;&#160;respective&#160;&#160;periods&#160;&#160;being presented.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Basis of Presentation:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Principles of Consolidation:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc.&#160;&#160;All significant inter-company transactions have been eliminated.&#160;&#160;All amounts are presented in U.S. Dollars unless otherwise stated.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <br /> <br /> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Reclassifications</font>:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Certain prior year amounts have been reclassified to conform with the current year presentation.&#160;&#160;Specifically, additional paid-in capital has been reclassified to show the effect of a forward 10 for 1 stock split effective January 7, 2010 and the values as if the Company were converted from a limited partnership to a corporation in 2009.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Development Stage Company</font>:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company complies with ASC No. 915-10 for its characterization of the Company as development stage.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Cash and Cash Equivalents:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents.&#160;&#160;At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance limits.&#160; The carrying amount approximates fair market value.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Fixed Assets:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Fixed assets are carried at cost.&#160;&#160;Depreciation is provided over each asset&#8217;s estimated useful life.&#160;&#160;Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income.&#160;&#160;&#160;Additions and significant improvements are capitalized and depreciated.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Advertising Costs:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company incurred no advertising costs for the years ended January 31, 2012 and 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Income Taxes:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code.&#160; Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration.&#160; Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Use of Estimates:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><br /> &#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Fair Value of Financial Instruments:</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Pursuant to ASC No. 820, &#8220;Fair Value Measurements and Disclosures&#8221;, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of January 31, 2012.&#160;&#160;The Company&#8217;s financial instruments consist of cash, accounts payable, advances and notes payable.&#160;&#160;The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Revenue Recognition:</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned.&#160;&#160;The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured.&#160;&#160;For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "<font style="font-style: italic; display: inline">Revenue Recognition in Financial Statements</font>", (formerly Staff Accounting Bulletin No. 104 (&#8220;SAB 104&#8221;)).&#160;&#160;&#160;Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Earnings per Common Share:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Earnings (loss) per share are calculated in accordance with ASC 260 &#8220;<font style="font-style: italic; display: inline">Earnings per Share</font>&#8221;.&#160;&#160; The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share.&#160;&#160;Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding.&#160;&#160;Dilutive potential common shares are additional common shares assumed to be exercised.&#160; Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">There were no potentially dilutive common stock equivalents as of January 31, 2012, therefore basic earnings per share equals diluted earnings per share for the year ended January 31, 2012.&#160; The Company had 6,127,500 options outstanding at January 31, 2012. As the Company incurred a net loss during the year ended January 31, 2012, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Recently Issued Accounting Pronouncements:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company&#160;does not expect&#160;the&#160;adoption&#160;of&#160;recently&#160;issued&#160;accounting pronouncements&#160;to have a significant impact on the Company&#8217;s&#160;results of&#160;operations, financial position or cash flows.</font></div></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 2 &#8211; DEFERRED FEES</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Deferred fees represent stock issued as fees to make or extend notes payable. Stock issued was valued at the date of issue and amortized over the term of the loan. Deferred fees at January 31, 2012 and 2011 were as follows:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> </div> <div style="text-align: left"> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; text-align: right"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt times new roman">2012</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: right; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; text-align: right; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; text-align: right"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt times new roman">2011</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Deferred Fees</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">304,200</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">161,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Less: Accumulated Amortization</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">(190,367 </font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">)</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">(40,250</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">)</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Deferred Fees - Net</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">113,833</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">120,750</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td></tr></table></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 3 - NOTES PAYABLE</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The components of the Company&#8217;s debt as of January 31, 2012 and 2011 were as follows:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: left"> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td colspan="2" style="text-align: right; vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt times new roman">2012</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td colspan="2" style="text-align: right; vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt times new roman">2011</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $202,500, 6% interest, payable $2,248 per month, due March 11, 2014</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">188,562</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2011</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">100,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">100,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $50,000, 12% interest payable monthly or accrued, due Nov 14, 2011</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">4,550</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $190,000, 12% interest payable monthly or accrued, due October 29, 2011</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">240,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">190,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $25,000, 12% interest payable monthly or accrued, due March 11, 2014</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">25,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">25,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2012</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">25,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">16,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $70,000, 12% interest added to note quarterly, due February 4, 2013</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">70,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $40,000, 12% interest added to note quarterly, due April 28, 2012</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">40,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2012</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">4,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Subtotal</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">520,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">508,112</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Less &#8211; currently payable</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">(495,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">)</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">(310,652</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">)</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Long-term debt</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">25,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">197,460</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company had accrued $36,046 and $9,386 interest on the notes at January 31, 2012 and 2011, respectively.&#160;&#160;As of January 31, 2011, $362,231 of unpaid interest had been added to the principal balance of the notes.</font></div></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-indent: 0pt; display: block"></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 4 - STOCKHOLDERS&#8217; EQUITY</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Preferred Stock:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share.&#160; There are no preferred shares outstanding at January 31, 2012 and 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Common Stock:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share.&#160; These shares have full voting rights.&#160; At January 31, 2012 and 2011, there were 43,315,000 and 40,700,000 shares outstanding, respectively.&#160; No dividends were paid in the years ended January 31, 2012 or 2011.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Options and Warrants:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company had the following options or warrants outstanding at January 31, 2012:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Issued To</font></div> </td> <td style="vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"># Options</font></div> </td> <td style="vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Dated</font></div> </td> <td style="vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Expire</font></div> </td> <td style="vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Strike Price</font></div> </td> </tr><tr style="background-color: #cceeff"> <td style="text-align: left; vertical-align: top; width: 16%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">President and CEO</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">4,000,000</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">11/18/2010</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">11/18/2015</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$0.25 per share</font></div> </td> </tr><tr style="background-color: white"> <td style="text-align: left; vertical-align: top; width: 16%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Vice President</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">2,000,000</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">11/18/2010</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">11/18/2015</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$0.25 per share</font></div> </td> </tr><tr style="background-color: #cceeff"> <td style="text-align: left; vertical-align: top; width: 16%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Shareholder</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">127,500</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">08/11/2011</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">08/10/2016</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$0.10 per share</font></div></td></tr></table></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 5 &#8211; EMPLOYEE BENEFIT PLANS</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">During the years ended January 31, 2012 and 2011, there were no qualified or non-qualified employee pension, profit sharing, stock option, or other plans authorized for any class of employees.</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 6 &#8211; INCOME TAXES</font></font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">MedCareers Group, Inc. has incurred losses since inception.&#160;&#160;Therefore, MedCareers has no federal tax liability.&#160;&#160;Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes.&#160;&#160;The net deferred tax asset generated by the loss carryforward has been fully reserved.&#160;&#160;The cumulative net operating loss carryforward is $3,407,669 at January 31, 2012 of which $2,463,034 is available for carryforward for federal income tax purposes and will expire in fiscal years 2026 to 2027.&#160; At January 31, 2012 and 2011, the deferred tax asset consisted of the following:</font></div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-indent: 0pt; display: block"><br /> </div> </div> <div style="text-align: center"> <table cellpadding="0" cellspacing="0" style="width: 50%; text-align: center; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr style="text-align: center"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">2012</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">2011</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Deferred tax asset:</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; width: 10%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; width: 10%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">&#160;&#160;&#160;From Net operating loss</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">837,432</font></font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">667,852</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">&#160;&#160;&#160;Less valuation allowance</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 2px solid"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">(837,432</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">)</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 2px solid"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">(667,852</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">)</font></font></div> </td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">&#160;&#160;&#160;Net deferred tax asset</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">0</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">0</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td></tr></table></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold; text-decoration: underline">NOTE 7 &#8211; COMMITMENTS AND CONTINGENCIES</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company may from time to time be involved with various litigation and claims that arise in the normal course of business.&#160;&#160;As of January 31, 2012, no such matters were outstanding.</font></div></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 8 - GOING CONCERN AND FINANCIAL POSITION</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">MedCareers&#8217; financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.&#160;&#160;The Company has incurred cumulative losses through January 31, 2012 of $3,407,669 and has a working capital deficit at January 31, 2012 of $633,717.</font></div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Historically, revenues have not been sufficient to cover operating costs that would permit the Company to continue as a going concern.&#160;&#160;The potential proceeds from the sale of common stock and other contemplated debt and equity financing, and increases in operating revenues from new development and business acquisitions might enable MedCareers to continue as a going concern.&#160;&#160;There can be no assurance that the Company can or will be able to complete any debt or equity financing, or develop or acquire one or more business interests on terms favorable to it.&#160;&#160;MedCareers&#8217; financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></div></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 9 &#8211; SALE OF WEBSITE</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">In August 2011 we sold the Uniform Resource Locator (&#8220;<font style="display: inline; text-decoration: underline">URL</font>&#8221;) www.WorkAbroad.com for which we paid $225,000 in 2010 and made some improvements of $9,500. Since the closing of the Nurses Lounge acquisition, the Company decided to sell this URL and focus on developing Nurses Lounge and businesses that are complementary to Nurses Lounge.&#160;&#160;</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="background-color: #ffffff; display: inline">This asset was sold in the current year whereby the Company received $1,000 cash and the buyer assumed the remainder of the note on the URL. At the time of sale the book value of the URL was $191,026 made up of $234,500 with $43,474 of accumulated amortization. The Company recorded a loss of $4,087.</font></font></div></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 10 &#8211; RECENT ACCOUNTING PRONOUNCEMENTS</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&#8217;s results of operations, financial position or cash flows.</font></div> 13990 35001 20153 8040 3265 23128 94428 38447 7430 12623 -9138 -59427 -18294 610 -9358 274816 491010 146399 54825 45493 21129 65024 24748 7712 5897 470174 2398674 81401 96974 23812 766119 2954908 252548 159511 75202 -775257 -3014135 -270842 -158901 -84560 0 -4087 -4087 0 -4087 0 223454 0 0 0 50586 318934 37471 17760 12124 -50586 -576475 -41558 -17760 -16211 -825843 -3560610 -312400 -176661 -100771 45016265 40838974 47256131 40840000 -0.02 -0.01 0.00 0.00 0 25826 17249 274816 465183 129150 75000 165000 0 178384 1686034 0 -400 59794 0 0 14938 0 51032 100710 35778 83664 158058 9494 -163347 -885067 -122009 0 -215543 0 0 -191026 -191026 46650 540650 155000 0 -35731 -7173 122000 122000 0 0 246670 0 0 -185939 -185939 0 209429 0 0 16000 0 167650 913079 -38112 4302 3584 30905 0 21693 6943 0 0 0 75000 165000 0 0 884741 0 309970 614170 11200 EX-101.SCH 5 mcgi-20121031.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statement of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Note 1 - Nature of Activities and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Note 2 - Deferred Fees link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Note 3 - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Note 4 - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Note 5 - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Note 6 - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Note 7 - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Note 8 - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Note 9 - Going Concern and Financial Position link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Note 10 - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 mcgi-20121031_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 mcgi-20121031_def.xml XBRL DEFINITION FILE EX-101.LAB 8 mcgi-20121031_lab.xml XBRL LABEL FILE Common Stock Equity Components [Axis] Issuance of Common Stock for Debt Equity Issued Since Inception by Issuance [Axis] (Deprecated 2012-01-31) Issuance of Common Stock for Services Issuance of Common Stock for Deferred Fees Additional Paid-In Capital Retained Earnings (Deficit) Paid-In Capital Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Property, Plant and Equipment: Equipment Less: Accumulated depreciation Total Fixed Assets Other Assets: Deferred Fees (net) TOTAL ASSETS LIABILITIES AND EQUITY Current Liabilities: Accounts Payable Accrued Expenses Due to Related Parties Accrued Interest Payable Current portion of notes payable Total Current Liabilities Long Term Liabilities: Notes Payable Less: Current Potion Total Long Term Liabilities Total Liabilities Equity: Preferred Stock, $0.001 par value, 10,000,000 shares authorized, 1,000 and 1,000 shares issued and outstanding Common Stock, $0.001 par value, 350,000,000 shares authorized. 40,840,000 and 40,700,000 shares issued and outstanding Additional Paid In Capital Accumulated Deficit TOTAL STOCKHOLDERS' EQUITY (DEFICIT) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Preferred stock, par or stated value Preferred stock, shares authorized Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of Sales Gross Profit (Loss) Operating Expenses: Depreciation and Amortization Selling and Marketing General and Administrative Total Operating Expenses Net Operating Loss Other Income (Expense): Other Expense Loss on Recapitalization Interest Expense Total Other Income (Expense) Net Loss Weighted Average Shares Outstanding, Basic and Diluted Basic and Diluted Earnings (Loss) per Share Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used (provided) by operating activiites Depreciation of Property and Equipment Amortization of Deferred Fees Shares Issued for Services Stock Option Expense Changes in assets and liabilities: (Increase) in Other Current Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Expenses Increase (Decrease) in Accrued Expenses - Realted Party Net Cash Provided (Used) by Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of Fixed Assets Sale of Fixed Assets Net Cash Provided (Used) by Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from Notes Payable Payments on Notes Payable Proceeds from Sale of Common Stock Debt Assumed in Acquisition Debt Assumed by Buyer In Asset Sale Interest Added to Notes Payable Common Stock Issued on Recapitalization Net Cash Provided by Financing Activities NET INCREASE (DECREASE) IN CASH AND CASH EQUAVILENTS CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS AT END OF PERIOD SUPPLEMENTAL DISCLOSURES Cash Paid During the Year for Interest Expense Cash Paid During the Year for Taxes Issuance of Common Shares for Services Issuance of Common Stock for Debt Issuance of Common Stock for Fees Accounting Policies [Abstract] Note 1 - Nature of Activities and Significant Accounting Policies Payables and Accruals [Abstract] Note 2 - Deferred Fees Note 3 - Notes Payable Equity [Abstract] Note 4 - Stockholders' Equity Compensation and Retirement Disclosure [Abstract] Note 5 - Employee Benefit Plans Income Tax Disclosure [Abstract] Note 6 - Income Taxes Commitments and Contingencies Disclosure [Abstract] Note 7 - Commitments and Contingencies Property, Plant and Equipment [Abstract] Note 9 - Sale of Website Organization, Consolidation and Presentation of Financial Statements [Abstract] Note 9 - Going Concern Accounting Changes and Error Corrections [Abstract] Note 10 - Recent Accounting Pronouncements Issuance of Common Stock Options for goods or services. Issuance of Common Stock for Services Performed Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Capital Lease Obligations Debt, Current Liabilities Liabilities and Equity Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Outstanding Common Stock, Shares Authorized Other General Expense Interest Expense Proceeds from Sale of Property, Plant, and Equipment Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments EX-101.PRE 9 mcgi-20121031_pre.xml XBRL PRESENTATION FILE XML 10 R8.xml IDEA: Note 3 - Notes Payable 2.4.0.800000008 - Disclosure - Note 3 - Notes Payabletruefalsefalse1false falsefalseFrom2013-08-01to2013-10-31http://www.sec.gov/CIK0001438901duration2013-08-01T00:00:002013-10-31T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_LoanCommitmentsPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 3 - NOTES PAYABLE</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The components of the Company&#8217;s debt as of January 31, 2012 and 2011 were as follows:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: left"> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td colspan="2" style="text-align: right; vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt times new roman">2012</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td colspan="2" style="text-align: right; vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt times new roman">2011</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $202,500, 6% interest, payable $2,248 per month, due March 11, 2014</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">188,562</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2011</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">100,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">100,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $50,000, 12% interest payable monthly or accrued, due Nov 14, 2011</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">4,550</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $190,000, 12% interest payable monthly or accrued, due October 29, 2011</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">240,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">190,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $25,000, 12% interest payable monthly or accrued, due March 11, 2014</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">25,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">25,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2012</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">25,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">16,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $70,000, 12% interest added to note quarterly, due February 4, 2013</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">70,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $40,000, 12% interest added to note quarterly, due April 28, 2012</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">40,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2012</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">4,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Subtotal</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">520,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">508,112</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Less &#8211; currently payable</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">(495,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">)</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">(310,652</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">)</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Long-term debt</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">25,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">197,460</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company had accrued $36,046 and $9,386 interest on the notes at January 31, 2012 and 2011, respectively.&#160;&#160;As of January 31, 2011, $362,231 of unpaid interest had been added to the principal balance of the notes.</font></div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for loan commitments accounted for as derivatives, including the methods and assumptions used to estimate fair value and any associated hedging strategies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2229141 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.DD.Q2) -URI http://asc.fasb.org/extlink&oid=15071916&loc=d3e417888-122833 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section DD -Paragraph Question 2 false0falseNote 3 - Notes PayableUnKnownUnKnownUnKnownUnKnowntruefalsefalseNoteshttp://nurseslounge.com/role/Note3-NotesPayable12 XML 11 R6.xml IDEA: Note 1 - Nature of Activities and Significant Accounting Policies 2.4.0.800000006 - Disclosure - Note 1 - Nature of Activities and Significant Accounting Policiestruefalsefalse1false falsefalseFrom2013-08-01to2013-10-31http://www.sec.gov/CIK0001438901duration2013-08-01T00:00:002013-10-31T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 1 &#8211; NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="font-style: italic; display: inline; text-decoration: underline">Nature of Activities, History and Organization</font>&#160;&#8211; The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007.&#160;&#160;On December 16, 2009, an amendment was filed with the State of Nevada to change the name to &#8220;MedCareers Group, Inc.&#8221; (the &#8220;Company&#8221; or &#8220;MedCareers&#8221;) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its common stock in exchange for 100% of Nurses Lounge, Inc. (&#8220;Nurses Lounge&#8221;), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers.&#160;&#160;As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers.&#160;&#160;The transaction was accounted for as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company.&#160;&#160;The share exchange was treated as a recapitalization of MedCareers.&#160;&#160;As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital.&#160;&#160;The Company operates a website for nurses, nursing schools and nurses organizations which enable the respective entities to communicate more easily and efficiently with their members.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Significant Accounting Policies:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company&#8217;s management selects accounting principles generally accepted in the United States of America and adopts methods for their application.&#160;&#160;The application of accounting principles requires the estimating, matching and timing of revenue and expense. The accounting policies used conform to generally accepted accounting principles which have been consistently applied in the preparation of these financial statements.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The financial statements and notes are representations of the Company&#8217;s management which is responsible for their integrity and objectivity. Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud.&#160;&#160;The Company's system of internal&#160;&#160;accounting control is designed to assure, among other items, that&#160;&#160;1) recorded&#160;&#160;transactions&#160;&#160;are valid;&#160;&#160;2) valid&#160;&#160;transactions&#160;&#160;are recorded;&#160;&#160;and&#160;&#160;3) transactions&#160;&#160;are&#160;&#160;recorded in the proper&#160;&#160;period in a timely&#160;&#160;manner to produce financial&#160;&#160;statements which present fairly the financial&#160;&#160;condition,&#160;&#160;results of operations&#160;&#160;and cash&#160;&#160;flows of the&#160;&#160;Company&#160;&#160;for the&#160;&#160;respective&#160;&#160;periods&#160;&#160;being presented.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Basis of Presentation:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Principles of Consolidation:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc.&#160;&#160;All significant inter-company transactions have been eliminated.&#160;&#160;All amounts are presented in U.S. Dollars unless otherwise stated.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <br /> <br /> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Reclassifications</font>:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Certain prior year amounts have been reclassified to conform with the current year presentation.&#160;&#160;Specifically, additional paid-in capital has been reclassified to show the effect of a forward 10 for 1 stock split effective January 7, 2010 and the values as if the Company were converted from a limited partnership to a corporation in 2009.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Development Stage Company</font>:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company complies with ASC No. 915-10 for its characterization of the Company as development stage.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Cash and Cash Equivalents:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents.&#160;&#160;At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance limits.&#160; The carrying amount approximates fair market value.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Fixed Assets:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Fixed assets are carried at cost.&#160;&#160;Depreciation is provided over each asset&#8217;s estimated useful life.&#160;&#160;Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income.&#160;&#160;&#160;Additions and significant improvements are capitalized and depreciated.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Advertising Costs:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company incurred no advertising costs for the years ended January 31, 2012 and 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Income Taxes:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code.&#160; Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration.&#160; Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Use of Estimates:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><br /> &#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Fair Value of Financial Instruments:</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Pursuant to ASC No. 820, &#8220;Fair Value Measurements and Disclosures&#8221;, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of January 31, 2012.&#160;&#160;The Company&#8217;s financial instruments consist of cash, accounts payable, advances and notes payable.&#160;&#160;The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Revenue Recognition:</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned.&#160;&#160;The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured.&#160;&#160;For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "<font style="font-style: italic; display: inline">Revenue Recognition in Financial Statements</font>", (formerly Staff Accounting Bulletin No. 104 (&#8220;SAB 104&#8221;)).&#160;&#160;&#160;Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Earnings per Common Share:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Earnings (loss) per share are calculated in accordance with ASC 260 &#8220;<font style="font-style: italic; display: inline">Earnings per Share</font>&#8221;.&#160;&#160; The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share.&#160;&#160;Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding.&#160;&#160;Dilutive potential common shares are additional common shares assumed to be exercised.&#160; Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">There were no potentially dilutive common stock equivalents as of January 31, 2012, therefore basic earnings per share equals diluted earnings per share for the year ended January 31, 2012.&#160; The Company had 6,127,500 options outstanding at January 31, 2012. As the Company incurred a net loss during the year ended January 31, 2012, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Recently Issued Accounting Pronouncements:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company&#160;does not expect&#160;the&#160;adoption&#160;of&#160;recently&#160;issued&#160;accounting pronouncements&#160;to have a significant impact on the Company&#8217;s&#160;results of&#160;operations, financial position or cash flows.</font></div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.No definition available.false0falseNote 1 - Nature of Activities and Significant Accounting PoliciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note1-NatureOfActivitiesAndSignificantAccountingPolicies12 XML 12 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended 40 Months Ended
Oct. 31, 2012
Oct. 31, 2011
Oct. 31, 2012
Oct. 31, 2011
Oct. 31, 2012
Income Statement [Abstract]          
Revenue $ 8,040 $ 3,265 $ 13,990 $ 20,153 $ 35,001
Cost of Sales 7,430 12,623 23,128 38,447 94,428
Gross Profit (Loss) 610 (9,358) (9,138) (18,294) (59,427)
Operating Expenses:          
Depreciation and Amortization 54,825 45,493 274,816 146,399 491,010
Selling and Marketing 7,712 5,897 21,129 24,748 65,024
General and Administrative 96,974 23,812 470,174 81,401 2,398,674
Total Operating Expenses 159,511 75,202 766,119 252,548 2,954,908
Net Operating Loss (158,901) (84,560) (775,257) (270,842) (3,014,135)
Other Income (Expense):          
Other Expense 0 (4,087) 0 (4,087) (4,087)
Loss on Recapitalization 0 0 0 0 (223,454)
Interest Expense (17,760) (12,124) (50,586) (37,471) (318,934)
Total Other Income (Expense) (17,760) (16,211) (50,586) (41,558) (576,475)
Net Loss $ (176,661) $ (100,771) $ (825,843) $ (312,400) $ (3,560,610)
Weighted Average Shares Outstanding, Basic and Diluted 47,256,131 40,840,000 45,016,265 40,838,974  
Basic and Diluted Earnings (Loss) per Share $ 0.00 $ 0.00 $ (0.02) $ (0.01)  
XML 13 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 5 - Employee Benefit Plans
3 Months Ended
Oct. 31, 2013
Compensation and Retirement Disclosure [Abstract]  
Note 5 - Employee Benefit Plans
NOTE 5 – EMPLOYEE BENEFIT PLANS
 
During the years ended January 31, 2012 and 2011, there were no qualified or non-qualified employee pension, profit sharing, stock option, or other plans authorized for any class of employees.
XML 14 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 15 R9.xml IDEA: Note 4 - Stockholders' Equity 2.4.0.800000009 - Disclosure - Note 4 - Stockholders' Equitytruefalsefalse1false falsefalseFrom2013-08-01to2013-10-31http://www.sec.gov/CIK0001438901duration2013-08-01T00:00:002013-10-31T00:00:001true 1us-gaap_EquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_StockholdersEquityNoteDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-indent: 0pt; display: block"></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 4 - STOCKHOLDERS&#8217; EQUITY</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Preferred Stock:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share.&#160; There are no preferred shares outstanding at January 31, 2012 and 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Common Stock:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share.&#160; These shares have full voting rights.&#160; At January 31, 2012 and 2011, there were 43,315,000 and 40,700,000 shares outstanding, respectively.&#160; No dividends were paid in the years ended January 31, 2012 or 2011.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Options and Warrants:</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company had the following options or warrants outstanding at January 31, 2012:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Issued To</font></div> </td> <td style="vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"># Options</font></div> </td> <td style="vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Dated</font></div> </td> <td style="vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Expire</font></div> </td> <td style="vertical-align: top; width: 16%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Strike Price</font></div> </td> </tr><tr style="background-color: #cceeff"> <td style="text-align: left; vertical-align: top; width: 16%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">President and CEO</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">4,000,000</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">11/18/2010</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">11/18/2015</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$0.25 per share</font></div> </td> </tr><tr style="background-color: white"> <td style="text-align: left; vertical-align: top; width: 16%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Vice President</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">2,000,000</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">11/18/2010</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">11/18/2015</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$0.25 per share</font></div> </td> </tr><tr style="background-color: #cceeff"> <td style="text-align: left; vertical-align: top; width: 16%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Shareholder</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">127,500</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">08/11/2011</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">08/10/2016</font></div> </td> <td style="vertical-align: top; width: 16%"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$0.10 per share</font></div></td></tr></table></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Article 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Section B -Paragraph 7, 11A -Chapter 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Preferred Stock -URI http://asc.fasb.org/extlink&oid=6521494 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(d),(e)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section C Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 17: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 18: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 19: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644 Reference 20: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 21: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644 Reference 22: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644 Reference 23: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph d -Article 4 false0falseNote 4 - Stockholders' EquityUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note4-StockholdersEquity12 XML 16 R12.xml IDEA: Note 7 - Commitments and Contingencies 2.4.0.800000012 - Disclosure - Note 7 - Commitments and Contingenciestruefalsefalse1false falsefalseFrom2013-08-01to2013-10-31http://www.sec.gov/CIK0001438901duration2013-08-01T00:00:002013-10-31T00:00:001true 1us-gaap_CommitmentsAndContingenciesDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_CommitmentsAndContingenciesDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold; text-decoration: underline">NOTE 7 &#8211; COMMITMENTS AND CONTINGENCIES</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company may from time to time be involved with various litigation and claims that arise in the normal course of business.&#160;&#160;As of January 31, 2012, no such matters were outstanding.</font></div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for commitments and contingencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 14 -Paragraph 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 9, 10, 11, 12 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseNote 7 - Commitments and ContingenciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note7-CommitmentsAndContingencies12 XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 1 - Nature of Activities and Significant Accounting Policies
3 Months Ended
Oct. 31, 2013
Accounting Policies [Abstract]  
Note 1 - Nature of Activities and Significant Accounting Policies
NOTE 1 – NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Activities, History and Organization – The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007.  On December 16, 2009, an amendment was filed with the State of Nevada to change the name to “MedCareers Group, Inc.” (the “Company” or “MedCareers”) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its common stock in exchange for 100% of Nurses Lounge, Inc. (“Nurses Lounge”), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers.  As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers.  The transaction was accounted for as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company.  The share exchange was treated as a recapitalization of MedCareers.  As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital.  The Company operates a website for nurses, nursing schools and nurses organizations which enable the respective entities to communicate more easily and efficiently with their members.
 
Significant Accounting Policies:
 
The Company’s management selects accounting principles generally accepted in the United States of America and adopts methods for their application.  The application of accounting principles requires the estimating, matching and timing of revenue and expense. The accounting policies used conform to generally accepted accounting principles which have been consistently applied in the preparation of these financial statements.
 
The financial statements and notes are representations of the Company’s management which is responsible for their integrity and objectivity. Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud.  The Company's system of internal  accounting control is designed to assure, among other items, that  1) recorded  transactions  are valid;  2) valid  transactions  are recorded;  and  3) transactions  are  recorded in the proper  period in a timely  manner to produce financial  statements which present fairly the financial  condition,  results of operations  and cash  flows of the  Company  for the  respective  periods  being presented.
 
Basis of Presentation:
 
The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States.
 
Principles of Consolidation:
 
The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc.  All significant inter-company transactions have been eliminated.  All amounts are presented in U.S. Dollars unless otherwise stated.
 


Reclassifications:
 
Certain prior year amounts have been reclassified to conform with the current year presentation.  Specifically, additional paid-in capital has been reclassified to show the effect of a forward 10 for 1 stock split effective January 7, 2010 and the values as if the Company were converted from a limited partnership to a corporation in 2009.

Development Stage Company:

The Company complies with ASC No. 915-10 for its characterization of the Company as development stage.
 
Cash and Cash Equivalents:
 
The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents.  At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits.  The carrying amount approximates fair market value.
 
Fixed Assets:
 
Fixed assets are carried at cost.  Depreciation is provided over each asset’s estimated useful life.  Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income.   Additions and significant improvements are capitalized and depreciated.
 
Advertising Costs:
 
The Company incurred no advertising costs for the years ended January 31, 2012 and 2011.
 
Income Taxes:
 
Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code.  Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration.  Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance.
 
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
 
Use of Estimates:
 
In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based.

 

Fair Value of Financial Instruments:

Pursuant to ASC No. 820, “Fair Value Measurements and Disclosures”, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of January 31, 2012.  The Company’s financial instruments consist of cash, accounts payable, advances and notes payable.  The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments.
 
Revenue Recognition:

Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned.  The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured.  For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "Revenue Recognition in Financial Statements", (formerly Staff Accounting Bulletin No. 104 (“SAB 104”)).   Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable.
 
Earnings per Common Share:
 
Earnings (loss) per share are calculated in accordance with ASC 260 “Earnings per Share”.   The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share.  Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding.  Dilutive potential common shares are additional common shares assumed to be exercised.  Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive.
 
There were no potentially dilutive common stock equivalents as of January 31, 2012, therefore basic earnings per share equals diluted earnings per share for the year ended January 31, 2012.  The Company had 6,127,500 options outstanding at January 31, 2012. As the Company incurred a net loss during the year ended January 31, 2012, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive.
 
Recently Issued Accounting Pronouncements:
 
The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows.
XML 18 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 3 - Notes Payable
3 Months Ended
Oct. 31, 2013
Accounting Policies [Abstract]  
Note 3 - Notes Payable
NOTE 3 - NOTES PAYABLE

The components of the Company’s debt as of January 31, 2012 and 2011 were as follows:

   
2012
   
2011
 
Note Payable - $202,500, 6% interest, payable $2,248 per month, due March 11, 2014
  $ -     $ 188,562  
Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2011
    100,000       100,000  
Note Payable - $50,000, 12% interest payable monthly or accrued, due Nov 14, 2011
    -       4,550  
Note Payable - $190,000, 12% interest payable monthly or accrued, due October 29, 2011
    240,000       190,000  
Note Payable - $25,000, 12% interest payable monthly or accrued, due March 11, 2014
    25,000       25,000  
Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2012
    25,000       -  
Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014
    16,000       -  
Note Payable - $70,000, 12% interest added to note quarterly, due February 4, 2013
    70,000       -  
Note Payable - $40,000, 12% interest added to note quarterly, due April 28, 2012
    40,000       -  
Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2012
    4,000       -  
Subtotal
    520,000       508,112  
Less – currently payable
    (495,000 )     (310,652 )
Long-term debt
  $ 25,000     $ 197,460  

The Company had accrued $36,046 and $9,386 interest on the notes at January 31, 2012 and 2011, respectively.  As of January 31, 2011, $362,231 of unpaid interest had been added to the principal balance of the notes.
XML 19 R11.xml IDEA: Note 6 - Income Taxes 2.4.0.800000011 - Disclosure - Note 6 - Income Taxestruefalsefalse1false falsefalseFrom2013-08-01to2013-10-31http://www.sec.gov/CIK0001438901duration2013-08-01T00:00:002013-10-31T00:00:001true 1us-gaap_IncomeTaxDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_IncomeTaxDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 6 &#8211; INCOME TAXES</font></font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">MedCareers Group, Inc. has incurred losses since inception.&#160;&#160;Therefore, MedCareers has no federal tax liability.&#160;&#160;Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes.&#160;&#160;The net deferred tax asset generated by the loss carryforward has been fully reserved.&#160;&#160;The cumulative net operating loss carryforward is $3,407,669 at January 31, 2012 of which $2,463,034 is available for carryforward for federal income tax purposes and will expire in fiscal years 2026 to 2027.&#160; At January 31, 2012 and 2011, the deferred tax asset consisted of the following:</font></div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-indent: 0pt; display: block"><br /> </div> </div> <div style="text-align: center"> <table cellpadding="0" cellspacing="0" style="width: 50%; text-align: center; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr style="text-align: center"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">2012</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">2011</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Deferred tax asset:</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; width: 10%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; width: 10%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">&#160;&#160;&#160;From Net operating loss</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">837,432</font></font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">667,852</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">&#160;&#160;&#160;Less valuation allowance</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 2px solid"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">(837,432</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">)</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 2px solid"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">(667,852</font></font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">)</font></font></div> </td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">&#160;&#160;&#160;Net deferred tax asset</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">0</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">0</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td></tr></table></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 136, 172 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 43, 44, 45, 46, 47, 48, 49 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseNote 6 - Income TaxesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note6-IncomeTaxes12 XML 20 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 6 - Income Taxes
3 Months Ended
Oct. 31, 2013
Income Tax Disclosure [Abstract]  
Note 6 - Income Taxes
NOTE 6 – INCOME TAXES

MedCareers Group, Inc. has incurred losses since inception.  Therefore, MedCareers has no federal tax liability.  Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes.  The net deferred tax asset generated by the loss carryforward has been fully reserved.  The cumulative net operating loss carryforward is $3,407,669 at January 31, 2012 of which $2,463,034 is available for carryforward for federal income tax purposes and will expire in fiscal years 2026 to 2027.  At January 31, 2012 and 2011, the deferred tax asset consisted of the following:

   
2012
   
2011
 
Deferred tax asset:
           
   From Net operating loss
 
$
837,432
   
$
667,852
 
   Less valuation allowance
   
(837,432
)
   
(667,852
)
   Net deferred tax asset
 
$
0
   
$
0
 
XML 21 R14.xml IDEA: Note 9 - Going Concern and Financial Position 2.4.0.800000014 - Disclosure - Note 9 - Going Concern and Financial Positiontruefalsefalse1false falsefalseFrom2013-08-01to2013-10-31http://www.sec.gov/CIK0001438901duration2013-08-01T00:00:002013-10-31T00:00:001true 1us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_LiquidityDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 8 - GOING CONCERN AND FINANCIAL POSITION</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">MedCareers&#8217; financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.&#160;&#160;The Company has incurred cumulative losses through January 31, 2012 of $3,407,669 and has a working capital deficit at January 31, 2012 of $633,717.</font></div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Historically, revenues have not been sufficient to cover operating costs that would permit the Company to continue as a going concern.&#160;&#160;The potential proceeds from the sale of common stock and other contemplated debt and equity financing, and increases in operating revenues from new development and business acquisitions might enable MedCareers to continue as a going concern.&#160;&#160;There can be no assurance that the Company can or will be able to complete any debt or equity financing, or develop or acquire one or more business interests on terms favorable to it.&#160;&#160;MedCareers&#8217; financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.No definition available.false0falseNote 9 - Going Concern and Financial PositionUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note9-GoingConcernAndFinancialPosition12 XML 22 R2.xml IDEA: Consolidated Balance Sheets (Unaudited) 2.4.0.800000002 - Statement - Consolidated Balance Sheets (Unaudited)truefalsefalse1false USDfalsefalse$AsOf2012-10-31http://www.sec.gov/CIK0001438901instant2012-10-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2012-01-31http://www.sec.gov/CIK0001438901instant2012-01-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_AssetsCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse52155215USD$falsetruefalse2truefalsefalse912912USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false23true 3us-gaap_AssetsNoncurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 4us-gaap_MachineryAndEquipmentGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse17991799falsefalsefalse2truefalsefalse17991799falsefalsefalsexbrli:monetaryItemTypemonetaryGross amount, as of the balance sheet date, of long-lived, depreciable assets used in the production process to produce goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 4 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6812-107765 false25false 4us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1799-1799falsefalsefalse2truefalsefalse-1799-1799falsefalsefalsexbrli:monetaryItemTypemonetaryThe cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.14) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 14 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false26false 4us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 12 -Paragraph 5 -Subparagraph b, c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false27false 4us-gaap_DepositsAssetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse148987148987falsefalsefalse2truefalsefalse113833113833falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false28false 4us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse154602154602falsefalsefalse2truefalsefalse114745114745falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false29false 4us-gaap_AccountsPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse67186718falsefalsefalse2truefalsefalse67186718falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 false210false 4us-gaap_AccruedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2263322633falsefalsefalse2truefalsefalse2247122471falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false211false 4us-gaap_DueToRelatedPartiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse158058158058falsefalsefalse2truefalsefalse7439474394falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(k)(1)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph k -Subparagraph 1 -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 57 -Paragraph 2 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 false212false 4us-gaap_InterestPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse8691586915falsefalsefalse2truefalsefalse3404634046falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6935-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Liabilities -URI http://asc.fasb.org/extlink&oid=6509677 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Section A -Paragraph 7 -Chapter 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e7018-107765 false213false 4us-gaap_NotesAndLoansPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse540650540650falsefalsefalse2truefalsefalse495000495000falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20 -Article 5 false214false 4us-gaap_LiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse814974814974falsefalsefalse2truefalsefalse634629634629falsefalsefalsexbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 false215true 3us-gaap_LiabilitiesNoncurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse016false 4us-gaap_CapitalLeaseObligationsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse565650565650falsefalsefalse2truefalsefalse520000520000falsefalsefalsexbrli:monetaryItemTypemonetaryAmount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 16 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false217false 4us-gaap_DebtCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse-540650-540650falsefalsefalse2truefalsefalse-495000-495000falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of the sum of short-term debt and current maturities of long-term debt and capital lease obligations, which are due within one year (or one business cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Article 5 false218false 4us-gaap_LiabilitiesNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2500025000falsefalsefalse2truefalsefalse2500025000falsefalsefalsexbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22, 23, 24, 25, 26, 27 -Article 5 false219false 4us-gaap_Liabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse839974839974falsefalsefalse2truefalsefalse659629659629falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false220false 4us-gaap_PreferredStockValueOutstandingus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryValue of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false221false 4us-gaap_CommonStockValueOutstandingus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4812648126falsefalsefalse2truefalsefalse4331543315falsefalsefalsexbrli:monetaryItemTypemonetaryValue of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false222false 4us-gaap_AdditionalPaidInCapitalus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse35000133500013falsefalsefalse2truefalsefalse28194702819470falsefalsefalsexbrli:monetaryItemTypemonetaryExcess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false223false 4us-gaap_RetainedEarningsAccumulatedDeficitus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-4233511-4233511falsefalsefalse2truefalsefalse-3407669-3407669falsefalsefalsexbrli:monetaryItemTypemonetaryThe cumulative amount of the reporting entity's undistributed earnings or deficit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false224false 4us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-685372-685372falsefalsefalse2truefalsefalse-544884-544884falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4I -URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4590271-111686 false225false 4us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse154602154602USD$falsetruefalse2truefalsefalse114745114745USD$falsetruefalsexbrli:monetaryItemTypemonetaryTotal of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 true2falseConsolidated Balance Sheets (Unaudited) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/BalanceSheets225 XML 23 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 4 - Stockholders' Equity
3 Months Ended
Oct. 31, 2013
Equity [Abstract]  
Note 4 - Stockholders' Equity
NOTE 4 - STOCKHOLDERS’ EQUITY
 
Preferred Stock:
 
The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share.  There are no preferred shares outstanding at January 31, 2012 and 2011.
 
Common Stock:
 
The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share.  These shares have full voting rights.  At January 31, 2012 and 2011, there were 43,315,000 and 40,700,000 shares outstanding, respectively.  No dividends were paid in the years ended January 31, 2012 or 2011.  
 
Options and Warrants:
 
The Company had the following options or warrants outstanding at January 31, 2012:

Issued To
# Options
Dated
Expire
Strike Price
President and CEO
4,000,000
11/18/2010
11/18/2015
$0.25 per share
Vice President
2,000,000
11/18/2010
11/18/2015
$0.25 per share
Shareholder
127,500
08/11/2011
08/10/2016
$0.10 per share
XML 24 R10.xml IDEA: Note 5 - Employee Benefit Plans 2.4.0.800000010 - Disclosure - Note 5 - Employee Benefit Planstruefalsefalse1false falsefalseFrom2013-08-01to2013-10-31http://www.sec.gov/CIK0001438901duration2013-08-01T00:00:002013-10-31T00:00:001true 1us-gaap_CompensationAndRetirementDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 5 &#8211; EMPLOYEE BENEFIT PLANS</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">During the years ended January 31, 2012 and 2011, there were no qualified or non-qualified employee pension, profit sharing, stock option, or other plans authorized for any class of employees.</font></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for pension and other postretirement benefits.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -URI http://asc.fasb.org/topic&trid=2235017 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Implementation Guide (Q and A) -Number FAS88 -Paragraph 63 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 03-2 -Paragraph 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 158 -Paragraph 7, 21, 22 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 87 -Paragraph 264 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 106 -Paragraph 518 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5 -Subparagraph h -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5 -Subparagraph q -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS106-2 -Paragraph 20, 21, 22 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 30 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 8 -Subparagraph m -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseNote 5 - Employee Benefit PlansUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note5-EmployeeBenefitPlans12 XML 25 R5.xml IDEA: Consolidated Statements of Cash Flows (Unaudited) 2.4.0.800000005 - Statement - Consolidated Statements of Cash Flows (Unaudited)truefalsefalse1false USDfalsefalse$From2012-02-01to2012-10-31http://www.sec.gov/CIK0001438901duration2012-02-01T00:00:002012-10-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-02-01to2011-10-31http://www.sec.gov/CIK0001438901duration2011-02-01T00:00:002011-10-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2009-07-01to2012-10-31http://www.sec.gov/CIK0001438901duration2009-07-01T00:00:002012-10-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-825843-825843USD$falsetruefalse2truefalsefalse-312400-312400USD$falsetruefalse3truefalsefalse-3560610-3560610USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false23true 2us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 3us-gaap_Depreciationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse1724917249falsefalsefalse3truefalsefalse2582625826falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false25false 3us-gaap_AmortizationOfDeferredLoanOriginationFeesNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse274816274816falsefalsefalse2truefalsefalse129150129150falsefalsefalse3truefalsefalse465183465183falsefalsefalsexbrli:monetaryItemTypemonetaryThe net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 30 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6378273&loc=d3e8446-111530 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Direct Loan Origination Costs -URI http://asc.fasb.org/extlink&oid=6510860 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.1) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 25 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6962437&loc=d3e7402-111529 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=16382787&loc=d3e8622-111531 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 91 -Paragraph 5, 6, 7 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false26false 3us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse7500075000falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse165000165000falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of expense reported during the period resulting from the transaction in which equity securities were issued to pay for goods or nonemployee services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 65 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false27false 3MCGI_IssuanceOfCommonStockOptionsMCGI_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse178384178384falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse16860341686034falsefalsefalsexbrli:monetaryItemTypemonetaryIssuance of Common Stock Options for goods or services.No definition available.false28true 2us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse09false 3us-gaap_IncreaseDecreaseInOtherCurrentAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-400-400falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse5979459794falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.No definition available.false210false 3us-gaap_IncreaseDecreaseInAccountsPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse1493814938falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false211false 3us-gaap_IncreaseDecreaseInAccruedLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5103251032falsefalsefalse2truefalsefalse3577835778falsefalsefalse3truefalsefalse100710100710falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false212false 3us-gaap_IncreaseDecreaseInDueToRelatedPartiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse8366483664falsefalsefalse2truefalsefalse94949494falsefalsefalse3truefalsefalse158058158058falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false213false 3us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-163347-163347falsefalsefalse2truefalsefalse-122009-122009falsefalsefalse3truefalsefalse-885067-885067falsefalsefalsexbrli:monetaryItemTypemonetaryThe net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 false214true 3us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse015false 4us-gaap_PaymentsToAcquirePropertyPlantAndEquipmentus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse-215543-215543falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 17 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false216false 4us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipmentus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse00falsefalsefalse2truefalsefalse191026191026falsefalsefalse3truefalsefalse191026191026falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 16 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false217true 3us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse018false 4us-gaap_ProceedsFromNotesPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4665046650falsefalsefalse2truefalsefalse155000155000falsefalsefalse3truefalsefalse540650540650falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from a borrowing supported by a written promise to pay an obligation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 19 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false219false 4us-gaap_ProceedsFromRepaymentsOfNotesPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse-7173-7173falsefalsefalse3truefalsefalse-35731-35731falsefalsefalsexbrli:monetaryItemTypemonetaryThe net cash inflow or outflow from a long-term borrowing supported by a written promise to pay an obligation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false220false 4us-gaap_ProceedsFromIssuanceOfCommonStockus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse122000122000falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse122000122000falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from the additional capital contribution to the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 19 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false221false 4us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1us-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse246670246670falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 32 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586 false222false 4us-gaap_RepaymentsOfAssumedDebtus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse-185939-185939falsefalsefalse3truefalsefalse-185939-185939falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow from the repayments of a long-term debt originally issued by another party but is assumed by the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 20 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false223false 4us-gaap_IncreaseDecreaseInInterestPayableNetus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse209429209429falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false224false 4us-gaap_StockIssuedDuringPeriodValueAcquisitionsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse1600016000falsefalsefalsexbrli:monetaryItemTypemonetaryValue of stock issued pursuant to acquisitions during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false225false 4us-gaap_NetCashProvidedByUsedInFinancingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse167650167650falsefalsefalse2truefalsefalse-38112-38112falsefalsefalse3truefalsefalse913079913079falsefalsefalsexbrli:monetaryItemTypemonetaryThe net cash inflow or outflow from financing activity for the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false226false 4us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse43024302falsefalsefalse2truefalsefalse3090530905falsefalsefalse3truefalsefalse35843584falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false227false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse912912falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false228false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse52155215falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse52155215falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false229true 4us-gaap_SupplementalCashFlowInformationAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse030false 5us-gaap_InterestPaidus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse69436943falsefalsefalse3truefalsefalse2169321693falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of cash paid for interest during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 false231false 5us-gaap_IncomeTaxesPaidus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -Subparagraph f -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 false232false 5MCGI_IssuanceOfCommonStockForServicesMCGI_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse7500075000falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse165000165000falsefalsefalsexbrli:monetaryItemTypemonetaryIssuance of Common Stock for Services PerformedNo definition available.false233false 5us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse884741884741falsefalsefalsexbrli:monetaryItemTypemonetaryThe net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.No definition available.false234false 5us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefitus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse309970309970USD$falsetruefalse2truefalsefalse1120011200USD$falsetruefalse3truefalsefalse614170614170USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe amount of income tax expense reduction and deferred tax asset recorded in the transaction in which equity securities were issued to pay for goods or nonemployee services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 65 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false2falseConsolidated Statements of Cash Flows (Unaudited) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/StatementsOfCashFlows334 EXCEL 26 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]D8F-E-F,T9%\W,F8R7S0U,65?8C0Y.5\S9#8W M.3DU-F0V.#(B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DYO=&5?-%]3=&]C:VAO;&1E#I%>&-E;%=O65E7T)E;F5F:71? M4&QA;G,\+W@Z3F%M93X-"B`@("`\>#I7;W)K&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\ M>#I0#I%>&-E;%=O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!);F9O M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^3V-T(#,Q+`T*"0DR M,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^9F%L2!A(%=E;&PM:VYO=VX@4V5A'0^3F\\2!A(%9O;'5N=&%R>2!& M:6QE'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!#;VUM M;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^43,\ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]D8F-E-F,T9%\W,F8R7S0U,65?8C0Y.5\S9#8W.3DU M-F0V.#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9&)C939C-&1? M-S)F,E\T-3%E7V(T.3E?,V0V-SDY-39D-C@R+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5D($%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D8F-E-F,T M9%\W,F8R7S0U,65?8C0Y.5\S9#8W.3DU-F0V.#(-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9&)C939C-&1?-S)F,E\T-3%E7V(T.3E?,V0V-SDY M-39D-C@R+U=O'0O:'1M;#L@8VAAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XS-3`L,#`P+#`P,#QS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQAF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU M-"PX,C4\'!E;G-E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D8F-E-F,T9%\W,F8R7S0U,65? M8C0Y.5\S9#8W.3DU-F0V.#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9&)C939C-&1?-S)F,E\T-3%E7V(T.3E?,V0V-SDY-39D-C@R+U=O'0O:'1M;#L@ M8VAA'!E;G-E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&5D($%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V1I3H@ M:6YL:6YE.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN92<^3D]412`Q("8C M.#(Q,3L@3D%455)%($]&($%#5$E6251)15,@04Y$(%-)1TY)1DE#04Y4($%# M0T]53E1)3D<@4$],24-)15,\+V9O;G0^/"]F;VYT/CPO9&EV/@T*#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^ M/&9O;G0@'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE)SY.871U2!A;F0@3W)G86YI>F%T:6]N/"]F;VYT/B8C M,38P.R8C.#(Q,3L@5&AE($-O;7!A;GD@=V%S(&9O28C.#(R,3L@;W(@)B,X,C(P.TUE9$-AF5D(&-A<&ET86P@;V8@=&AE($-O;7!A;GDN($]N M($YO=F5M8F5R(#4L(#(P,3`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`[)B,Q-C`[8V]N9&ET:6]N+"8C,38P.R8C,38P.W)E28C,38P.R8C,38P.V9O M3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[ M(&UA2!P2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA2!T6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@ M8FQO8VL[(&UA6QE/3-$)V1I M65A2P@861D:71I;VYA;"!P86ED M+6EN(&-A<&ET86P@:&%S(&)E96X@2!W97)E(&-O;G9E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;B<^/&9O;G0@3H@:6YL:6YE.R!T M97AT+61E8V]R871I;VXZ('5N9&5R;&EN92<^1&5V96QO<&UE;G0@4W1A9V4@ M0V]M<&%N>3PO9F]N=#XZ/"]F;VYT/CPO9&EV/@T*#0H\9&EV('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^5&AE M($-O;7!A;GD@8V]N&EM871E3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$ M)V1I&5D($%S6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[(&UAF5D M(&%N9"!D97!R96-I871E9"X\+V9O;G0^/"]D:78^#0H-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA M6QE/3-$)V1I65A M2`S,2P@,C`Q,B!A;F0@,C`Q,2X\+V9O;G0^/"]D M:78^#0H-"CQD:78@3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA M2UF;W)W87)DF%T:6]N('!R:6]R('1O('1H96ER(&5X M<&ER871I;VXN)B,Q-C`[($%C8V]R9&EN9VQY+"!T:&4@9G5T=7)E(&EN8V]M M92!T87@@87-S970@86UO=6YT6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;B<^26YC;VUE('1A>&5S(&%R92!A8V-O=6YT960@9F]R('5N M9&5R('1H92!AF5D(&EN('1H92!T87@@"!R971U"!C"!P87EM96YT'!E;G-E M"!A"!R871E'!E8W1E9"!T;R!A<'!L>2!T;R!T87AA8FQE(&EN8V]M92!I M;B!T:&4@>65A'!E8W1E9"!T;R!B92!R96-O=F5R960@;W(@3H@ M8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;B<^/&9O;G0@3H@:6YL:6YE.R!T97AT M+61E8V]R871I;VXZ('5N9&5R;&EN92<^57-E(&]F($5S=&EM871E6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA2P@87)E(&1I2!F6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE)SY&86ER(%9A;'5E M(&]F($9I;F%N8VEA;"!);G-T6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I&-L=61E9"!F6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I2!I;F-U65A6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA'0M9&5C;W)A M=&EO;CH@=6YD97)L:6YE)SY296-E;G1L>2!)6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I3H@8FQO8VL[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[ M(&UA28C,38P.V1O97,@;F]T(&5X<&5C="8C,38P M.W1H928C,38P.V%D;W!T:6]N)B,Q-C`[;V8F(S$V,#MR96-E;G1L>28C,38P M.VES7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0G/CQD:78@ M3H@8FQO8VLG/CQB M3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/@T*/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QLF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$ M)W9E6QE/3-$)V1I"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B!B;VQD(#$P<'0@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`R M<'@@'0M86QI9VXZ(')I9VAT)SX-"CQD:78@'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B!B;VQD(#$P M<'0@=&EM97,@;F5W(')O;6%N)SXR,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXS M,#0L,C`P/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE M/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M*#$Y,"PS-C<@/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^*3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('!A M9&1I;F6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N)SXQ,3,L.#,S/"]F;VYT/CPO=&0^#0H\ M=&0@;F]W6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@"<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^,3(P+#'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I'1087)T M7V1B8V4V8S1D7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I'0M86QI M9VXZ(&IU6QE/3-$)V1I3H@:6YL:6YE.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN M92<^3D]412`S("T@3D]415,@4$%904),13PO9F]N=#X\+V9O;G0^/"]D:78^ M#0H-"CQD:78@3H@ M8FQO8VLG/CQB6QE/3-$)V1I3H@8FQO8VLG/CQB"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(&)O;&0@ M,3!P="!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@ M3H@8FQO8VL[(&UA6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M+3PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)V)A8VMG3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6%B;&4@+2`D,3`P+#`P,"P@,3(E(&EN=&5R97-T('!A>6%B M;&4@;6]N=&AL>2!O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,3`P+#`P,#PO9F]N=#X\ M+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W M:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^,3`P+#`P,#PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E M>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M3F]T92!087EA8FQE("T@)#4P+#`P,"P@,3(E(&EN=&5R97-T('!A>6%B;&4@ M;6]N=&AL>2!O'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W9E6QE/3-$)V1I'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^,C0P+#`P,#PO9F]N=#X\+W1D/@T*/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,3DP+#`P M,#PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I6%B;&4@;6]N=&AL>2!O M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^,C4L,#`P/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXR-2PP,#`\ M+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)A8VMG6%B;&4@ M+2`D,C4L,#`P+"`Q,B4@:6YT97)E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N)SXR-2PP,#`\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`] M,T1N;W=R87`@'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$ M)V)A8VMG6QE/3-$)W9E M6QE/3-$)V1I2P@9'5E($IA M;G5A6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)W9E3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N)SXM/"]F;VYT/CPO=&0^#0H\=&0@;F]W M6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^3F]T92!087EA8FQE("T@)#3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXW,"PP M,#`\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)V)A8VMG6QE/3-$)W9E6QE M/3-$)V1I2P@9'5E($%P'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W M:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^+3PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[ M('!A9&1I;F6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E"<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^+3PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A M<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W M:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W9E M3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^-3(P+#`P,#PO9F]N M=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^*#0Y-2PP M,#`\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@"<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^*#,Q,"PV-3(\+V9O;G0^/"]T9#X- M"CQT9"!N;W=R87`],T1N;W=R87`@3H@ M8FQO8VL[(&UA"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^,C4L,#`P/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E"<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,3DW M+#0V,#PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)V1I3H@8FQO M8VL[(&UA3H@8FQO8VLG M/CQB3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA M2!H860@86-C2XF(S$V,#LF(S$V,#M!3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]D8F-E-F,T9%\W,F8R7S0U,65?8C0Y.5\S M9#8W.3DU-F0V.#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9&)C M939C-&1?-S)F,E\T-3%E7V(T.3E?,V0V-SDY-39D-C@R+U=O'0O:'1M;#L@8VAA6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@ M:6YL:6YE.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN92<^3D]412`T("T@ M4U1/0TM(3TQ$15)3)B,X,C$W.R!%455)5%D\+V9O;G0^/"]F;VYT/CPO9&EV M/@T*#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I3H@ M8FQO8VL[(&UA2!IF5D('1O(&ES M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I3H@ M8FQO8VL[(&UA'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE)SY#;VUM;VX@4W1O8VLZ/"]F M;VYT/CPO9F]N=#X\+V1I=CX-"@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0G/B8C,38P.SPO M9&EV/@T*#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I2`S,2P@,C`Q,B!A;F0@,C`Q,2P@=&AE6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA'0M9&5C;W)A M=&EO;CH@=6YD97)L:6YE)SY/<'1I;VYS(&%N9"!787)R86YT6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA2!H M860@=&AE(&9O;&QO=VEN9R!O<'1I;VYS(&]R('=A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1IF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('9E"!S;VQI9"<^#0H\9&EV M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'0[ M(&1I'0M:6YD96YT M.B`P<'0[(&1I'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E"!S M;VQI9"<^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E'!I6QE/3-$)W9E"!S;VQI9"<^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E M'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W9E'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^,3$O,3@O,C`Q-3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('9E6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA6QE/3-$ M)V1I6QE/3-$ M)W9E'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('9E6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W9E'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^,#@O,3$O,C`Q,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA6QE/3-$)V1I'1087)T7V1B8V4V8S1D7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[('1E M>'0M86QI9VXZ(&IU6QE/3-$)V1I3H@:6YL:6YE.R!T97AT+61E8V]R871I;VXZ('5N M9&5R;&EN92<^3D]412`U("8C.#(Q,3L@14U03$]9144@0D5.149)5"!03$%. M4SPO9F]N=#X\+V9O;G0^/"]D:78^#0H-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[(&UA6QE/3-$)V1I M65A2`S,2P@,C`Q,B!A;F0@,C`Q M,2P@=&AEF5D(&9O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M&5S/&)R/CPO"!$:7-C;&]S M=7)E(%M!8G-T&5S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I2<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B!B;VQD(#$P<'0@5&EM97,@ M3F5W(%)O;6%N)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[('1E M>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE)SY.3U1%(#8@)B,X,C$Q.R!)3D-/ M344@5$%815,\+V9O;G0^/"]F;VYT/CPO9&EV/@T*#0H\9&EV('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I2XF(S$V,#LF(S$V,#M!9&1I=&EO;F%L M;'D@=&AE"!A69O69O"!P=7)P;W-E'!I2`S,2P@,C`Q,B!A;F0@,C`Q M,2P@=&AE(&1E9F5R"!A6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D M/@T*/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S M;VQI9"<^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V1I6QE/3-$)V1I'0M:6YD M96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P M=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V)A8VMG6QE/3-$)W9E6QE M/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T M:#H@.24G/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@.24G/@T*/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=&5X="UI;F1E;G0Z(#!P M=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V)A8VMG3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[(&UA6QE M/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)W9E'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)W9E"<^#0H\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[(&UA6QE/3-$)V)A8VMG6QE M/3-$)W9E6QE M/3-$)V1I6QE/3-$)W9E"<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E"<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/CPO='(^/"]T86)L93X\ M+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I2<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7=E:6=H=#H@8F]L9#L@=&5X M="UD96-O6QE/3-$)V1I2!F2`S,2P@,C`Q,BP@;F\@7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M2<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B!B;VQD(#$P<'0@5&EM97,@3F5W(%)O;6%N M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[('1E>'0M9&5C;W)A M=&EO;CH@=6YD97)L:6YE)SY.3U1%(#D@)B,X,C$Q.R!304Q%($]&(%=%0E-) M5$4\+V9O;G0^/"]F;VYT/CPO9&EV/@T*#0H\9&EV('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL:6YE.R!T97AT+61E8V]R871I M;VXZ('5N9&5R;&EN92<^55),/"]F;VYT/B8C.#(R,3LI('=W=RY7;W)K06)R M;V%D+F-O;2!F;W(@=VAI8V@@=V4@<&%I9"`D,C(U+#`P,"!I;B`R,#$P(&%N M9"!M861E('-O;64@:6UP3H@8FQO8VLG/CQB6QE/3-$)V1I6QE M/3-$)V)A8VMG'1087)T7V1B8V4V8S1D7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%T:6]N+"!#;VYS;VQI9&%T:6]N(&%N9"!0'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN92<^3D]412`X M("T@1T])3D<@0T].0T523B!!3D0@1DE.04Y#24%,(%!/4TE424]./"]F;VYT M/CPO9F]N=#X\+V1I=CX-"@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:R<^/&)R("\^#0H\+V1I=CX-"@T*/&1I=B!S M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0G/CQF;VYT('-T>6QE/3-$)V1I2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L M97,@87!P;&EC86)L92!T;R!A(&=O:6YG(&-O;F-E2`S,2P@,C`Q,B!O9B`D-C,S+#6QE/3-$)V1I2P@2!T;R!C;VYT:6YU92!A2!F:6YA;F-I;F2!C86X@;W(@=VEL;"!B92!A8FQE('1O(&-O;7!L971E(&%N>2!D M96)T(&]R(&5Q=6ET>2!F:6YA;F-I;F2!A9&IU7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I'0M9&5C;W)A=&EO;CH@=6YD M97)L:6YE)SY.3U1%(#$P("8C.#(Q,3L@4D5#14Y4($%#0T]53E1)3D<@4%)/ M3D]53D-%345.5%,\+V9O;G0^/"]F;VYT/CPO9&EV/@T*#0H\9&EV('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^5&AE M($-O;7!A;GD@9&]E2!I3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]D8F-E-F,T9%\W,F8R7S0U,65?8C0Y.5\S M9#8W.3DU-F0V.#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9&)C M939C-&1?-S)F,E\T-3%E7V(T.3E?,V0V-SDY-39D-C@R+U=O&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U'1087)T7V1B8V4V8S1D7S XML 27 R4.xml IDEA: Consolidated Statement of Operations (Unaudited) 2.4.0.800000004 - Statement - Consolidated Statement of Operations (Unaudited)truefalsefalse1false USDfalsefalse$From2012-08-01to2012-10-31http://www.sec.gov/CIK0001438901duration2012-08-01T00:00:002012-10-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2011-08-01to2011-10-31http://www.sec.gov/CIK0001438901duration2011-08-01T00:00:002011-10-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2012-02-01to2012-10-31http://www.sec.gov/CIK0001438901duration2012-02-01T00:00:002012-10-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$From2011-02-01to2011-10-31http://www.sec.gov/CIK0001438901duration2011-02-01T00:00:002011-10-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$From2009-07-01to2012-10-31http://www.sec.gov/CIK0001438901duration2009-07-01T00:00:002012-10-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_IncomeStatementAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_Revenuesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse80408040USD$falsetruefalse2truefalsefalse32653265USD$falsetruefalse3truefalsefalse1399013990USD$falsetruefalse4truefalsefalse2015320153USD$falsetruefalse5truefalsefalse3500135001USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false23false 2us-gaap_CostOfGoodsSoldus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse74307430falsefalsefalse2truefalsefalse1262312623falsefalsefalse3truefalsefalse2312823128falsefalsefalse4truefalsefalse3844738447falsefalsefalse5truefalsefalse9442894428falsefalsefalsexbrli:monetaryItemTypemonetaryTotal costs related to goods produced and sold during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a)) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 false24false 2us-gaap_GrossProfitus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse610610falsefalsefalse2truefalsefalse-9358-9358falsefalsefalse3truefalsefalse-9138-9138falsefalsefalse4truefalsefalse-18294-18294falsefalsefalse5truefalsefalse-59427-59427falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 false25true 2us-gaap_OperatingExpensesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse06false 3us-gaap_DepreciationAndAmortizationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5482554825falsefalsefalse2truefalsefalse4549345493falsefalsefalse3truefalsefalse274816274816falsefalsefalse4truefalsefalse146399146399falsefalsefalse5truefalsefalse491010491010falsefalsefalsexbrli:monetaryItemTypemonetaryThe current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false27false 3us-gaap_SellingAndMarketingExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse77127712falsefalsefalse2truefalsefalse58975897falsefalsefalse3truefalsefalse2112921129falsefalsefalse4truefalsefalse2474824748falsefalsefalse5truefalsefalse6502465024falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate total amount of expenses directly related to the marketing or selling of products or services.No definition available.false28false 3us-gaap_GeneralAndAdministrativeExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse9697496974falsefalsefalse2truefalsefalse2381223812falsefalsefalse3truefalsefalse470174470174falsefalsefalse4truefalsefalse8140181401falsefalsefalse5truefalsefalse23986742398674falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 false29false 3us-gaap_OperatingExpensesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse159511159511falsefalsefalse2truefalsefalse7520275202falsefalsefalse3truefalsefalse766119766119falsefalsefalse4truefalsefalse252548252548falsefalsefalse5truefalsefalse29549082954908falsefalsefalsexbrli:monetaryItemTypemonetaryGenerally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.No definition available.false210false 3us-gaap_OperatingIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-158901-158901falsefalsefalse2truefalsefalse-84560-84560falsefalsefalse3truefalsefalse-775257-775257falsefalsefalse4truefalsefalse-270842-270842falsefalsefalse5truefalsefalse-3014135-3014135falsefalsefalsexbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No definition available.false211true 3us-gaap_OtherIncomeAndExpensesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse012false 4us-gaap_OtherExpensesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse-4087-4087falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse-4087-4087falsefalsefalse5truefalsefalse-4087-4087falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents a sum total of expenses not separately reflected on the income statement for the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4,6) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 false213false 4us-gaap_OtherGeneralExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse00falsefalsefalse5truefalsefalse-223454-223454falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of general expenses not normally included in Other Operating Costs and Expenses.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.6) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 6 -Article 5 false214false 4us-gaap_InterestExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-17760-17760falsefalsefalse2truefalsefalse-12124-12124falsefalsefalse3truefalsefalse-50586-50586falsefalsefalse4truefalsefalse-37471-37471falsefalsefalse5truefalsefalse-318934-318934falsefalsefalsexbrli:monetaryItemTypemonetaryThe cost of borrowed funds accounted for as interest that was charged against earnings during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 34 -Paragraph 21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher OTS -Name Federal Regulation (FR) -Number Title 12 -Section 563c.102 -Paragraph 9 -Chapter V -Subsection II -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy. It will be removed from future versions of this taxonomy. false215false 2us-gaap_OtherIncomeus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-17760-17760falsefalsefalse2truefalsefalse-16211-16211falsefalsefalse3truefalsefalse-50586-50586falsefalsefalse4truefalsefalse-41558-41558falsefalsefalse5truefalsefalse-576475-576475falsefalsefalsexbrli:monetaryItemTypemonetaryReflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.4) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 4 -Article 7 false216false 2us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-176661-176661USD$falsetruefalse2truefalsefalse-100771-100771USD$falsetruefalse3truefalsefalse-825843-825843USD$falsetruefalse4truefalsefalse-312400-312400USD$falsetruefalse5truefalsefalse-3560610-3560610USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false217false 2us-gaap_WeightedAverageNumberOfSharesIssuedBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4725613147256131falsefalsefalse2truefalsefalse4084000040840000falsefalsefalse3truefalsefalse4501626545016265falsefalsefalse4truefalsefalse4083897440838974falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThis element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e2646-109256 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false118false 2us-gaap_EarningsPerShareBasicAndDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.000.00USD$falsetruefalse2truefalsefalse0.000.00USD$falsetruefalse3truefalsefalse-0.02-0.02USD$falsetruefalse4truefalsefalse-0.01-0.01USD$falsetruefalse5falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalThe amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.No definition available.false3falseConsolidated Statement of Operations (Unaudited) (USD $)NoRoundingNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/StatementOfOperations518 XML 28 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 HtmlAndXml 10 92 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://nurseslounge.com/role/DocumentAndEntityInformation Document and Entity Information R1.xml true false R2.htm 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://nurseslounge.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) R2.xml false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://nurseslounge.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) R3.xml false false R4.htm 00000004 - Statement - Consolidated Statement of Operations (Unaudited) Sheet http://nurseslounge.com/role/StatementOfOperations Consolidated Statement of Operations (Unaudited) R4.xml false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://nurseslounge.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) R5.xml false false R6.htm 00000006 - Disclosure - Note 1 - Nature of Activities and Significant Accounting Policies Sheet http://nurseslounge.com/role/Note1-NatureOfActivitiesAndSignificantAccountingPolicies Note 1 - Nature of Activities and Significant Accounting Policies R6.xml false false R7.htm 00000007 - Disclosure - Note 2 - Deferred Fees Sheet http://nurseslounge.com/role/Note2-DeferredFees Note 2 - Deferred Fees R7.xml false false R8.htm 00000008 - Disclosure - Note 3 - Notes Payable Notes http://nurseslounge.com/role/Note3-NotesPayable Note 3 - Notes Payable R8.xml false false R9.htm 00000009 - Disclosure - Note 4 - Stockholders' Equity Sheet http://nurseslounge.com/role/Note4-StockholdersEquity Note 4 - Stockholders' Equity R9.xml false false R10.htm 00000010 - Disclosure - Note 5 - Employee Benefit Plans Sheet http://nurseslounge.com/role/Note5-EmployeeBenefitPlans Note 5 - Employee Benefit Plans R10.xml false false R11.htm 00000011 - Disclosure - Note 6 - Income Taxes Sheet http://nurseslounge.com/role/Note6-IncomeTaxes Note 6 - Income Taxes R11.xml false false R12.htm 00000012 - Disclosure - Note 7 - Commitments and Contingencies Sheet http://nurseslounge.com/role/Note7-CommitmentsAndContingencies Note 7 - Commitments and Contingencies R12.xml false false R13.htm 00000013 - Disclosure - Note 8 - Subsequent Events Sheet http://nurseslounge.com/role/Note8-SubsequentEvents Note 8 - Subsequent Events R13.xml false false R14.htm 00000014 - Disclosure - Note 9 - Going Concern and Financial Position Sheet http://nurseslounge.com/role/Note9-GoingConcernAndFinancialPosition Note 9 - Going Concern and Financial Position R14.xml false false R15.htm 00000015 - Disclosure - Note 10 - Recent Accounting Pronouncements Sheet http://nurseslounge.com/role/Note10-RecentAccountingPronouncements Note 10 - Recent Accounting Pronouncements R15.xml false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Jul. 31, 2010' Process Flow-Through: 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00000004 - Statement - Consolidated Statement of Operations (Unaudited) Process Flow-Through: 00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited) mcgi-20121031.xml mcgi-20121031.xsd mcgi-20121031_cal.xml mcgi-20121031_def.xml mcgi-20121031_lab.xml mcgi-20121031_pre.xml true true XML 29 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (Parenthetical) (USD $)
Oct. 31, 2012
Jan. 31, 2012
Statement of Financial Position [Abstract]    
Preferred stock, par or stated value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 350,000,000 350,000,000
Common stock, shares outstanding 48,126,000 43,315,000
XML 30 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 9 - Going Concern and Financial Position
3 Months Ended
Oct. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Note 9 - Going Concern
NOTE 8 - GOING CONCERN AND FINANCIAL POSITION

MedCareers’ financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.  The Company has incurred cumulative losses through January 31, 2012 of $3,407,669 and has a working capital deficit at January 31, 2012 of $633,717.

Historically, revenues have not been sufficient to cover operating costs that would permit the Company to continue as a going concern.  The potential proceeds from the sale of common stock and other contemplated debt and equity financing, and increases in operating revenues from new development and business acquisitions might enable MedCareers to continue as a going concern.  There can be no assurance that the Company can or will be able to complete any debt or equity financing, or develop or acquire one or more business interests on terms favorable to it.  MedCareers’ financial statements do not include any adjustments that might result from the outcome of this uncertainty.
XML 31 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended 40 Months Ended
Oct. 31, 2012
Oct. 31, 2011
Oct. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Loss $ (825,843) $ (312,400) $ (3,560,610)
Adjustments to reconcile net loss to net cash used (provided) by operating activiites      
Depreciation of Property and Equipment 0 17,249 25,826
Amortization of Deferred Fees 274,816 129,150 465,183
Shares Issued for Services 75,000 0 165,000
Stock Option Expense 178,384 0 1,686,034
Changes in assets and liabilities:      
(Increase) in Other Current Assets (400) 0 59,794
Increase (Decrease) in Accounts Payable 0 0 14,938
Increase (Decrease) in Accrued Expenses 51,032 35,778 100,710
Increase (Decrease) in Accrued Expenses - Realted Party 83,664 9,494 158,058
Net Cash Provided (Used) by Operating Activities (163,347) (122,009) (885,067)
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchase of Fixed Assets 0 0 (215,543)
Sale of Fixed Assets 0 191,026 191,026
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from Notes Payable 46,650 155,000 540,650
Payments on Notes Payable 0 (7,173) (35,731)
Proceeds from Sale of Common Stock 122,000 0 122,000
Debt Assumed in Acquisition 0 0 246,670
Debt Assumed by Buyer In Asset Sale 0 (185,939) (185,939)
Interest Added to Notes Payable 0 0 209,429
Common Stock Issued on Recapitalization 0 0 16,000
Net Cash Provided by Financing Activities 167,650 (38,112) 913,079
NET INCREASE (DECREASE) IN CASH AND CASH EQUAVILENTS 4,302 30,905 3,584
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 912    
CASH AND CASH EQUIVALENTS AT END OF PERIOD 5,215   5,215
SUPPLEMENTAL DISCLOSURES      
Cash Paid During the Year for Interest Expense 0 6,943 21,693
Cash Paid During the Year for Taxes 0 0 0
Issuance of Common Shares for Services 75,000 0 165,000
Issuance of Common Stock for Debt 0 0 884,741
Issuance of Common Stock for Fees $ 309,970 $ 11,200 $ 614,170
XML 32 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (Unaudited) (USD $)
Oct. 31, 2012
Jan. 31, 2012
Current assets:    
Cash and cash equivalents $ 5,215 $ 912
Property, Plant and Equipment:    
Equipment 1,799 1,799
Less: Accumulated depreciation (1,799) (1,799)
Total Fixed Assets 0 0
Deferred Fees (net) 148,987 113,833
TOTAL ASSETS 154,602 114,745
Accounts Payable 6,718 6,718
Accrued Expenses 22,633 22,471
Due to Related Parties 158,058 74,394
Accrued Interest Payable 86,915 34,046
Current portion of notes payable 540,650 495,000
Total Current Liabilities 814,974 634,629
Long Term Liabilities:    
Notes Payable 565,650 520,000
Less: Current Potion (540,650) (495,000)
Total Long Term Liabilities 25,000 25,000
Total Liabilities 839,974 659,629
Preferred Stock, $0.001 par value, 10,000,000 shares authorized, 1,000 and 1,000 shares issued and outstanding 0 0
Common Stock, $0.001 par value, 350,000,000 shares authorized. 40,840,000 and 40,700,000 shares issued and outstanding 48,126 43,315
Additional Paid In Capital 3,500,013 2,819,470
Accumulated Deficit (4,233,511) (3,407,669)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) (685,372) (544,884)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 154,602 $ 114,745
XML 33 R7.xml IDEA: Note 2 - Deferred Fees 2.4.0.800000007 - Disclosure - Note 2 - Deferred Feestruefalsefalse1false falsefalseFrom2013-08-01to2013-10-31http://www.sec.gov/CIK0001438901duration2013-08-01T00:00:002013-10-31T00:00:001true 1us-gaap_PayablesAndAccrualsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 2 &#8211; DEFERRED FEES</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">Deferred fees represent stock issued as fees to make or extend notes payable. Stock issued was valued at the date of issue and amortized over the term of the loan. Deferred fees at January 31, 2012 and 2011 were as follows:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> </div> <div style="text-align: left"> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; text-align: right"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt times new roman">2012</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: right; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; text-align: right; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; text-align: right"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: bold 10pt times new roman">2011</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: bold 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Deferred Fees</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">304,200</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">161,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr style="background-color: white"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Less: Accumulated Amortization</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">(190,367 </font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">)</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">(40,250</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">)</font></td> </tr><tr style="background-color: #cceeff"> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">Deferred Fees - Net</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">113,833</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">120,750</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td></tr></table></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20, 24 -Article 5 false0falseNote 2 - Deferred FeesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note2-DeferredFees12 XML 34 R3.xml IDEA: Consolidated Balance Sheets (Parenthetical) 2.4.0.800000003 - Statement - Consolidated Balance Sheets (Parenthetical)truefalsefalse1false USDfalsefalse$AsOf2012-10-31http://www.sec.gov/CIK0001438901instant2012-10-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$AsOf2012-01-31http://www.sec.gov/CIK0001438901instant2012-01-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1true 1us-gaap_StatementOfFinancialPositionAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_PreferredStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false33false 2us-gaap_PreferredStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse1000000010000000falsefalsefalse2truefalsefalse1000000010000000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false14false 2us-gaap_PreferredStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesAggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false15false 2us-gaap_CommonStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value of common stock per share; generally not indicative of the fair market value per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false36false 2us-gaap_CommonStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse350000000350000000falsefalsefalse2truefalsefalse350000000350000000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false17false 2us-gaap_CommonStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4812600048126000falsefalsefalse2truefalsefalse4331500043315000falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1falseConsolidated Balance Sheets (Parenthetical) (USD $)UnKnownNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/BalanceSheetsParenthetical27 XML 35 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 8 - Subsequent Events
9 Months Ended
Oct. 31, 2012
Property, Plant and Equipment [Abstract]  
Note 9 - Sale of Website
NOTE 9 – SALE OF WEBSITE

In August 2011 we sold the Uniform Resource Locator (“URL”) www.WorkAbroad.com for which we paid $225,000 in 2010 and made some improvements of $9,500. Since the closing of the Nurses Lounge acquisition, the Company decided to sell this URL and focus on developing Nurses Lounge and businesses that are complementary to Nurses Lounge.  

This asset was sold in the current year whereby the Company received $1,000 cash and the buyer assumed the remainder of the note on the URL. At the time of sale the book value of the URL was $191,026 made up of $234,500 with $43,474 of accumulated amortization. The Company recorded a loss of $4,087.
XML 36 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 7 - Commitments and Contingencies
3 Months Ended
Oct. 31, 2013
Commitments and Contingencies Disclosure [Abstract]  
Note 7 - Commitments and Contingencies
NOTE 7 – COMMITMENTS AND CONTINGENCIES

The Company may from time to time be involved with various litigation and claims that arise in the normal course of business.  As of January 31, 2012, no such matters were outstanding.
XML 37 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 2 - Deferred Fees
3 Months Ended
Oct. 31, 2013
Payables and Accruals [Abstract]  
Note 2 - Deferred Fees

NOTE 2 – DEFERRED FEES

Deferred fees represent stock issued as fees to make or extend notes payable. Stock issued was valued at the date of issue and amortized over the term of the loan. Deferred fees at January 31, 2012 and 2011 were as follows:

   
2012
   
2011
 
Deferred Fees
  $ 304,200     $ 161,000  
Less: Accumulated Amortization
    (190,367 )     (40,250 )
Deferred Fees - Net
  $ 113,833     $ 120,750  
XML 38 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 39 R13.xml IDEA: Note 8 - Subsequent Events 2.4.0.800000013 - Disclosure - Note 8 - Subsequent Eventstruefalsefalse1false falsefalseFrom2012-02-01to2012-10-31http://www.sec.gov/CIK0001438901duration2012-02-01T00:00:002012-10-31T00:00:001true 1us-gaap_PropertyPlantAndEquipmentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_PropertyPlantAndEquipmentDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 9 &#8211; SALE OF WEBSITE</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">In August 2011 we sold the Uniform Resource Locator (&#8220;<font style="display: inline; text-decoration: underline">URL</font>&#8221;) www.WorkAbroad.com for which we paid $225,000 in 2010 and made some improvements of $9,500. Since the closing of the Nurses Lounge acquisition, the Company decided to sell this URL and focus on developing Nurses Lounge and businesses that are complementary to Nurses Lounge.&#160;&#160;</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman"><font style="background-color: #ffffff; display: inline">This asset was sold in the current year whereby the Company received $1,000 cash and the buyer assumed the remainder of the note on the URL. At the time of sale the book value of the URL was $191,026 made up of $234,500 with $43,474 of accumulated amortization. The Company recorded a loss of $4,087.</font></font></div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13-14) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0falseNote 8 - Subsequent EventsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note8-SubsequentEvents12 ZIP 40 0001121781-13-000363-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001121781-13-000363-xbrl.zip M4$L#!!0````(`#2*-T,NECXM73```)#W`0`1`!P`;6-G:2TR,#$R,3`S,2YX M;6Q55`D``_.O0%+SKT!2=7@+``$$)0X```0Y`0``[#UK<^,VDM^OZOX#SEN7 MRU1)MEY^3B9;CCV>T^V,QVM[_/HXB]B"TD2I^M]?<;^PQ$0_]0L'I]!;"_BCA4^LMM-P<[3)+QV<'!9#+9C]4# MGRC]N]D/U&K@[E2J`Y'#^G3QH-\%)>U_IP4&KT6@>_./3Q[M@*$:\+F.3\#@0>]E;D8Q_KWJO>7IZ M>D!/LZ%S(Q%YAJ-]@(][W!20D<`GQL]1`D_#)'_!'WQX8!^6ALK*H4=VJ,R& MAF)FG!'!_D`]',"#`URL>J-9;S>SX5KT%Y)\=`!/LX'2J$ZK>?S4_.R([(74 MU`>"!`SDO;"_J,)]]SC9#H6[_:,1-7<8P<9*"N1 M@8H3\9@P&;[;N])JA`I0;YP`D8FBS\U&O<"?OR;B1";3_-O\>QGBD[X$U2(J M18GCV6)>=/^V]S/H1K/3/CEM-'\ZF'VY0'=0B<]A&PLM53A/!4BJ3E"A?RZF MDT$JGLV]!O:G>(GF7:`/2Z]DWY<(R+YT+%W,YW/SN6\).ZTW#E\8;ZT=2'XN M)I"C<$]VRJ36BQ1`CTFMLB1])299F_*"F403^#I,99*?_+'4OKU^;QSI4]C:9G\Y>YRCILCP4VJQ<\N/SR# M,1FP[%$9!4);`/]NR+4P"U$X)M"@C7$`?3<+\(3R`99QGK?X[G4ZLC4=[_'Z M/)BEL0JJA_12Q&HDXV5HE_-E%F\5X.QYB0M5#`V%/'M/,GTK!M(D&JPE%GF8 M$YY;S+:?"BH_O;^\.+]]__[VCGVX_?SEIL:Z<;#_T\$BP/.(+T"G-(^Z<2@> M_R:F*V/V]78A-!_=I0I@B>+D?CI>?7[PX^\6OO]Z%=@;TL'W5D-7AN_;TH70 M?'3G\#3$$5<1'ZR,IL\C(RR&$@`?\D6J-7XM3<"C_Q-I;9/`5M7@#^ M5T31WV(UB>]`SE4LPJXQ*1CN5=%>*U\`%D";1_NKBM(8C/"4RKEF0W0S4"K$ MV_+A5HR53F0\L,73#;%5`YM'2L1<`+<'2J^N473WT22J"K M],"NN)7?*_AN];G^O5W6@3E(B]&A@*V'#&LZ5>AR2!5+J48C%=\E*OC=>IW/ M:8+Q)>XKE/#.%+T86EQZX)P5"T4@@=GFW5[W^FKOY\/6<>/DY*A=6NHGD&6D MN?KLV;J$94Q82ECGI-DZ`D/[T\$JJ+8GRY6+EY+5;CAZ' M[_^9RC$N_@>MC%F-5Q@Y>10UP$DA`&H%:AY=B MK`$D3Z2*X7,D\`,`.!^A4?@7?7^C%82=Y;JK\[5F MN7#@M=AX?3Q5>PK\]J0L9^*&I`!;E9&).3=&))MK>N?D].2XH*`,=1.<*TA- MLWW2;J^*<\OY'7:.&BU/1M?&L=PZ4X@D!!9&5N^)3W(N$BGTWG=73< M/"EI7@7L;2A8/NL-*="I"#]*WI.13*0P6[*AU3KR)6DA_"T)6-(X]%9F,89M:5G.E>-.^[2S"2E=0`=!3[(;93DY M.FUZ^ED-?!L2EG.BW6ETCM8E87=ZG&D?MSE'K=!W<%WPL M$QY]A(17?.Y%;)PK>)@2V=01EL)>PL"5G`"VQ&PL7*W3Q/DI!+L@9\WP?1URSL-0HLKS MZ(;+L!L[@[`I6]HH?$T_&*J&OQ49*^C`2?.T<]Q8FXQ;D7!([M'9DVU)&X#544"FTP94RFW3B( M4A2Z&\RW(?5.$BU[:8+!QKU":P34:A5%,"2+13;F[]')8?O8R[%V0\ZWG.0* MRW38Z9R<=+[V)#UC"NG_/(Y=I<'+\.R&KO53YW7I*EMT5G#R&])J,9VGR5!I^2\1;E6";[K>^D4D MSB+;!6DKEN&_!FF[VKE80M3*8<]N-RXVI\K;X/A6:KL"RIU1N;G";D?E3E65 M0LK&T_M2B[5A;:I6E+DMJ>)F"*X%?Z!+>>`1)&7F/+G@6D]!3HG1&U<:6GZ= M:254.Z1ON;L];;:^%WE9)^93Y'5.3XZVI.]:)10Z?%0\WE&I?;9Z\@2*K:E9 MOH2SQ94UJ/&T9%>Y..VG5^KALNQW;6)68`WNHJ]%3-&=<)/V(AE<18I7KLQ\ MYT.5\L\W/7A@9QGP"S<2@(/;-+!6W&V0WLE!+"')P_T_NZ5""04`@9#X'JCZ M)8+Y5#6%5)[\^B%*WH;R@9ED&HEW>_A.7<;8#GK&&N/D+0NE&4=\>L9Z"/G>#X/D+6+K`V49NARXC"'I M$6\9/@14$-&S)D!B]W(D#+L6$W:K1CQ>#0AA!\XK34P[@S6!!`&?T?O7G^_? MLR;[@8_&;_]RTFHVW[+K\_LOM^_9YRMV?G'?_;5[WWU_Q\ZO+]E=]\-U]ZI[ M<7Y]#X\N/G^YON]>?V`WGS]V+V`,DG*`M&1TE7\!QM+GOS3;[G_K<3N?;D^S M@P+2+D"OM)![)9RST,OKZ]B^&Y2KB-=[Z,G<_%%FW&9MP`W/2 M(PA\X-/M/]A=H.48HKH:^_CQ@JF878I`C/!,<[M18ZU&HX,#.;M6.ADR<'A@ M`&+.(CF2\!;\M%DRIMT6`Q((-N%!:'R>*'Q7//"0P[=Z[.8\AQP[6TO8#PGY M\?[LE/#39V]<\X@&GM8`,>-9_Z6=IXR`@HD$NA-@`46OR%9'#I`6#'D\$/0T MQLY<^"IC7*OQ]I,`CZ\%-C!^T"H=6RKS`<#9'_%-[PW'97^(TM4@O3%O+,\* M6K@7G;H2*)"=%,NXSX`%U^K!8U435LL;P22V9H:LU:F!C\;_F&U\1DB2&@S0 M)8'"&A=8.!DJ*)H6E>3&*9ETIZ1H>2@$`"GX&JE MN'A8:P5.5\R9FR:S&#A8C-]@$9)I1NF#HKY-R['E6%'KL#7;\(`D'B626S\* MX)'+W-*%ERD(-A)Z`&LY&0HM>M,9DB;$R!BF#$])J7I.4G+'#!\A,M6"P.(" MER:I72&7N<)?F7[&^PF\B`"+A>`1"&$Z&/KCI*%!D1B`2(ZY"QZM2"[B07F! M:2J)%IA(9@QP,NX,VFH+:M)@."LL/Z(:X=2'9"LAR`P9I\@]>_B$EJ5X1>?-NN,4I!A0[9,QK0+*AOP!Y57$;`SO<6WG)TM\ M'G+X,IKPJ;$CD8@"B6=!:V@+Y]6#A8"NYDR%G2O9+9RX%LJZ!??`<77ANF2& M`MN\`"HNQ42`5B76!-@[!&KTD\0^&"H5&4)EGS'EN2$#DBN#(?`1HWXW,3,6 MZ,&$Y2YN]*'-!<,#H6N`QGBD<'(0?4;6;X@^;BK`:/@]L]M2@VZ@G0-9V"SN M^8KA0\';.6J>`WD[CF[6C62\#((5*03+BJ?QX;';PU@ MB_F`3!@S(@)]-;Y3&6L)AFX<`;@!W=83H:8&@<"H#<,&5/0O,86"%%^1/ST' M9P:K3BK-0S4&F",!WB2DV-,I-1^/([0"&!@LLE'>&(1;39@6Y/BL21?`^!'' M(3686H(]V@.B`[[&CP`%/6Z<6J,I'LZPF MD-\,2/!YPO#<)L1%*A(@8+,H2`O)C8.HSH@LQJTN0Z,X*8$>-& M^IV9*8COB/('W#*.@4,>G"RPQ/?&I&))!B84"450('5E=]W7[#5@!=]76&K3!3&"M6C;1GI'$< M1T,+$E@U"G0AQC1#(:0P#3Q=JQKNJ9]5':=TK,^E!AE/ADL`@%#8?I]:]>PP M(23EM2'P0NY@1G$[E+:H4L54O-3/73*^YCR6XB MH@A_5A2_*XN1,-IXA0Z*6.M9+<\/O;QL4.#^2L:&MA,):2--_85Z_O+FXQ./7I1H;FMB;D4002)#\F6# M5']M*ZS,"UCIU_UC*QL70F."C8$!I`-3P76N]X6QT+D`V*PV*T?E.YO962%Z MWR]-5!J7.\@M2)@@^(#4.#\3P<9XY";:@+,4$ULM:W?ASR%0B`L M,TRXQFX*NX7H-LJ`'S)Q`W$KX']XG.*VW;'=M+2UN2$ES2F65VC+Q-_(G`C; MV.@VE/M:C5BQ_PP16P*!E!G*L=UK]C>982ZX-;RI,?R*_1+/5R*WM5:7XD%$ MRE[E`"'LH"B+[<)J_2F7Q$]2,*Z(L#!-RG]^=\&NU3X[;1[6G=[1UM^08U5/ M:&]+U5`WG?6=&P&96L)WWPVE)?\X[OIINV0P.\&,3O M0T`$V7TD866P!M[#U,`D.G4E32H-X!Y56C290#["1H!PB)OKC")[V^N!]4XQ'^H07<@Y@B#-OD0]F"-0=7(L02!'.7GD"&8U*-K\", M"B?J]_M<778O2HU+,G^%'+)/%VVI!:Y!VD4UN/&EU2/NT`%=6,?%9?E=)-;] MORP;]/*$=5N32R=\J\6IEON'"6\=Q>#40'?4"O,!BG%G&35)H#_^(K MW!@#S<,;2T.F()1F@@=#"[&T7^GVSV%4:D0_C4"O^Z(2_)>QPLP@D=KN3-). M'\Q+&1[9-CN"3O2Y!J6(N_WR[!`QF$6/1KO#-0+R7)A?JME0,T$\=8U\:%,& MF#FAG<1+W61>ZLD+J;COJ*G,XL5`L4`[#&%4]:P\:^H2(XNY5.$9(2NSG6%: M#=?`AK.+O5F]U$+,R]&,;4W:>8AYI33V1D[S:M>^6_0D[;4DV&?!N+(&3';RAZ`+*J$Q)ND!#92H MN'`EBM0$.(L^ICCT9-M:]R&%MA<.%.)D M2B-EWCD8J('MT9\,0<*H&Z&-G?QD3U33LK.UD[>2KP1:OE;2\ MNBNV>@J14?X\7),71!1H?^CX`@T/X#WI`GG^P&5D#S`H6)4^+CB.&?.IG5B8 M4AW%F1`*1F:PEU<\Q[["E#?AY)+%V0$7*X38_W;&#W0D"N8& M]"819%Q4>,IVID`Q5I@5;6"Y(S9(6#X3ZM;UN5JFWO4]VOY;FWVZ-G3D":7% M>&+G93F(YT#>=PY0OQ@Z*/K>%4->@]1OZY`9MAV[1F'JR5OH]7;::U?SN_5' MP!CX_??\2`D^_RT-!\6!`.PN'XUMC8A,`+=&AX(%%TS:TWU+C'S6)(_%*O(7 MU*AN3R<.J+96:;9JN%4.@76-3".P.0#/]C0J:QRQ?C:BJ%X8%:59>8R.#&?G M:9"%]B!*/O^Y20.OH]#9:+]"!HRF%,,#[UH4Z)Q?(F%=J/P'$;7'(?G'Z.I;6YW>?GI9@EO-^=FLVWZO^LJXX6:O10)UO\JUJUOL M2^[$T_TINS1N4FU2W!X`MY7U99RT&C7_^@=O`3[9(+IP`)?6?L-W_MT0LY_\9SODF#-!S,,NTW,S%!@>DO!\&QE==F1 MK=(64C5:=_X1H>/N=*W8V!G;FZ*P%>W!;E@7I^W1Z_-XOS*EMFSFQX+GJ>_VLH>E=W; M'VIJ6YK:K#!Z:[/'G9T'^%.:UHR9%%3244\>N#TA5'RW'8Q56CS(:C.!OA#& MQHET;$>ZXAIJM0;%I!(*;BW5QU$Z5S[AUH[D$*D'7^CLXB0,@[WN?,%UO*"1 M?T%[D'O9%C'LZT`E&&&!._3X`4TX[HAKK$E0=)QWXZJ>OK-BO<#G8(MN! MN(IX[2[W5R4KLE=C/Y*(XNE8&-/O^[=N_))&^+?/8@I,FHU.J;'K[OP7_,[O M[7JSI#\BH[)<(J.J)*@*A$*&;GY9+-#B$=8$UM0MP-36\&A52-A58#>$W9U- M'#-Y2.H#0EDIV:[-)!!R3(&&*]NZYI>>C22>G:=Z+<4]Y4BS/SU`>X_V'DU& M%^N^UN2^X2KFJ_`C;IZ\H<6P5U/9_J] M,%^5QHL,^D0@:]"-@]'!\PEQ2K?H86+B[L1S%^5YU\"&*17$J&DNN^S`70YC MK[0:IPF5I61`WJ.25]5=>C)*D1KA3\UCK06=[;4D3T_`44YW<"CT=Y*JGB'B M0&N\<(*+2)1Z$":4DS!;I;3Z*6-[N*]<=&4 MYZY&L^ELWM00+N:HY69^."C;*:5+]^9:%?*&)$Y-@[B8-1<98K.!K?5.J`3: M$_[U?%CAK&?S>5D.Y^59IGM:.SHD%JNGI9[DQVNB7U#L<.TGM.\ZH]&%)`$8 M3"*>D#6_8VU!P]ILMWPA?2$[JC5;Q[7#1B.7>-\>\60>&-ZN62H6S6 MT&4C+CMWV]9K9TD@QK0U4>AH=IFBH8L(*1(G-7&GE:HY_ZHV+SPL@]S$;N=T M[3VS_O5^6L4*&[=V5U!^7JOZ9]U^F"OX(MM"!>,PZ;:M&=Y]5O[=1O;^,147 MWZA^Z:(I$J;B&WM[<>557^.2>'GXE.W?^[&^QP9"#^:Z7]^KL_J/J663UEK'DO,D*7),`T<"#$D&>W3Y,DMZR'\+ M"V+3NR4:>4T=F+1./7T@.VT.8WJ^1G.W:&@?WCNE.4U>X.3C.)/CWU4+<98? MD9C+M!,`QC`7Z>BZ2(&5-G"G%_4G;6HH#8CG3=`7]9^Q`PK]/0+1G_V>ONK- M'<8O7VA]^X4]IWFS8":_22'N>?+9>01+GCR0_F'DC%T/IKCT^!*@_<%;@'*3<#-HJ37,!>\8/8_N7M;)J1Y":K+=462X#E5%. M['MY*]&"H-R3H5S%5+"+UVE3;DF5]O;BQJ2Z0MN@PH]/R]V2*/J"Q^^SFBJ= MY+"@H#O@_M5>'_0M%:MJ8=6BP=E,0$EP@NV<(EJMRR#J^\:R2Q107^F=ZR M+BN@>2Q+Q?B3Y3"6V\#Q,<;?I;53(AKV\GYT02JE7KRXW:DETK!($@T-$/CA M0;KK_-GY>MM=I9:C"!IH8$`)+8X=C">!3]*&1.LZB-+*X<61RDT,Z!#Q&R)^ M@\\M-\-$-GOTQWW+77O\1K-NN05AGRIAB_"-6H['CO4DC!8#3OT)L$//5%G% M=*B69/XBT1Z+)(I;64PM?-Q2=9LF)]$&*BU:J>6[$PY>)"4QE_2Z#](:?1IP M#,[^?GSY\WJ]^.,ZUA(TVTB:56R[99@%IN`I46X]T1^GH@_!!\:`H):DJ'.% M.-.'5`EZM*:*DYS$)1JQ%[Q*.E6'UVJ^C'_B`. ML.BK%"1PH.L04%:1;>2&Q7D-7D*J89,PG8*2EH(!?F1Q8OU`:YS!`4?'JQ0 MD,*'K$5%ZLPJ,CED56UQR-HXXF^`>!$A.X*"CYN"A8(4Y;&WZ,SCNI<4E8(_ M8*5@O7XUW#`Z$ZPB6*6)"K\1-";0XN;]@'B=$4? M*,$DQ\0DFB*W3*-F)2X:01V;2@]@'C$)Q[0!P.'5M^AN<[K=;0Z17=,P"A-, M(IAD\RR4MM72S8_()<5]H&:?[MI9AD&G5GC[;+%VZUO3T!9":<,@Z<499B4G MI#/-;,FZ29L#G;5;FFW.K[H#G_89PHON2'+B]1V%6A(\/R&#V'TEWOM%CEIF M/W6*>A+!?V%\M:5J"GXZ]2>..YR/CSB?"/'G=^X(9Q*Z_L"=.)[TY'B./R!9 M/R2*\V*]\9/[>=Z+K+")V'*GL8<8]NHE\$"21-V_IV[\CI$"5ZLMRHZN^]BG ME55J-GW7T,=,E\ZEA\?^Y?_\JW][U;U_R/77DKK_^^/F\<]5$EMO;!]@)1=E M]:GU0MMUC^_"K&DNY>J"YF?'LIG'MW=Y)>2"2IG&+T'H_B>1[6X430E\E\9< MP?^EZ,4!-8#2?6G/6J`97L',D1PP>$+IU?&F5`FRK-"V+O2[.44DP=#8 M]"Y$-0$J)'M?-L8TCF+09O2E&Q3=!NTB"*0!S(V:'*P6P=D-Y&S-F+/V(-FG ME/N`X]@X.2+95T$0$&DT]3SI-8B1>^F\HOSSG8V&:TSE`NV(J6LM3:&'&_1S M76Y92Y)H+B766KQ2+X!->'5A3X91\M[4J*4VZCMQPDB"SV!E5E`%82ID"NQG M0;^-%CS]"?XUHH3SAQ.&#O@2IRN`DL.&YNS>LG.+G)8TMT61$*1[`^SUEF[- M-H7?C):XBR=%1]/Y=I52EL^RXF`R/\@RMUZNE;J5.21-%JW3#2J]H?08['(; M4\?"#0B>MS1IZ?XAI>)4+!WKTETY,1F*96-=MN[/B1ON%/;T,=?M(0[=OPCX MY^Z@PNKQN>IG5C='J4[NP-]`IR*F)N9EM[]'8CU28M0S]U(LSDN!)V)*2[D.Y" MNA^C=!<&/+I*N,1)#(F@Q!4N5:V6(43[ZL+(]F>08+OVS#O=M9%Q;4RQ-@6B M79'+B/;>!R&!`/P MOA*?C-PX:EILW6*P;7H;U[#`-6,AJ;/[_>ZV_V>W*WWM]KK7-X_2W6VG][!* M""=R)=G`.^6K:8C7BUNO_0N#$?P`:TMY[LB%KP0A_.Z?S_]`QA,O>"<$.)PR M4TN:A`'P#>5V&IX0(7NF5Y\M?$&`+Y=@`OY">,8(V\_Y[]+`D,D M[5P(5.7E99EPXP^",7ET?@J^9^=[]=Z;'S?UTNW"YB\;D+AN]D M>`E*&12G]`T>^I),)P2<\=N[&3 M1%"XXTD0`;@GD!=@-CD8U!2"0'$&R>=O+^[@A7YK2$`$T."O)R(%;SX@>G$G MTN#%\9])M&X:8,3$\-4T-A,A@U""/SV#)`GQ9A-'1GF*JR,-G#!\AWF_.>&0 M3I?F"F`PV#M&9Y'PE0S7CC28CJ>>@^%;=-!@@@.@N%Y]M1M)9UI+EZV6:;8+ MPT-!;"93/U-;NJFU9$VG47"OCNO1L`V4L@OOQ#]D6^-2X4>G.YF&N,))'-&; MZWD2H3>3&#XV`M$(3R>J1)55$U<7_K68@MV*EA<$;.1&N+QI)L4L=F9;',SI M2!%6L9*8_$M'&A5"=`QY*9$K\R7V%K53>C9\ZJ/LZ,CD:'N5%G?);FP(X$&` MQ.'__DDMG?DGGVHTP9;O)]<`A755.?G^S263HP,LZ)J9K@N.^$Z;KA>N#RKK MGE)$T<":'5W(W%7F%P M3,UDS[^B;!TB?E[P]UA)HW:WF\]*-DZ]<,TQ.05^.3K`@L$%@W]0!E^TJ[9E MZ&P*JE\.P,^5P.[XPTL8&^9(_(%+&I>*,UOMQL7Z5P_SQP_/WT@"!5,&RD7^ M6PN1_Y?][]]O'K]W>X\/4J=W!;_W'F]ZW[J]RYN]IP*<;K!^OK;@V'F71GCG MC`Q,Z]'COT\8GOT:>*\$8[;C%^G5"=U@&DF>&[O/Z`%0,8Q)@#0-*)< MG4/6ROAL(F%9H-RZ?T_=H1N_'XWX.#@)UI`J9$OGTK<^"`44#I?=^QX5%-$M*@H+>8)./FV`2/7=X!Q@,>!&6.:'!?1-)E)2"8. MNO/(\,_2#]^-:9%S!SMN)%DOF,WB###_A]"N'<&4,F+6!L/#9)')Q`.K!9,/ M0"8YTG.`#P"3#4CHIYDIE.7&,!=\,PJ=D,`J_B>13B!/Z%E"DG?B4=:=?9)E M#0'?5Q-8B]59YEAP2/OT MT<\(S9W/1`2F[N)?@4>`0:.$Y>83FZT&'1,=B"'\Q0LFXZPR8,:)("K@Q9&; M).:-<8LDXE,9D4L2K+8((+@&CH]V#]@<(#BF(6W#0]<[O\3X$!9=QCPV>#@3 M4+`\(+9B0O..Z3K`0ZO+`'],)X<_TNF@0>,3_'405%F([HQH5381#6PX#2'FR+-QTFR)TA,D_R,9UZLLB`8^K%+OX` MTZ7S%`;.\`($!,T(3DRUM[1EQ)F:M-I$%8#%W:A\'SM#G`D(%'<,&N@UE4]H MV[2QA-*%].`FPAB$-/`Y+8"?9/7VT%J+8+)3\./R^J&U(+5A2F[:;BTB(+FI MU(+9T.%'P6!*I6PJFO'U2^_-*2$R\W9)*O41+1IE\/*%K_'L>5%G-O!'Y:[E M[Q?<[([H_W(0<[?+CTA32?+Y&]@=E#-3WX+Z!O!BS','A@"]GN;\9_09D@%Q M\:SE3$EZR3C1"Z4Z?.AI^@Z6%MHDM/P`]7/&#BY9F&\3F+4V!+*^P)QY_)F> MY<`SU(JC[PJ"O^8M:=+'*=XSI0UCJV;"C=,)93]5TY$!DR.@,QV\%4NGGM4@ M]7/0?P.[)4Z]K@OI<7%6>!H/CR05"/"->DNVBUR5\A8#BQ6P;$'`AG=F[B:\ MR`_0=)F=!R65'&[\_#.91RHLB[*6!4CUO&EQW[WL]AZESN5E_P<]O)7N[OL] M^/FR2\]U&VYK-%=>Y5EM&.#E"UCSY"=V<**<[0R34DG(=RA@_-A[3_I6+1VZ MY-D`M1AU2QTI@HF[X)$"FZ%B=@:S[JGIJ#D/(TI]!,KDJ6\'3EHKYWE,@D0S M2[1N",BWD1>\E:K(Q(-KER7!?>9UEN1F('0W>>C'P]4G:E",'2_"ZA?_K6CM MMCR'F[V:84BY?2Y;+$-J()65G894E-PLE1)#8KU9;;)E9VK*^V[KB M)&V626JJ:6P?\3*(XO[H6Q`,HP>4IQQH2-44UU2L`>B`3ZP7:"Q4S[IB&K M^MYAL=N=.DB+_<-BMA8L1:UEL9A(WK#;5A54WY)[>62+X=CUW2@.Z24V1ZK7 M+5FQ\NIV\Y"[(V1F`%5KVV:M$)F9P5;TO-^W?X"L;-$VV[6O(!.'J)J=9UQ& M@/WLVCK]G,OY@66:BI)3""N#5$'!3OUM4)>RS1D&N[@W5$/GCH*5C!6C;2C* M'M:"B58M0Y75*B"2,.E;6O:7@V]H`1##*@`R'Z<:%'9O49,57=&,/6!A]Q]5 M2[;UHOW9&0HKN9XKH/CE(GKEL2IL3J:M&Z;,A@1#B7@*U/SP^7>S#LQ.GKIL M6YP&9Z='GH.S4B"O)6>G-]99IQJ?HV6[//?%$:J!8%??J@;^[AZ0,-/A/I9C M9WKDM1),M,D&XB:-^.-(F89LV+ESMJ41V`&PWU,I=EO3.2)@OU:P=$OA"8#9 ME+2LO#[DL@*,]PJ*6GX+**$FNIJ+[;A$@KG7LXUT_J1>R3F[*#8JF'KN:/>A1%8AZ_@E(#%NW"G ML]/X[.2F`8/+W(:O0'.F:2H<9\](>+)L666'_X,FI))AYQ4T\3/I3<=/).R/ M:"?3Z(8&QWQU(G?`3I;)*_+@;GK7>`DA`V?DHPK*0N`)?3-)K8,NVYJ]<)QW M".B;R7$==$LU3$53#K[J&TAY_:H#,^?9N2KTKA/ZX'A'=R2DS]*'.O[PRO6F M&+E91?+>K4%]+E_DCZJV#,T!Z58AN0FI4B?2K?)T'5(`*M>\I)LE[UZ`YJ]E M.7OC^5TZ;@/'[X?NL^O3 M#ZX)B7J$2UC17UC&@B*LB&1_$V*F*<5L^(QV.>W;<3+?+[_=?$%S M!C-O^Z-+FG%,6W+W)TG*+X]8;0ML6K!HMPZV"ZH*9&&;LK9O6%7VMC2@^?%2 MDN5]19)_;WQZ$G"9I$!UDI(,/'S^!8^WS*BDJ`$/P0F]S955XW%XHLJ9NP;DT M+">H['LNRY:R;4WW@Y7]1L2PK&WTR0SU:DH>@WM"4T+OG)`7"=B::6Z4G07C M\@++3@2&+1L;5W:/:)G)H*UOUDHEL(*S<.E$+W=A\(KI]5_??X#M!XHB"_GH M@)GWRDT7C@%3)D5)PN#^"@2FC"YF/02:K> MK$WCYFPCE!^8*V1V(E$5P\C?81T(^"Z6Q`Z0T\)3B.'!\<#3J(T^RH_,%S0[ MA2AM1@5!LA_HO2`F/'T+W32--;21'VH'2.S>HR[O&Q/[Z:*Q>(I5 M!=,]F:32HC_BO8UKH*T;DA/,*G$#5OZ*LD:L[!QL*9;&#VKAB1*7\SVT6-;L M?^&@/%"R>PJ'0+F39F<%V`M\+/+1#]%U2'_IS,MS79$G/$/"BD8*9XYG&)DO M:/8K0U`W5A.0[T(9.X#."X[T&7R<,SVL&:4ZF`J&FVVTM?8>(56I?5`)TNHQ M019.F@I]3O?&&X_25H?D!).=@^6VGD_EKA$KWQ/?[3"IE$^"C:ZF(199(J$; M#/^-M>0Z^;J\?'>_[+`%F&);R>=)5\>-7\,R;?`/^O2OX.WCU1(ELF5! MQ,6'U_*!B"RCH:B;K3<".?N5DMR6#3[0YYK(Y5)8K2#U!E_-."R[9:"8 M^=HS.PS-O!EF6R\]=)Z#[VA?%0V^/I;F.@BS^"B. M87.EQML57.40N%K0\0UY*@!6QHJZ#/Q7$D8T]#+Y.7;!R'X@`W@2528H5_"Z MQU7NPEV!1=.8)YL5\8*>HN4<\+T_JOSS^?0L_]@O^%7_\?4$L#!!0````( M`#2*-T/<%36+*04``+0>```5`!P`;6-G:2TR,#$R,3`S,5]C86PN>&UL550) M``/SKT!2\Z]`4G5X"P`!!"4.```$.0$``,U96U/;.!1^WYG]#UKW8=L'Q78, MA:2P'1HNDQD*+(%.WSJ*+2<:%(M*,@G_?H]\26(PCC/8+'DPMJSSG>]-4HH&8 MW7.J*;Q(%?>1U]FE".,:L#]H%`AY>SU$M MJYB_QD2QODKHG0N?Z"3#-JI!+\XP3SB?ALT0=KO8 M6C-_PK!)!M=)U7ZH(ZL?[V'5*&:2WD+V*YA^(]QX=C2E5*M-U$HGM\3EBDAP MPI1JYA.^%;%2R>98F@5'38`NP\M[LQU!7#9ZKE*H!6[J,AP0-3WE8EZ?6YE0 M<]PNA*8NOH#=2M++\,C7[(%I1A7D^8A-(A9"N"#K?1_D--2**\&9#^\WT7\M M;K,6=O$Q#:F4-#BE];B72S3+RL/F"BOCD8P-WF96Y1+-LMK!(RW\NZG@`13M MD]\Q;'9UN%7)-"&+<<^X)EUZ2-0X:=5CA2>$W-LF'VS*MUW8=8@EJ;)K67(RI/0PHV#);BU+E#'%(*$$Z@U- M>?7!1L':SZ;59,KG0@$>/!AX9'K15(,QU^*5LONU%H*=PZV\I3E`+G7BGG="-8(?R-GK;( MK5'?<+BR3MYU2LF;M9]CH`P$92BMTR\_?BFP=DM9FS6FXJBF8(%7:H%9NBMYE`.TSGJ+(YN"%3NE5IC%G."A M##")Q!(2K3#;+VZUCW,*=NV65S*ST%.X0K%Z`FB,RCI%L] M[.Q!L1V3@61@IWB%HHH!E@Q3QR2'Q0_WO M7^O14E<./R_BB#Q#HK@41Y;;E9,PA"D;D3/KT4H3R$[EF,8S(!0A(F);))_*-1:EY(L<\ M@H2$?&9SF3RJ MGB^;R4UDFOA0:GTYO;@DWT_NKHCK_$MN?"VG"-QWW'YO$6(D9TQC*[SW;&=H M][VO?6/(_,U90H(#HU0HX7B1]9:C'.O M)Y,'N^\XKOW]R]7$GT',*!=FB'RP"BNC4F?G#H=#.WM;-/VEY6*:1(4/SRYP M2F5\&^C28+WQP,Y?KC?E&Z37H!4?J2R2*^DSG4W&K43DU1;FCA;-J'E$W3[U MW-Y"!58Q3EEG)S*".PB)^<5)57H5::)`13(5#X"3*;9-`QO',XU!Z&,1G`O- M]8L9W"3.@#&(3'&60'ADQ?X#IV;>N$[N]L\FMOKE"1>8XF9]6,1^`^D)BTS/ M3F8`6FU#JVW<$ MHEVJ/3K1TG^/QN_34!?MVJ7;D@O)'8`]H,/B<`>&7.!FQYGT:U4O,G)8C>5EC._ M0^_`ATHB3J3`2S_?>QJE^:8BF]A9XA?X=8W7*5XY-Q;'5W-@'&1P,Y1(_'0* M-.`(HK)N7#I:[Y]2A0MM8U-[V<:N%>B>NW1&`QDSOB/TK];O0)QYHC'$6'#M MB%LU[9Z51=%NA)E!]UQ"ZN-=T0J;=YV3$+(TTO][4A;F569\S$66Z:[PML(- M"PTB@*`@-X(M5'KXV.@L2WB74%)8K5\R$9!<@E0TNJ2O+^@JN'UD+"L$O,:= M0^$).L`G`5G:DUR`?+@7+`TXOOG[';GKZ[U*$-XN053T.@YD9'ED*9N-02I*59N=[6N/BN1+6H'X#,VL\EZOL M43\)FI@.L_]ARG^K\,E_4$L#!!0````(`#2*-T//46*5[AH``.=F`0`5`!P` M;6-G:2TR,#$R,3`S,5]L86(N>&UL550)``/SKT!2\Z]`4G5X"P`!!"4.```$ M.0$``-U=;7/;1I+^?E7W'^:T5Q6G2K(D.]E=:Y--T1+E9846&9%V-K5UY0+! M(84SB.$.0%G*K[]Y`4B\S!M(>M"Y5"6AR.[!T\"#F9Z>GIX??GI:Q>@1TS0B MR8\GER\O3A!.0C*/DN6/)Q\F9[W)]6!P@M(L2.9!3!+\XTE"3G[Z^W_^!V+_ M_/!?9V?H-L+Q_`K=D/!LD"S(W]!=L,)7Z!U.,`TR0O^&/@;QAG]#;J,84W1- M5NL89YC]("]\A5Z__!ZCLS.'9C_B9$[HA_O!MMF'+%M?G9]_^?+E94(>@R^$ M?DY?AL2MN0G9T!!OVWI__6Z`_OGV?H@N+WY!HS`C,P;XU<7EJY=/"V;)39`Q M*?;WZ_.+-^>O7D]?75Q]_]>KR]>.5\N";)-NKW;Q=)'_(]5_B*/D\Q7_SRQ( M,6*/)DFOGM+HQY.2C5]>OR1T>?[JXN+R_)_OAY/P`:^"LRCACRC$)X46;T6E M=_GFS9MS\6LAVI!\FM&XN,;K\P+.MF7V:V20+R%)HZM4P!N2,,@$PZR705H) M_M=9(7;&OSJ[?'7V^O+E4SH_*6Z^N(.4Q/@>+Y`P\RI[7C/6IA$GW4G^W0/% M"S68F-)SKG^>X"5[V'-^H3?\0I=_YA?Z4_[U,)CA^`1Q2<9%K5UO*FWE2N>^ MP8XQC/?G%U&.3.ZZBY1H\6T`,:6NS/)4K(R7 MSV\0,0A]BF?;]N2=9)?4`*^(49P*+Z#5@RRCM]V]'-DJ9I+@7A6;,[P]KDPP=`)N:O[9%-;H\I< M<]4%P\26@#4=EM1'H@&T;0'-Y"^"R+(C0R]N\)KBD'MN:$>J;V'0>1+$..6O M6Y3R`$?:2^:W&*?&/L^BXW4@=8%?&4A-"F`HZH*R5?\YP?0Q"G$*@W0W>($I MQ7,^Z.,D%1&7R4-`\=L@9;/@X)G[$&8.MFO"[\CX!N.?[+ M]A%_#6"0N#>?1]S,(!X'T7R07`?K*`MB(VLM.CYIZ@2_S$NC`A@BNJ"L,V^G M@[C2V2!!N1H,IMWC+(@2/.\'-(F2I;ECU`G[Y)89<)E4:DDP;#+"J].H$$:% M-/?\%E$8949?[X_SCK_R^EP>,9V1;9QSCY?]E>8Y'?D=7X7+2+RYEQ?Y>\O7 MYC[=D'##!SWFNO63C$\X$C:0K<3(V)NE&0W"K&96"ST?;W-K,SB3G)4Z?\?; M(JW3J%!%3!=)9532/N;0D>+PY9(\GL]Q)$<-]J$^6+"O/DD4]W@9<>1)QM=R M:U;KQ7Q0R@:2,T@GTSEA+,`:<0))B9VL6%KOCA;7C*LTB`?)'#_]C)^UQC7D M_!)#`[/*C)H0(&JHD6FXD0LC(8V8>!?L*/JQ*6M685;U9U]<4($J*%#^#<23 M5P#2#A9`@ M)0F>BP6P>A3*0=ZO.VF!774K-<(@2.2"L!E2+R:F`>*:9Y^Y*BITY1HF_:D[ M4GTD\2;)`OHL\JWK:^8&.;\DTL"LDJGZZ9=&W/,\F0'E+';))L/F:C:-+ M0O41D)J47^XH(58I4Q$!Q!05+DWD(]]?D\MV1XCQ9A9'X6U,@GHP7B/CEPP* M>%4JE`0`$:&)2D,#*8B$9(=CS"X-6N0LI*--)O:1L;Y+WRT:E3R/-PX&U$8= M@P8@(CG`U(562QDDIT@JHY)VES$X.;&389];]IW*G3'(^H[%:>'6XW$-01!, MLJ'3QN7R^7<>GA,JW;.&1P/<.%.2[(8Q#:AJOFS%`+*ECLW&%1&K.3I3CK!- M9K2XC9(@"2/V!I`T,B0AM%/M9-.,@S'*O3,&O,N?_X[MR'H-8;#;,K@-*GYF3 M+ZI7:(QWU/6ZF[B-.94=QBZ*8&C7!FV#ADP)L1D<"OD'O%.'04CY1MVQ1]VB M*U.)^^_-]*";'5I3%@RY+``;N<"4K#'-GD_1..8I>IQ:G)1K[D7>!^%# ME&#ZS)-4"VSO*$EU>TQ-"CZ)90=>II9>&@RYK!!5>T6%$`PF]4(V7=W$?">J MW),:B51E]CG&8H*1S'LKOF;SN_B^>#G$JU$V6??N':UYK]W?D6]*I;L\4MM^ MW@!E#:BO^J0UK\T0I^D5*ET$S4M7@?$N:6VZP[KWPZSBD_,NX,L\-LF#Z9T= M0-:))FI6H=OHB5%,>@XPR#7*'C!UBH\H)7U2R0"US""%&!CBZ+'5^2(DUD"#"V4L!HK`.6-Z>A%@LV;/7U/18VS MI"ZFF?I))9CG;GS>T]&T-T208J?#*)A%<91%F)<)$0O>#R2>8YK*2C66`<1= MW2=9VAI5II.K+AC"M03<\)8'O;>#X6`ZZ$]0[^X&]7_Y,)C^!HZ<;M%]DT)' M!'2(\^NE(9*L7<2_I`C$Y6$30[))LG0S&.=`]5-5I;#G$(,!<"U@H)`$ M0R(CO,8"8RZ,*62&76.16A@2D8P(%5SB\JC_Q,M+ M02D!=;/!4W*/18AJ'%`[F4P*7N=D5N"5^9E6&@R?K!`;\[8-1AE!N0K*=6#0 M:I!DF-V@S&E\TPG[I),9<)E*:DDP-#+"T_5)A1*L<>Z.9&(Z,21!XN8I&35\ MTLD!>IE3!G$PQ+)CU+G?8@\527A.7\(;06M(+'-VH[KVG]P<)\`>D[.K)-,&:,"1'8YY\X,2;)$4TQ7`$,$>6V_(0Y2/)K%T5*L M'.O"X5IIO]E_1LC5?#^EJ%W,[I8 M2`*O5VF"TS`#&A]:+]I"6:9MMS#[!UB*;;WX*H6`>+UCFF>C"#/$/@I]*0-7 M);]YB2X&5#,331I@>.4$L[DYH4@NRLL8_/?%RXN+2[0.*'KD39RBRXO3BPOQ M+TIEC8-@DST0&OV.Y^Q7\0/?TW!9%HGDT47\>_)U*B(!'1_X:-3HZ#-*% MN09Q,+2U8S0=%:DB[.OO#8Q]B;Z[./WK=Q=;VK*/?ZD*0^:NYC@"W1*H3AK` M*3#*166U*!BNFO%9SGQ!T,]\J>RX$(>*:&Z#BV*79\'H#3&="]/4`L,[9ZB* M]]HQW(UJI=E-)IM,AZHFQ(^(2=)QNX4@[(LED.= M/>S]&N]VFG/(#3%/B?9I&=G;H=&^:2MTQ4V>`GI%U#>A,U."U,K`Q\X?+O[8!U(Z* MP;8TP4;!KH)1>W.P332U2D)P8:12T*WE8.VDV5%(M,TP[:`&9LKCCE43*BT- MRH"&XD;E9>LX;-3HB'0N([!!'%[79P=K9AG0@;=%!78WE4[YYK[P`Z_V>@N0 M3DP#-[H.DI"L\+96KB710BOM=WN-$7)U?XU2%`RMS/@:I\D(:;0K;`RMA/$] M?L3)1IO%M?O9[XI+%51U747^!H80-4!U!N0_PWC:UR3-1HMWA,S3"8GU?E!- MRN]8I(18'7XJ(F"8H,;5'&124=]\$L10LO=$`<@Q)0OMFFQ%PB<=%-#*5"C] M#(8&34QU"@@))$70BR'[`\BRSXBY\`$_\*S8I6ZKW::7]UK!S0:[4L=-)PR& M0#:$C9INA?RVN`"0;,YR9!TXF!H9,S*LP"M9%EII,/2R0FR<]B(5!+&V M*C!8]0XGK$N-^5LR7T5)Q+O?+'K$9FI9M;PZ3FXF5)PILPH8IKGA;#A=4DOV M8Q4]&)QKC/JNWD''OI:3CP6&.SIDZGU63<\*&%=D?&FH/TE!*=D)7YI0E8S9 MB<'C3`-;8_\WSDJEI'=B MJ*$VZ%$5@W:VB1YBLP!.FB(VM[_'H=PZ!&IN7V33FXG3D.JB;J"!,#41:&11 MPVNN8^85`N'U+G(8M`^OG3DL%N\$UA!3P:29%"F]#QB,8`ZX=4I4D_%:%U(% MKU()LBP`AADJ5*JI#YP)SZ\X6CZPGJ_WR`;!);[;K&:8CA8R$6@@=F"_#=(H MU!CLKNZ3/6V-*A/+51<,YUH"KM.Q4$>Y/I**J)0$=HI$`R(@>!/%FPQ*+F&Q M#[?(OA4PV>PP!ZFY858MGU1U-*',4(L*&&*ZX:SSL4$U5+23)P"@-1M418,P M2+A-61LM^)'%MS'Y8@L8F57\;G>V@Z]N8M;+@R&>`\C&$MLV[Y`LD#AY6FB! MRT)DS@-'-Z;D,9JSCOWY0XKG@V0;2NV%6?0HM[F:*;A/0YX=P#T-K7F)+5L! M0^*]H3?2Z'J3?Z#;X>C7";J]'[U'HW'_OC<=W+U#O>OIX*/8U@PD(MJ;_^\F MS?AK*"H_,O,'[*U,^7$/G#)1C"L.]I0K/.K?HMFSXALU]H"<X!N=(BE)CB!*V?SPN!M,>?% M<['1@4U\V8B!5^N8/&,\P?0Q"G$ZI4&2\BZ9))9LS'U;\SJ;/,SDRD1SOZ;` M6A"*BB8.Y?HJ7$:"P9<7.7_?7[\;?.)7"MCS9C/HW>[0 MT5IULH:#O`\..L/F++,*=\XC5X3-0`8305(&UAHD\XHI/QSD!LO_,S^8KX_M MG&%Q%C<_.*M4_Q\[[-H]K%7/NWN/<0MJNX`/:;)SGA_7CD;LXX']Q4L))R@0 M#0@'-P9WAI'&^N+T9@&]W8VKJ0)@N=(8!RI7]*#S506V3LH7A>ZWG)2N-K)TJ MW>;^-%0[)Z3&&"LG:WJP::D&Z\Y,@.>"-^U4G$_M?(^4NMURTV".F9P*1<#L MU*/=DY[H#-WC("Y.''^&05?W5<6#ER6AKAL&; M$,M%NZU9NV9`$WB0/.+T&`D0QH8`$-K!4`=B&UJ!3G`[=%L"Q.#N8W]22X"` M06[F1!07ZW)C9E#&M[T52W.:>]:F`:^EBEL;5JE:[*P-AKRM M(3=*&#,T#]S+(`MT&SWQ_%Q`H0%F38CQ/+UE3YF7YQHM6C.U30M^JVJW-JU: M8=M9'=H&I_;0&XL/3`LF8=T'DX-'(ZANPF'N`9B>M37D-G[OMI4_BM][&R5! M$A[![S4V!(#0#H8Z$-O0"G2"VZ';_-[;P5WO[AJDWUL:>>Y(ABT+#'KQKAP% M%6B=5U"6!4,Z"\#F`1M2'/%;@H0"K`6#LCWW>)U[XZ-%2W;I5;MBFLT8'>MT M>B`9:`';8&,NS`LT`.>B,J/'X8YH]+IBH=$,'0652B#Y9T)J[@J+&5#Y;&P8 M+,RW*XPH7XW(_Q"QB50;9U'Y1,:`1*\(@U3-A=^B8$_N,N@WD;BI=KM8KS?&O%;?U`-#Q!9@M;68 M>G,>YLD(1.]0N`@RL?]F0_GIV>)P,'&J7*E/UL4EW=6]GZ+>PJC&.>D.NF`8 MVA*PYBPMF;B?[_``6VG./3AU<'0+:MCQL'`C&-:VAFR/H[.!?ZL.+H#.H?:2 M.?\?7\9Z9"X)SY$5KVI]C-'#T+:@_C*@=%M=`'P^`]0#CF_^>#?0WP9-M6P%L]UC[[WNF!>G3P-^MU+&I+!7%1CFJ0+`A=R0.& M+*7"7+6]NO?M3*IX]VZJ8`:9=G@;"3$?QN-A_SUC9V^(;@:3Z^%H\N$>RK+K M;B(=Z6HE5D6Z*!A=!J>J%LU_!\,6!:A&]R5<9O8[DI-%E#U@]!L.J-C6#[-\ MM"QH-`V>^$J<@2LU*?\')S<@-@],WHH`(HT*5SO>"&V?M2!N"2U*4-3,"Y`X"AU*QAH4O-8/M`*O5`O42H-AH!5BHQ+@5@$5&N"J=O.:]BG? M3H-3'DC(SY6>1,LD6D0AWUO3L'J*G[*WL3XY\+`F?5+T&,:727Q(>V!H?@0C M&FL9),/H$IVANR#;4-'C[M;@1-VK4O-(\=K`>%?RY`P^]HB2"D%LZXN-&IYW MN=J@U[:UZL3!\-2.49&,+33D\=&Y#K@>N58CJ3"O4I[F)DK#F*3L7;)UQGNW MUH&KL*_)"C^B;5-@6'T8?F7'^XIUO`"+$/.BRMSOCN0\573USYJ[HI'UR5$C MW#(#E8)@^&5"IV3/:SYLP\M-Y*NSV;-E^*T+>3T]2PFPV,:L1*G51!L/`MHB5_=9WK-\J-_0- MDDW!("KK@ODB:C&[NL=91,52_LY*2]_6J@6O"7_M3:ND#KFK@R%L>\R*3.MM M"V)ZLFL#[1H!U]^.&69ILZ@5/"8,W19X'GYM,5G9OSFO<^D#C:Y,M/=L"PSU M#S1`V75_S[KN?A[91WD;B!?Z`3)SV69%.'?61HU.`9ST1$W'$2 M5@),=B>T31N>W=#VYM4<4?<&P'!T']2J;7]Y&\(7K;0"NLQ(86KHB553F M$7JG8EJ35<\V!=>M:JUL,;-OU00(AKK.X%OHP^=MR\[T#0^RYG6E?L6S-,J` M+`^-Z#)(\O($K'=/21S-B_!<.;-EM,BWA0?QA'V#Y0AC[F*/U+9/DA_U=I39 M?Y2&P;P6Q[2F_KZ4VSY%E=9%]U]N7Q:JSJ^`=I<`-S(,(]9QS*/LV7TD,*MX M7=%W`%]9V#?(@Z&P`TAM3_Z.\)R[:W[G*)"B+KM

);O69E5X<;5'ZHK4>9]2KB;V*RWYGBC$/J3Y M3JB78![:0?N9X3^\)MI6&\T*733&E)?NP/..:OVPMW^SVHA#)F_PF@VA42#+ M];*^))\"]5:$9OD4IM7)0\=JVW,I*(L;44 MU0*+I]7(8F=EI$2UR"&O=C::Q=$RT%;8U(@">O`VA,WB&$(>"054TNCH8?"] MW?F1[JH'4/H9T$U7H5(5>CXM3JOOZ.9:CLDN'S`-Y^:J4-5O;DFF^UO+MR,V M4H0M]UNI`_,AF*$:GLRVLS=G.7_5Q91\GY$P8!S0$1712UF[@KDX8A>_>AG% M11/0`VL)N+D"6.S($OJG_"1N[K_+-I!HA/N$L@0.B,A=GU5)!?C#4B%U?5HEW:YDPN*$TEYN&\32*7_1U.,`WBO-RA^WQ2&DXSV@?U&YGJX$,O_S!BO'!X0%5>Z%1.`T2V2'XQ&4/>7@[MKG>*^*D7O++.[IH*PI6_&K)/ M[.OB*_:?69!B]LW_`5!+`P04````"``TBC=#I_V".*(1``#^[0``%0`<`&UC M9VDM,C`Q,C$P,S%?<')E+GAM;%54"0`#\Z]`4O.O0%)U>`L``00E#@``!#D! M``#M74MSX[@1OJBS'\NQN3E,0"_/,PB[PZSA-#XPTY_=V_' MPW%`0Q)//^Q\&?F#T?'Y^8Z7I"@.441C_&$GICN__.NO?_'@Y_W??-\[(S@* MC[P3&OCG\83^[%VB&3[R/N$8,Y12]K/W&XHR_H2>D0@S[YC.YA%.,7R1O_C( M.]A]C3W?UV#[&XY#RKY7T^_G3N_?'Q^L+K[_W;&P8I'8/`^WO]_=V'"6AR@E(H!?\?]/8.>_L'-_M[ M1Z_?'?4/--^6HC1+EF_;>]@K?G+R]Q&)OQWQ7V.48`^@B9.CAX1\V"GI>'^P M2]FTM[^WU^_]\?EB%-SB&?))S"$*\,Z"BG.1T?4/#P][XMM%T;62#V,6+=YQ MT%N(L^0,WQ)%^9(D"3E*A'@7-$"IJ&&-K_%J2_#__$4QGS_R^_O^07_W(0EW M%L87%F0TPM=XXO&_4%.6;XTSEN`DHED\Q5!#9CU>H`<@93,COY:_]28!I!]1Q"T[ MNL4X39I$DQ;>DBQ7B($1;G%*`A09"2:E[$Y*[G"8`S2<#.>\.0)<&BVG)-J" M;,EP$R%\T$@J.G26@RZ ME?F=/\K&"?Z>P2M/[_A[=02MI^I6ND/_$P4#@!T"S&*PR!F)H=,C*+JB"=&) M+,RX=-SR[_G7.,"5AIC1&#X&>=^CU=_SO055^2.,A[R$9HG.-B=TKM>B$F/R\\_"$7\ MO7X1F/\$C[[F,ESC*>&OCE,^&))(#D7E)5<%+=>*`0L\RJ!O`<06/!$+*G5A M?2Q1E.C-1?CI![7U@3AM4L@-.ENK^/]'4?1KS&]CT<8)33&X7F29)BI.N!:$DUDWKB$ MC)85[,'S&XU@A(+8HYB@2%2PK!75A..M>W#4:&TQ/,W]]QK/*>/CQ7RZ1!FE MUE!H@O+./5#4-K"'C:@CQ]"83BE3#AQ6"FHB<>@>$E*-[0%PE8TC$IQ%%,E& M_4NI*\6TQVSN65^BKL6&B`^1CH#)[5="**XKK@.#GTKE7?/B8\+-=&I%18%P\G!^,UJDO0>-]; MT^X"'FPU*2Y?*5#)@N][OK><>H;/QS1.:$1">!)Z!;V7,_#^\25&64C@FW^V M2H>7Z]@$)6.!5Y;X4X3F>47#49HLGJS6N.+QU](D_MJLB2)[7I#K46_L0NW5 M&R0)V+I9D=5RME+I1G:M^E&-)MTW:)NB483NNJ"L%;>685=;6`9#C:INH,'7 MQ?!):/C#UQO-^2=&$UD\5Q"I:*REF76M3K55 M<0FF00"!9Q;Q\.P$@TVAG^46A<\1%J:-P\&,)YC^%,^O&)UC!H/N".4Q[D(U MA;=U]@9K^>QV5:!KTY8J#'#+%Q=>Y.:NT>\P#]MC/.5"B+)6*UNMBI=848'4 M5-:RZNTJA8X)W&@9ANDM9KJC!VEA:QG==M`H%'8#$6@Y^`@HR66L!V.UG+WD M;CL@Y'JZ@4&3[4UMON6H7[^S,[%1I)!5&>-+R^OBXTITIM;;&6Q8!M'\ M6E52PE-'HHM0]PL@6B.DUMX-D$XR?$.OL1C\72&FA9**1AE9?G6Q4JF^>[S[(\]WSQ8X6^QGO$SQ.FP._+6J9$%@L`E(O;%_.=JKI=$'K?JWN!J#I&<,-X$K+[_51 M4Q+I0K:UB9)6D6:S&=S`:Q"&8HDKBJX0"<_C(D16I';K"'1QVMI@K0U.#>J[ M@=$U3A&)<7B*6`P5**FL\YF0@"AZ,!U:7>2<&LOI&\4-$-=[WO,XB+)0'"7' MA*G3E)%QEO*DVPWEAJ!Q"D8$4::+]*E)J-*.OVYE<&HXV*UQW:@P31/N[1'J@,5Z[N>Y,>05K9`'9AL@:KP^_\VJ&<:P8#5 MATS('(IX\`HSL3M5=R133_]RMTV96>A'2$%4--9*G7':M-U;2YIUB;I>DM/&B$I];T)E M,/5*-9AZ^H).O"=.CAPLD9_&OI2Q>1!52V`UV7F'XTPUP_I4PO+8I\'>:PG+ MJF*N]&,).,4G2L-D1"-EW[52T/:@P\SZ-7JZ`8+8IGW%Z$25R:\4LAWRFQE? MHI\;AB^:\'AZ^C#',70<&AM/ZTEL1W!FH#3J[@9$Y9WL*QO850O<%$2V0ZYF MPZ_M3FVR@!M0C;"83@$9/R/V#9=45.1Q%32VCU\P!:I9?S=PRN\_C'A="FZ%\ICAJ2% MK1^2T!J1=94=P82?IY$+QP\ZT0_I&NBL'ZU@C)26(1P"3:-%JQ:S=^:JF8DE MN#C:GG'1BNZP,0Z0%K9^H$5[2.1ZO_SCKQ8+FQH!72NH"^;V!DEMP*S1]^4# M6;*&5C?FP$$EALF(=07=:!@@\.[J"% MGN++;#;&;#C))YS$)3WA1Y20H!X:?0[6SU0P0\W4-&X`NEBOO9C6%R)"$W]" MHBQ539XW$EH_;,$,/DU#N#:#*KW=O3*#^EIK!C7A4ZBQ\OQ9.F:^T8EV_!R9W%J+9KK76%+B[G1 MO&XW7MD64!M8_<5$,H/POUF2WT//MSR`NN=0.1-^:E4`_Y,(5X2_H9UY[O;? M;'LZNH6C/Q<<;E2^\ARBWK2I_>6DSX90_72K6R"69WZ'DY-%)H.B>,C(E,3B MBS.,$^7IYF9<;*]IL%0)VIC:C4JR&$O@4"QV@@$%V`W/YA%]Q'B$V1T)<'+# M4)R`]J!$\PQ]6X:VUUE8JCH;`K!I+9H%T_RNN_Y>43/X+7%?>3Z`[P.$#O)I MV>YP7G?\%Z=1D]A>G/'"^4:FSD,\&[@K9\6[2)M[\!"M^T@;VY&I^$_C^]PTM'LC9*7]15=SUH=-,SJ1K6` M.$0,>V_H(/B>$89;W)%IPL/Z6K`-`*.MM78*<48#C,/D#"PS0A$>3MI`;L+$ M^O*Q[C`WM]W+7R^H;[TN>@P'KMWJK+J86\Z-)J)&[N),ATYB!24OZ_=%/6NL MH&%6-ZI%N?43E_LT)G[J*:POC]P`C/H^0685]["[QO,B=AE.S'&LI[:^9G(K MF#99RSU\I3-+>N#6D%J_X6HKR"KMY`:LQ6SDD/&44O&/&&[DARKQFVN@+\IF M..PKNF`3)KI0;VVE3F=0M["=&Z"76YQ"0BYL/<"U!+I@;BWITAF8#39Q`[CU ML''EIDKE6BH]:NO7V'4&J8FUW,!7=!#Y9IB3C/'SX,5Y@N)DR5++HA@'ZW.P M?B=>9SB;6LT-K/75[V+LZ\#->=WUN\:6%1O:,4 M8G?[*?#GJ")?]_4KB?L9%&V5.ZDF3ISH/,KF\TBL!D718C7H>3RA;(8TKR'1 M96#]XL'N8D,SF[G183P-4XABBWFUE/6+!TTM+3\,I:RR*V#P5?DWZ($G9M5X MK!2T?L?@II!(%7_.+1]GE"WVH$CL7KO)H4)F_;[`EBCH:>>2IZC&X<E;3+M4APM7F/]"L'-O'0K1F\=+<$KQC3!#L1* MAOO:H)G[B&.L/--\$YZZM6QKNTPVK&4;F].1DV'X!&O?OT1IQJ!5+861<3@B MTYA,2,#76>6;*,2%G!$)RIFDRN$Q;SS?.R%)$-$$^,$_G+W7YQ_$&_BI,4_O M\%`<>J6W>$^O\9;OL;AA>TUIC<,:%#06O9^?3I3PM7,E)VL`^`8JT\=(.8^] M&5?+I\LTH[OB\EW8T"&GW_<7^^+Y1GBY.[^5NO,^?UK0>H+8ZFIJ/G'%FRNQ M_0=%&DZJ)+)Y0D1UJ]I"O,J6IB%@\8U,(T.POJ^5L9SHJ&'#C&O55!BPL^Y(<'UD: MPL0B#OG4:_^T&,D68U:^UT8>(O;WI%[%#Q%=\/`*)E[.Q>9E>3-^5L\B7$S:I*?.JFUEZ& M$[WU2Z$Q7W1!16B-X]K,:']?ZE1OQ0';2U8B(5IE9K6[K%/1L,,T86/Y@O!& M235\TY2/_>[1'&?)9>+FIG/(H]_YHVR20A_XG"FT(-"4! M9CSR+I:ZH0BB;U(YW;GBH*^D#LIS/X*?5S`4/>V2I;?D:?&2*#9%<7%F\=.= M&_FHHSSG-)PLQ7ZZC4/CEL1NV-O,PQ*HP2%)'XU\74UEV;<[Q7PU@:MA+H?\ MO;_G7^,`5V91&8WA8X!G]?WQ:_F"`YZ5RME5UA14&;HP.W)\B\`4/&@Z98RR M8\H8%@M&C.9+=+A8W=EU7X'-D550)``/SKT!2\Z]`4G5X"P`!!"4.```$.0$` M`.U:W7/:1A!_;F?Z/UQY:?L@A"#^@$`Z#C8.C6-^&0&4C'!.Q6G6JL0X*[P&)]T M*N^'UM&PV^]7R)^O?OF9X%_[5\LB/0:^UR+'PK7Z?"Q>DG,:0(N<`@=)M9`O MR0?JAV9%])@/DG1%,/5!`Q)B32W2J.X!L:P-8#\`]X1\?]E?PEYK/6W9]MW= M796+&;T3\D957;$9W%"$TH4EUKON:9]\?'UY1IS:WV3@:C%"@^LUIUZ=C]&3 M8ZJ1"^\;=JUIUQM7]5IK[[#E-#;4IJD.U5);;5Y+_C83?\>4NQ2V;S]\5@?S M2_9Q,N"'X?FG-SUW2(/N6WK17'SVONY_NIG/_O&_CJ^"MP>+3[$#(YA3$,??;T-J<_&#+P*T51.0)OR M4%/JP@:(:9U1S@66(VZ_9,6L3:<,ZPT7?FJ;Q+2D\.%J,05B+G#3/8QO&&PL MV-!8>\2]$ZZ97ICJE4&DI4*8UZF47RJ/7)Z*Q32)RP+N;C&6\!N/!U'0?J##9`\6D M\A2\*$M!1A!CDD'^V!2K>5"#<9>JZYXO[M;SD".5YV%OHSPHDP@#22+,'XG` M1)P+#8YUCEVGA,'XR-5LADI!X?$[9!..381+\3!V7933V.1?8%A=I,>Y>K1T M>3KWS>F-K:PO%`+CC=%#S/$>JS)YS)1%Y_N*.I+I(ZG"GK MF5M;+\_)06%.3#.0@A"#LM.!;ECF%P_Q!1WYD`5Z;;T\T(>%@6XD%XHD*#L= MZ!?64`OWYEKX'DAUYT6@ZM83A2O12!2G$%2Z M]U#NS5P01$Q!FM=F.S4^!=!,&_&+%37$Z,&BL9_"99^.MG491*EDU=UDC&5GE7;T](V M0#87W.)A`)*YFU7*JN1Y+&A*I6E*Q=G_3F,>9\BWK$@FXE&K8Z;H7\IFRD9[YNO%=14]2+Y3)E#M^ MLL8+9P(::-XADC$F#$=-XQA`=-Y>*Y7.L).00Y8RZ4NY?G^^]=;-MQ MK>/EOU!+`0(>`Q0````(`#2*-T,NECXM73```)#W`0`1`!@```````$```"D M@0````!M8V=I+3(P,3(Q,#,Q+GAM;%54!0`#\Z]`4G5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`#2*-T/<%36+*04``+0>```5`!@```````$```"D@:@P M``!M8V=I+3(P,3(Q,#,Q7V-A;"YX;6Q55`4``_.O0%)U>`L``00E#@``!#D! M``!02P$"'@,4````"``TBC=#<-B.,;`$``!-'```%0`8```````!````I($@ M-@``;6-G:2TR,#$R,3`S,5]D968N>&UL550%``/SKT!2=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`-(HW0\]18I7N&@``YV8!`!4`&````````0```*2! M'SL``&UC9VDM,C`Q,C$P,S%?;&%B+GAM;%54!0`#\Z]`4G5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`#2*-T.G_8(XHA$``/[M```5`!@```````$```"D M@5Q6``!M8V=I+3(P,3(Q,#,Q7W!R92YX;6Q55`4``_.O0%)U>`L``00E#@`` M!#D!``!02P$"'@,4````"``TBC=#YY7`)"H&``!,)0``$0`8```````!```` MI(%-:```;6-G:2TR,#$R,3`S,2YX`L``00E#@``!#D! 8``!02P4&``````8`!@`:`@``PFX````` ` end XML 41 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 10 - Recent Accounting Pronouncements
9 Months Ended
Oct. 31, 2012
Accounting Changes and Error Corrections [Abstract]  
Note 10 - Recent Accounting Pronouncements
NOTE 10 – RECENT ACCOUNTING PRONOUNCEMENTS

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows.

XML 42 R15.xml IDEA: Note 10 - Recent Accounting Pronouncements 2.4.0.800000015 - Disclosure - Note 10 - Recent Accounting Pronouncementstruefalsefalse1false falsefalseFrom2012-02-01to2012-10-31http://www.sec.gov/CIK0001438901duration2012-02-01T00:00:002012-10-31T00:00:001true 1us-gaap_AccountingChangesAndErrorCorrectionsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: bold 10pt Times New Roman"><font style="display: inline; text-decoration: underline">NOTE 10 &#8211; RECENT ACCOUNTING PRONOUNCEMENTS</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&#8217;s results of operations, financial position or cash flows.</font></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 01 -Paragraph b -Subparagraph 6 -Article 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22499-107794 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22580-107794 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Accounting Change -URI http://asc.fasb.org/extlink&oid=6503790 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Direct Effects of a Change in Accounting Principle -URI http://asc.fasb.org/extlink&oid=6510796 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Indirect Effects of a Change in Accounting Principle -URI http://asc.fasb.org/extlink&oid=6515603 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Change in Accounting Principle -URI http://asc.fasb.org/extlink&oid=6507316 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.10-01.(b)(6)) -URI http://asc.fasb.org/extlink&oid=6958853&loc=d3e46468-122699 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22583-107794 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Retrospective Application -URI http://asc.fasb.org/extlink&oid=6523989 false0falseNote 10 - Recent Accounting PronouncementsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note10-RecentAccountingPronouncements12 XML 43 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information (USD $)
9 Months Ended
Oct. 31, 2012
Sep. 05, 2013
Document And Entity Information    
Entity Registrant Name MEDCAREERS GROUP, Inc.  
Entity Central Index Key 0001438901  
Document Type 10-Q  
Document Period End Date Oct. 31, 2012  
Amendment Flag false  
Current Fiscal Year End Date --01-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? No  
Entity Filer Category Smaller Reporting Company  
Entity Public Float   $ 52,708,863
Entity Common Stock, Shares Outstanding   52,708,863
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2013  
XML 44 R1.xml IDEA: Document and Entity Information 2.4.0.800000001 - Document - Document and Entity Informationtruefalsefalse1false falsefalseFrom2012-02-01to2012-10-31http://www.sec.gov/CIK0001438901duration2012-02-01T00:00:002012-10-31T00:00:002false USDfalsefalse$AsOf2013-09-05http://www.sec.gov/CIK0001438901instant2013-09-05T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1MCGI_DocumentAndEntityInformationAbstractMCGI_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2dei_EntityRegistrantNamedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00MEDCAREERS GROUP, Inc.falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false03false 2dei_EntityCentralIndexKeydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse000001438901falsefalsefalse2falsefalsefalse00falsefalsefalsedei:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false04false 2dei_DocumentTypedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0010-Qfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:submissionTypeItemTypestringThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".No definition available.false05false 2dei_DocumentPeriodEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002012-10-31falsefalsetrue2falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.No definition available.false06false 2dei_AmendmentFlagdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:booleanItemTypenaIf the value is true, then the document is an amendment to previously-filed/accepted document.No definition available.false07false 2dei_CurrentFiscalYearEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00--01-31falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No definition available.false08false 2dei_EntityWellKnownSeasonedIssuerdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.No definition available.false09false 2dei_EntityVoluntaryFilersdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.No definition available.false010false 2dei_EntityCurrentReportingStatusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false011false 2dei_EntityFilerCategorydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Smaller Reporting Companyfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:filerCategoryItemTypestringIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false012false 2dei_EntityPublicFloatdei_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse5270886352708863USD$falsetruefalsexbrli:monetaryItemTypemonetaryState aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.No definition available.false213false 2dei_EntityCommonStockSharesOutstandingdei_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse5270886352708863falsefalsefalsexbrli:sharesItemTypesharesIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.No definition available.false114false 2dei_DocumentFiscalPeriodFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Q3falsefalsefalse2falsefalsefalse00falsefalsefalsedei:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No definition available.false015false 2dei_DocumentFiscalYearFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No definition available.false0falseDocument and Entity Information (USD $)NoRoundingNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/DocumentAndEntityInformation215